{
  "meta": {
    "title": "Medicine_Test-_2",
    "url": "https://brainandscalpel.vercel.app/medicine-test-2-c94b9906.html",
    "scrapedAt": "2025-11-30T12:49:04.864Z"
  },
  "questions": [
    {
      "text": "A woman presents with insidious onset worsening exertional breathlessness and occasional exertional chest pain. On examination, she has increased JVP, peripheral edema, ascites, and a loud P2. Her investigations are given below. What is the most likely diagnosis?<div class='question-desc-html'><ul>\n<li>Chest X-ray - enlarged central pulmonary arteries and vascular pruning </li>\n<li>Echocardiography - hypertrophied right ventricle</li>\n<li>ECG - right ventricular hypertrophy</li>\n</ul>\n<p>JVP: Jugulovenous pulse, STEMI: ST-segment elevation myocardial infarction</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Acute STEMI"
        },
        {
          "id": 2,
          "text": "Pulmonary hypertension"
        },
        {
          "id": 3,
          "text": "Left sided heart failure"
        },
        {
          "id": 4,
          "text": "Hypertrophic cardiomyopathy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most likely diagnosis is <strong>pulmonary hypertension.</strong> </p>\n<p>Pulmonary hypertension (PH) is characterized by an elevation in pulmonary arterial pressures and increased vascular resistance caused by various causes. It is defined by <strong>mean pulmonary artery pressure </strong>(mPAP) <strong>&gt; 20mmHg</strong></p>\n<p>Clinical features include <strong>dyspnea, edema, chest pain, </strong>and<strong> syncope</strong>. It is irreversible as it does not have a curative treatment and thus can lead to decompensated right heart failure and death. </p>\n<p>Clinical signs may include <strong>right heart failure</strong> features such as <strong>elevated JVP</strong>,<strong> edema</strong>,<strong> ascites</strong> as a result of disease progression. Chest auscultation may reveal <strong>loud P2</strong>, <strong>S3</strong> and <strong>S4</strong>. </p>\n<p>Investigations of PH include: </p>\n<ul>\n<li><strong>Echocardiogram</strong> with<strong> bubble</strong> <strong>study</strong> - it is an important <strong>screening test</strong>. It usually shows a dilated, hypertrophied right ventricle and increased pulmonary artery systolic pressure.</li>\n<li><strong>Right heart catheterization</strong> - it is the<strong> gold standard</strong> <strong>test</strong> to establish the diagnosis of PH and to select appropriate therapy.</li>\n<li><strong>Chest X-ray </strong>- may show obliteration of retrosternal space, enlarged pulmonary arteries, and peripheral vascular pruning.</li>\n<li>ECG - right ventricular hypertrophy</li>\n</ul>\n<p>Other options: </p>\n<p>Option A: <strong>Acute STEMI</strong> would reveal <strong>ST elevations</strong> in ECG. It is an <strong>acute event</strong> while this patient has had insidious onset exertional chest pain. Pain is classically described as heavy, squeezing, and crushing. <strong>Cardiac biomarkers</strong> are also raised in STEMI.</p>\n<p>Option C: <strong>Left-sided</strong> <strong>heart failure</strong> is characterized by pulmonary edema, dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. Elevated JVP, weight gain, gastrointestinal symptoms and ascites are signs of right-sided heart failure. </p>\n<p>Option D: <strong>Hypertrophic cardiomyopathy</strong> is the most common cause of sudden death in young individuals. It is characterized by exertional dyspnea, angina, left-sided congestion, and left-ventricular outflow obstruction.</p><hr><h3>Related Pearl: Classification of Pulmonary Hypertension & its Causes</h3><p>Based on underlying mechanisms, the World Health Organization has classified pulmonary hypertension into five groups.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Classification</strong></p>\n</td>\n<td>\n<p><strong>Causes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 1</strong></p>\n<p><strong>Pulmonary arterial hypertension (PAH)</strong></p>\n</td>\n<td>\n<p>Idiopathic PAH</p>\n<p>Hereditary PAH - BMPR2 gene (most common mutation)</p>\n<p>Drug or toxin-induced PAH</p>\n<p>PAH associated with</p>\n<ul>\n<li>Connective tissue disorder (limited systemic sclerosis)</li>\n<li>Portal hypertension</li>\n<li>HIV</li>\n<li>Schistosomiasis</li>\n<li>Congenital heart diseases</li>\n</ul>\n<p>PAH long-term responders to calcium channel blockers</p>\n<p>PAH with overt features of a pulmonary veno-occlusive disease or pulmonary capillary hemangiomatosis</p>\n<p>Persistent pulmonary hypertension of the newborn syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 2</strong></p>\n<p><strong>Pulmonary hypertension associated with left heart disease </strong></p>\n</td>\n<td>\n<p>Left ventricular systolic or diastolic dysfunction</p>\n<p>Valvular heart disease</p>\n<p>Congenital cardiomyopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 3</strong></p>\n<p><strong>Pulmonary hypertension associated with lung</strong> <strong>disease</strong></p>\n</td>\n<td>\n<p>Chronic obstructive pulmonary disease</p>\n<p>Interstitial lung disease</p>\n<p>Sleep-disordered breathing</p>\n<p>Alveolar hypoventilation disorders</p>\n<p>Chronic exposure to high altitude</p>\n<p>Developmental lung disorders</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 4</strong></p>\n<p><strong>Chronic thromboembolic pulmonary hypertension</strong></p>\n</td>\n<td>\n<p>Chronic thromboembolic pulmonary hypertension</p>\n<p>Congenital pulmonary artery stenosis</p>\n<p>Pulmonary arteritis</p>\n<p>Pulmonary angiosarcoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 5</strong></p>\n<p><strong>Pulmonary hypertension with unclear and/or multifactorial mechanisms</strong></p>\n</td>\n<td>\n<p>Hematological disorders (chronic hemolytic anemias)</p>\n<p>Metabolic disorders (glycogen storage diseases)</p>\n<p>Systemic disorders (sarcoidosis)</p>\n<p>Others (tumor obstruction, fibrosing mediastinitis)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Drugs used in Pulmonary Arterial Hypertension (PAH)</h3><table>\n<tbody>\n<tr>\n<td><strong>Drug Class</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td>Prostacyclin derivative</td>\n<td>\n<p>Epoprostenol</p>\n<p>Iloprost</p>\n<p>Treprostinil</p>\n</td>\n</tr>\n<tr>\n<td>Endothelin receptor antagonist</td>\n<td>\n<p>Bosentan</p>\n<p>Ambrisentan</p>\n<p>Macitentan</p>\n</td>\n</tr>\n<tr>\n<td>PDE5 inhibitor</td>\n<td>\n<p>Sildenafil</p>\n<p>Tadalafil</p>\n</td>\n</tr>\n<tr>\n<td>Soluble guanyl cyclase stimulator</td>\n<td>Riociguat</td>\n</tr>\n<tr>\n<td>Calcium channel blocker</td>\n<td>\n<p>Nifedipine</p>\n<p>Diltiazem</p>\n<p>Amlodipine</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2126",
      "difficulty": "easy"
    },
    {
      "text": "A 50-year-old female patient presented with breathlessness and fatigue for 5 months. Chest X-ray showed left atrial enlargement with straightening of the left cardiac border. Echocardiogram showed reduced opening of the mitral valve during diastole with thickening of the valve leaflets. Which among the following findings can be heard during auscultation?",
      "choices": [
        {
          "id": 1,
          "text": "Mid-diastolic murmur"
        },
        {
          "id": 2,
          "text": "Mid-systolic murmur"
        },
        {
          "id": 3,
          "text": "Pansystolic murmur"
        },
        {
          "id": 4,
          "text": "Early diastolic murmur"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>mitral stenosis </strong>(MS), and a <strong>mid-diastolic murmur</strong>&nbsp;can be heard during auscultation.</p>\n<p>MS is a valvular heart disease, most commonly caused by&nbsp;<strong>rheumatic fever</strong>. Other causes include:</p>\n<ul>\n<li>Congenital defects like cor triatriatum and parachute valve</li>\n<li>Mitral annular calcification with leaflet involvement</li>\n<li>Systemic lupus erythematosus, rheumatoid arthritis</li>\n<li>Left atrial myxoma</li>\n<li>Infective endocarditis with large vegetations</li>\n</ul>\n<p>Chronic inflammation causes thickening of the valve leaflets and shortening and fusion of chordae tendineae, leading to the formation of a <strong>funnel-shaped</strong> or <strong>fish-mouth valve</strong>. <strong>Calcification</strong> immobilizes the leaflets and narrows the valve further. <strong>Thrombi</strong> are also commonly formed from the calcified valve or dilated left atrium (in atrial fibrillation).</p>\n<p>Patients present with <strong>dyspnea</strong> and cough in early stages of the condition. But as the disease progresses, daily acitivities are limited and the patient develops <strong>orthopnea</strong> and <strong>paroxysmal nocturnal dyspnea</strong>. <strong>Hemoptysis</strong> can occur due to rupture of&nbsp;pulmonary-bronchial venous connections as a result of pulmonary venous hypertension.</p>\n<p>Auscultatory findings of MS include:</p>\n<ul>\n<li>Accentuated and slightly delayed&nbsp;first heart sound (S1)</li>\n<li>Close splitting of the second heart sound (S2)</li>\n<li>Accentuated pulmonic component of S2 (P2) when pulmonary artery pressure is elevated</li>\n<li><strong>Opening snap (OS)</strong> of the mitral valve following the aortic component of S2 (A2):\n<ul>\n<li>Audible during expiration at or just medial to the cardiac apex</li>\n</ul>\n</li>\n<li><strong>Mid-diastolic murmur</strong> following OS:\n<ul>\n<li>Low pitched, rumbling</li>\n<li>Heard best at the apex with the patient in the left lateral position</li>\n<li>Accentuated by mild exercise</li>\n<li>Duration of the murmur correlates with the severity of the stenosis</li>\n<li>Reappears or becomes louder during atrial systole in patients with sinus rhythm (presystolic accentuation)</li>\n</ul>\n</li>\n<li>Soft systolic murmurs heard at or medial to the apex (signify mixed mitral valve disease with regurgitation)</li>\n</ul>\n<p>When the cardiac output is severely reduced, the typical auscultatory findings may not be heard. This is known as<strong> silent MS</strong>. Hepatomegaly, pedal edema, ascites, and pleural effusion, may occur in patients with right ventricular failure.</p>\n<p>Other associated murmurs include:</p>\n<ul>\n<li><strong>Pansystolic murmur </strong>of <strong>functional tricuspid regurgitation</strong>:\n<ul>\n<li>Occurs with severe pulmonary hypertension</li>\n<li>Audible along the left sternal border</li>\n<li>Louder during inspiration and reduces during forced expiration (Carvallo&rsquo;s sign)</li>\n</ul>\n</li>\n<li><strong>Graham Steell murmur</strong> of <strong>pulmonary regurgitation</strong>:\n<ul>\n<li>High-pitched, diastolic, decrescendo blowing murmur</li>\n<li>Audible along the left sternal border</li>\n<li>Occurs with severe pulmonary hypertension</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fa37729c9f5442399693aadbed454406x1280x1191.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option B:</p>\n<p>An <strong>ejection mid-systolic murmur</strong>&nbsp;can be auscultated in <strong>aortic stenosis</strong>. It begins after S1, increases in intensity toward the middle of ejection, and ends just before aortic valve closure. It is low-pitched, rough, and rasping in character. It is best heard at the base of the heart, most commonly in the second right intercostal space.</p>\n<p>A systolic ejection click can be heard in young patients with a bicuspid aortic valve, but disappears as the valves become calcified. A2 and P2&nbsp;may be heard at the same time or A2 may follow P2, resulting in paradoxical splitting of S2. A fourth heart sound (S4) is often heard at the apex, indicating the presence of left ventricular hypertrophy.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c2ee26acb8fe4f2397862950428c6decx1280x1190.JPEG\" alt=\"Explanation Image\"><p>Option C:</p>\n<p>A <strong>pansystolic murmur</strong>&nbsp;of at least grade III/VI intensity can be auscultated in chronic severe&nbsp;<strong>mitral regurgitation</strong>. It is heard best at the apex and radiates to the axilla. Ruptured chordae tendineae may produce a murmur with a cooing or &ldquo;seagull&rdquo; quality, whereas a flail leaflet may produce a murmur with a musical quality.&nbsp;</p>\n<p>S1 is generally absent or soft. Wide splitting of S2 may occur due to premature closure of the aortic valve. A low-pitched third heart sound (S3) may occur following A2. S4 can also be audible in patients with acute severe MR.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/33e48c417e99465c8b119b5fedae047ex1280x1191.JPEG\" alt=\"Explanation Image\"><p>Option D:</p>\n<p>An <strong>early diastolic murmur</strong> can be auscultated in chronic&nbsp;<strong>aortic regurgitation</strong>. It is high-pitched and blowing in character. It is best heard in the third intercostal space along the left sternal edge. It may be accompanied by a mid-systolic ejection murmur in isolated AR or the Austin Flint murmur in severe AR. The latter is a soft, low-pitched, rumbling, mid-to-late diastolic murmur&nbsp;produced by the displacement of the anterior leaflet of the mitral valve by the AR stream.</p>\n<p>A2 is usually absent and occasionally, S4 also may be heard.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/14b8186c1464498fb5b9ca24f18c625dx1280x1190.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Dynamic auscultation of murmurs</h3><table>\n<tbody>\n<tr>\n<td><strong>Bedside Manoeuvre</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>\n<p>Inspiration</p>\n<p>(&uarr;venous return to right atrium)</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of right-sided sounds</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Handgrip</p>\n<p>(&uarr;afterload )</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of MR, AR, and VSD murmurs</li>\n<li>&darr; hypertrophic cardiomyopathy and AS murmurs</li>\n<li>MVP: delayed onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Valsalva-Phase II, standing up</p>\n<p>(&darr; preload)</p>\n</td>\n<td>\n<ul>\n<li>&darr; intensity of most murmurs (including AS)</li>\n<li>&uarr;&nbsp;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>MVP: earlier onset of click /murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rapid squatting</p>\n<p>(&uarr;venous return,&uarr;preload,<br />&uarr; afterload)</p>\n</td>\n<td>\n<ul>\n<li>&darr;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>&uarr;&nbsp;intensity of AS, MR, and VSD murmurs</li>\n<li>MVP: later onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: The causes of holosystolic murmur are:</h3><p>&nbsp; 1. Mitral regurgitation</p>\n<ul>\n<li>Best heard at the apex</li>\n<li>Radiates to axilla or base</li>\n<li>Decreases in intensity with amyl nitrate</li>\n<li>A2 is not heard at the apex</li>\n</ul>\n<p>&nbsp; 2. Tricuspid regurgitation</p>\n<ul>\n<li>Best heard at lower left sternal border</li>\n<li>Radiates to the epigastrium and right sternal border</li>\n<li>Increases in intensity during inspiration</li>\n<li>Prominent c-v waves seen in JVP</li>\n</ul>\n<p>&nbsp; 3. Ventricular septal defect</p>\n<ul>\n<li>Beat heard over left 3<sup>rd</sup> and 4<sup>th</sup> intercostal space</li>\n<li>Radiates widely</li>\n<li>Palpable thrill present</li>\n<li>Decreases in intensity with amyl nitrate</li>\n<li>Wide splitting of S2 seen</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME6960",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following conditions is not associated with an ST-segment elevation?",
      "choices": [
        {
          "id": 1,
          "text": "Prinzmetal’s angina"
        },
        {
          "id": 2,
          "text": "Pericarditis"
        },
        {
          "id": 3,
          "text": "Ventricular aneurysm"
        },
        {
          "id": 4,
          "text": "Unstable angina"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>There is no ST-segment elevation in unstable angina.</p>\n<p><strong>Differential diagnosis </strong>of ST-segment elevation<strong>&nbsp;</strong>(Mnemonic-ELEVATION):</p>\n<ul>\n<li><strong>E</strong>lectrolytes(Hypercalcemia, Hyperkalemia)</li>\n<li><strong>L</strong>eft bundle branch block</li>\n<li><strong>E</strong>arly(Benign) repolarization,&nbsp;<strong>E</strong>mbolism(Acute pulmonary)</li>\n<li><strong>V</strong>entricular hypertrophy</li>\n<li><strong>A</strong>rrhythmia(Brugada syndrome), <strong>A</strong>neurysm of LV, <strong>A</strong>ortic dissection, <strong>A</strong>ntiarrhythmic&nbsp;drugs(Class 1c)</li>\n<li><strong>T</strong>ako-tsubo syndrome, <strong>T</strong>umor invading left ventricle, <strong>T</strong>rauma to ventricles</li>\n<li><strong>I</strong>nfarction(MI), <strong>I</strong>nflammation(Myocarditis, Pericarditis)</li>\n<li><strong>O</strong>sborn J waves (Hypothermia or hypercalcemia)</li>\n<li><strong>N</strong>on-atherosclerotic vasospasm(Prinzmetal's angina)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3872",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old male patient comes with complaints of progressive weakness that worsens in the evening. He is diagnosed with myasthenia gravis. Which of the following drug can exacerbate symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Edrophonium"
        },
        {
          "id": 2,
          "text": "Prednisone"
        },
        {
          "id": 3,
          "text": "Pyridostigmine"
        },
        {
          "id": 4,
          "text": "Azithromycin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Azithromycin</strong> can <strong>exacerbate</strong> the symptoms of <strong>myasthenia gravis&nbsp;</strong>(MG) by affecting presynaptic neuromuscular transmission.&nbsp;</p>\n<p>Many drugs are known to increase weakness in patients with MG, and hence must be avoided:</p>\n<ul>\n<li><strong>Antibiotics</strong> like aminoglycosides, quinolones, and macrolides (azithromycin)</li>\n<li>Beta-blockers</li>\n<li>Botulinum toxin</li>\n<li>Local anaesthetics</li>\n<li>Magnesium</li>\n<li>Non&ndash;depolarising muscle relaxants</li>\n<li>Penicillamine</li>\n<li>Quinine derivatives</li>\n</ul>\n<p>Preferred drug for <strong>diagnosis&nbsp;</strong>of MG: <strong>Edrophonium</strong></p>\n<p><strong>Treatment</strong> for myasthenia gravis involves:</p>\n<ul>\n<li class=\"bulletIndent1\"><strong>Symptomatic treatment</strong>: Anticholinesterase agents &ndash;&nbsp;<strong>pyridostigmine</strong> is the <strong>initial therapy of choice</strong>.</li>\n<li class=\"bulletIndent1\"><strong>Chronic immunomodulating therapy</strong>: Glucocorticoids like&nbsp;<strong>prednisone</strong>&nbsp;and immunosuppressive drugs like azathioprine, mycophenolate mofetil, cyclosporine. These are used when patients are significantly symptomatic despite on pyridostigmine</li>\n<li class=\"bulletIndent1\"><strong>Rapid immunomodulating treatment</strong>: IVIG and therapeutic plasma exchange. Thses are used to in severe illness like <strong>myasthenic crisis</strong> and as <strong>bridge therapy</strong> before surgery, or starting chronic immunomodulating treatment</li>\n<li class=\"bulletIndent1\"><strong>Monoclonal antibodies: Rituximab</strong> is used<strong>&nbsp;</strong>in patients with <strong>MuSK antibody positive</strong>. Eculizumab is other monoclonal antibody used in the treatment of MG</li>\n<li class=\"bulletIndent1\"><strong>Surgical approach</strong>: Thymectomy and surgical removal of thymoma.</li>\n</ul><hr><h3>Related Pearl: Auto antibodies in a few disorders</h3><p>Auto-antibodies in <strong>myasthenia gravis</strong>:</p>\n<p>i)&nbsp;Anti-acetylcholine receptor (<strong>AChR</strong>) antibodies</p>\n<p>ii)&nbsp;Anti-muscle-specific kinase (<strong>MuSK</strong>) antibodies</p>\n<p>iii)&nbsp;Anti-low density lipoprotein receptor-related protein 4 (<strong>LRP4</strong>) antibodies</p>\n<p><strong>Anti-C1q antibodies</strong> are associated with <strong>systemic lupus erythematosus </strong>(SLE) and membrane proliferative glomerulonephritis (MPGN).&nbsp;</p>\n<p><strong>Anti-Smith</strong> antibodies (Anti-Sm) are associated with SLE.</p>\n<p>Anti-lysosome associated membrane protein-2 <strong>(LAMP-2)</strong> antibodies are associated with certain types of vasculitis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3812",
      "difficulty": "medium"
    },
    {
      "text": "A girl was brought by her parents with an itchy rash as shown in the image below. She also complains of difficulty in climbing stairs. A muscle biopsy reveals peri-fascicular atrophy. Immunohistochemistry revealed positive Myxovirus resistance protein A. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 2,
          "text": "Sarcoidosis"
        },
        {
          "id": 3,
          "text": "Dermatomyositis"
        },
        {
          "id": 4,
          "text": "Osteoarthritis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image of <strong>Gottron's papules</strong> along with the history suggestive of <strong>proximal&nbsp;muscle weakness</strong> and the investigation findings are suggestive of <strong>dermatomyositis.</strong></p>\n<p><strong>Dermatomyositis</strong> is an idiopathic inflammatory myopathy. It is characterized by <strong>proximal skeletal muscle weakness</strong>, muscle inflammation, and a variety of <strong>characteristic skin manifestations.</strong> &nbsp;</p>\n<p>The classic cutaneous features in dermatomyositis include:</p>\n<ul>\n<li><strong>Gottron&rsquo;s sign</strong> - erythematous to violaceous rash that occur symmetrically over the extensor (dorsal) aspects of the metacarpophalangeal (MCP)/ knuckle joints, elbows, knees, and ankles. Raised erythematous rash over the knuckles is <strong>pathognomic</strong> of dermatomyositis is called <strong>Gottron's papules</strong>.</li>\n<li><strong>Heliotrope rash</strong> - erythematous discoloration of eyelids with periorbital edema</li>\n<li><strong>Shawl sign</strong>- macular erythema of the upper chest and back</li>\n<li><strong>V sign</strong> - rash on the neck and chest in a V shaped manner due to sun exposure.</li>\n<li><strong>Poikiloderma</strong> - areas of hypopigmentation and hyperpigmentation, atrophy and telangiectasia</li>\n<li>Nail fold changes</li>\n<li>Mechanic's hands</li>\n<li>Cutaneous calcinosis</li>\n</ul>\n<p>In dermatomyositis, skeletal muscle weakness involves proximal muscles in a symmetric manner and the <strong>muscle biopsy </strong>shows<strong> peri-fascicular atrophy</strong>. However, the <strong>Myxovirus resistance protein A</strong> immunohistochemistry test is <strong>more specific</strong> than biopsy.&nbsp;A highly raised creatinine kinase can help in diagnosis as well.</p>\n<p>The image below shows <strong>heliotrope rash</strong>:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1571819fb26343389d5ac9138085705ex720x1009.JPEG\" alt=\"Explanation Image\"><p>The image below shows the&nbsp;<strong>shawl sign:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4d6659c5bedf42c4b48ae18a795e7c95x720x540.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Inflammatory myopathy</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Dermatomyositis</strong></td>\n<td><strong>Polymyositis</strong></td>\n<td><strong>Inclusion Body Myositis</strong></td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Adulthood and childhood</td>\n<td>&gt;18 years</td>\n<td>&gt;50 years  </td>\n</tr>\n<tr>\n<td>Familial Association</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Skin Manifestation</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Muscle involvement</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Asymmetric</p>\n</td>\n</tr>\n<tr>\n<td>Histopathological Findings</td>\n<td>\n<p><strong>Perimysial</strong> <strong>CD4+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates and <strong>perifascicular atrophy</strong></p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates </p>\n<p>Perivascular infiltrates  </p>\n</td>\n<td>\n<p><strong>Endomysial</strong> <strong>CD8+</strong> cellular infiltrates</p>\n<p>Perivascular infiltrates with amyloid inclusion bodies and rimmed vacuoles   </p>\n</td>\n</tr>\n<tr>\n<td>Association with connective tissue disease</td>\n<td>Scleroderma and mixed connective tissue only</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Association with other autoimmune diseases</td>\n<td>Infrequent</td>\n<td>Frequent</td>\n<td> Infrequent</td>\n</tr>\n<tr>\n<td>Association with malignancy</td>\n<td>Yes (breast, ovarian, lung) and ILD</td>\n<td> Yes (incidence much lesser than dermatomyositis)</td>\n<td> No</td>\n</tr>\n<tr>\n<td>Immunotherapy</td>\n<td> Responsive</td>\n<td> Responsive</td>\n<td> Resistant</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Antibodies in Dermatomyositis</h3><ul>\n<li><strong>Anti-Mi2 antibodies</strong> (directed against a helicase implicated in nucleosome remodeling) show a strong association with prominent Gottron papules and heliotrope rash.</li>\n<li><strong>Anti-Jo1 antibodies</strong> (directed against the enzyme histidyl t-RNA synthetase) are associated with interstitial lung disease, nonerosive arthritis, and a skin rash described as &ldquo;mechanic&rsquo;s hands.&rdquo;</li>\n<li><strong>Anti-P155/P140 antibodies</strong> (directed against several transcriptional regulators) are associated with paraneoplastic and juvenile cases of dermatomyositis.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8be1c64435894f52a05268d139a36935.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7716",
      "difficulty": "easy"
    },
    {
      "text": "A 27-year-old woman presents with dry cough and mild fever for 5 days and musculoskeletal pain for one week. Examination reveals increased respiratory rate and skin lesions all over her body as shown below. Other findings are given below. What is the most effective drug for this condition?<div class='question-desc-html'><p>Temperature: 37.8 degrees</p>\n<p>Pulse rate: 98 bpm</p>\n<p>Blood pressure: 100/70mmHg</p>\n<p>Chest X-ray shows patchy consolidation</p>\n<p>Bronchoalveolar lavage culture shows a fried egg appearance</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Amoxicillin"
        },
        {
          "id": 2,
          "text": "Cefotaxime"
        },
        {
          "id": 3,
          "text": "Azithromycin"
        },
        {
          "id": 4,
          "text": "Ciprofloxacin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario point towards pneumonia whereas the constitutional symptoms, patchy consolidation on chest Xray and<strong>&nbsp;fried egg appearance</strong> on culture is suggestive of&nbsp;<strong>atypical pneumonia</strong> caused by <em>Mycoplasma pneumoniae</em>. <strong>Azithromycin</strong> is the most effective drug&nbsp;for the treatment of<strong>&nbsp;</strong><em>M. pneumonia</em>.</p>\n<p>Pneumonia due to&nbsp;<em>M. pneumonia </em>is also referred to as Eaton agent pneumonia, <strong>primary atypical pneumonia</strong>, and walking pneumonia. Other bacterial causes of atypical community-acquired pneumonia are&nbsp;<em>Chlamydia pneumonia</em> and <em>Legionella</em>.</p>\n<p><strong>Upper respiratory tract infection </strong>(tracheobronchitis/ pharyngitis) and <strong>pneumonia</strong>&nbsp;are common pulmonary manifestations. Majority of patients with Mycoplasma pneumonia&nbsp;present with dry cough, sore throat and fever.</p>\n<p>It is also can present with&nbsp;<strong>extrapulmonary manifestations </strong>including&nbsp;<strong>erythema multiforme</strong>/Steven-Johnson syndrome (SJS),&nbsp;cold agglutinin disease,&nbsp;Guillain Barre syndrome, and transverse myelitis, arthritis, myocarditis, pericarditis and encephalitis.</p>\n<p>Investigations include <strong>PCR</strong> of respiratory secretions and chest X-rays. <strong>Chest X-ray </strong>shows<strong>&nbsp;patchy consolidation</strong>&nbsp;with thickened bronchial markings and subsegmental atelectasis.</p>\n<p>Culture shows a typical<strong> fried egg&nbsp;appearance</strong>&nbsp;(central opaque granular area of growth sorrounded by a flat translucent peripheral zone) on PPLO agar.&nbsp;The diagnosis is made by serology or by PCR.&nbsp;</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p><strong>Azithromycin</strong> is the most effective drug for management. Other&nbsp;drugs used are doxycycline, clarithromycin, erythromycin, moxifloxacin, levofloxacin, gemifloxacin.</p>\n<p>Other options:</p>\n<p>Options A and B:&nbsp;<strong>Amoxicillin</strong> and<strong> Cefotaxime</strong> are <strong>beta-lactam antibiotics</strong>&nbsp;(cell-wall synthesis inhibitors), hence they are not effective on <em>M.pneumoniae</em> as they lack a cell wall.</p>\n</div>\n</div>\n<p>Option D:&nbsp;<strong>Ciprofloxacin</strong> and ofloxacin are not recommended&nbsp;because of their high minimal inhibitory concentrations against&nbsp;<em>M. pneumoniae</em> isolates.</p>\n<p>Radiological image showing patchy consolidation at the hilum:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ec32bead186a4eedab6f2e1399b015bdx720x476.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Typical Pneumonia  v/s  Atypical Pneumonia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Typical pneumonia</strong>&nbsp;</span></td>\n<td><span><strong>Atypical pneumonia&nbsp;</strong></span></td>\n</tr>\n<tr>\n<td><span>Extracellular organism&nbsp;</span></td>\n<td><span>Intracellular organism</span></td>\n</tr>\n<tr>\n<td><span>Alveolar exudates in air spaces </span></td>\n<td><span>Interstitial involvement</span><br /><br /></td>\n</tr>\n<tr>\n<td><span>Neutrophilic in nature</span></td>\n<td><span>Lymphocytic in nature</span></td>\n</tr>\n<tr>\n<td><span>High-grade fever</span></td>\n<td><span>Low-grade fever</span></td>\n</tr>\n<tr>\n<td><span>Productive cough</span></td>\n<td>\n<p><span>Dry cough</span><br /><span>hemoptysis &nbsp;&nbsp;</span><span>scanty sputum</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Pleuritic chest pain </span></td>\n<td><span>Extrapulmonary manifestation</span></td>\n</tr>\n<tr>\n<td><span>X-Ray shows large areas of consolidation</span></td>\n<td><span>X-Ray shows an interstitial pattern of involvement.</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><span>The most common cause of <strong>Community-acquired Pneumonia</strong>- <em>Streptococcus pneumoniae.</em></span></li>\n<li><span>The most common cause of <strong>Atypical Pneumonia</strong>- <em>Mycoplasma&nbsp;pneumoniae.</em></span></li>\n<li><span>The most common&nbsp;cause of <strong>Nosocomial Pneumonia</strong>-</span>\n<ul>\n<li><span>Overall- gram-negative bacilli (implicated as a group)</span></li>\n<li><span>The single most common agent-&nbsp;<em>Staphylococcus aureus</em> (i.e.,&nbsp;gram-positive cocci)</span></li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/788eb4488f054109ae5a0d183c4128c5x1280x732.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e923543c1ecb4afbb29a9791790e7791.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9961",
      "difficulty": "medium"
    },
    {
      "text": "The most common pattern of renal involvement in systemic lupus erythematosus (SLE) is:",
      "choices": [
        {
          "id": 1,
          "text": "Class I lupus nephritis"
        },
        {
          "id": 2,
          "text": "Class II lupus nephritis"
        },
        {
          "id": 3,
          "text": "Class III lupus nephritis"
        },
        {
          "id": 4,
          "text": "Class IV lupus nephritis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Class IV lupus nephitis</strong> is the most frequent pattern of renal involvement in systemic lupus erythematosus <strong>(SLE)</strong>.</p>\n<div class=\"page\" title=\"Page 8577\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Lupus nephritis</strong> is one of the common serious complications seen in systemic lupus erythematosus (SLE). It occurs due to the <strong>deposition</strong> of <strong>circulating</strong> <strong>immune complexes</strong> of <strong>DNA</strong> and <strong>anti-DNA</strong>. This further activate the complement cascade and lead to complement-mediated damage.</p>\n<p>Most common finding is <strong>proteinuria</strong>. Other features include&nbsp;hematuria, hypertension, varying degrees of renal failure.&nbsp;</p>\n<p>Laboratory findings include presence of <strong>anti-dsDNA antibodies</strong> and <strong>reduced complement levels</strong>.&nbsp;Red blood cell casts can be present on examination of urine sediment.</p>\n<p>It is classified into <strong>6 subtypes</strong> (classes) based on histological findings of the <strong>biopsy</strong> specimen taken from affected kidney. The most common histologic pattern is <strong>Class IV</strong> with diffuse lesions involving &gt; 50% of all glomeruli.</p>\n<p><strong>Treatment</strong> is based on the histologic subtype of lupus nephritis:</p>\n<ul>\n<li>Class I and II - lesions are limited to the renal mesangium. They need no therapy and have an excellent prognosis</li>\n<li><strong>Class III</strong>&nbsp;- characterized by focal nephritis. <strong>Mild proliferation</strong> involving a small percentage of glomeruli respond well to&nbsp;<strong>steroids</strong>.</li>\n<li><strong>Class IV </strong>- characterized by diffuse nephritis&nbsp;\n<ul>\n<li><strong>Initial</strong>&nbsp;<strong>therapy</strong>&nbsp;-&nbsp;<strong>high dose steroids,&nbsp;</strong>cyclophosphamide or mycophenolate&nbsp;</li>\n<li><strong>Maintainance therapy</strong>&nbsp;- low dose steroids, mycophenolate or azathioprine</li>\n</ul>\n</li>\n<li>Renal failure due to lupus -&nbsp;<strong>renal transplantation</strong> is recommended after 6 months of disease inactivity</li>\n</ul>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Classification of Lupus Nephritis (International Society of Nephrology and Renal Pathology Society)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Class&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Findings</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal mesangial lupus nephritis (class I)</p>\n</td>\n<td>\n<p><strong>Immune complex deposition</strong> in&nbsp;the mesangium without structural changes by light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mesangial proliferative lupus nephritis (class II)</p>\n</td>\n<td>\n<p><strong>Mesangial cell proliferation</strong> with mesangial immune deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal lupus nephritis (class III)</p>\n</td>\n<td>\n<p>Focal, segmental <strong>glomerulonephritis</strong> involving <strong>less than 50%</strong> of all glomeruli.</p>\n<p>Focal subendothelial deposits with or without mesangial changes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse lupus nephritis (class IV)</p>\n</td>\n<td>\n<p>The most common and severe form of lupus nephritis</p>\n<p>Diffuse&nbsp;<strong>glomerulonephritis</strong> involving <strong>more than 50%</strong> of all glomeruli</p>\n<p>Diffuse subendothelial deposits with or without mesangial changes<strong>. &ldquo;Wire loop&rdquo;</strong> structures on light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous lupus nephritis (class V)</p>\n</td>\n<td>\n<p>Global or segmental&nbsp;<strong>subepithelial</strong> immune deposits with or without mesangial proliferation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Advanced sclerosing lupus nephritis (class VI)</p>\n</td>\n<td>\n<p><strong>Sclerosis</strong> of <strong>more than 90%</strong> of the glomeruli&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>Focal- Involves only a few glomeruli</li>\n<li>Diffuse- Involves almost all the glomeruli</li>\n<li>Segmental- Involves only a part of glomerulus</li>\n<li>Global- Involves entire glomerulus</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b83e16725c9e4acbae2e0ff8275ec1a5x1279x911.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3887",
      "difficulty": "medium"
    },
    {
      "text": "A 7-year-old girl is brought with complaints of hematuria and melena for 10 days. Laboratory investigations reveal mild thrombocytopenia and normal coagulation tests. Peripheral smear is given below. Which organism is most frequently involved in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "E.coli O157:H7"
        },
        {
          "id": 2,
          "text": "Shigella"
        },
        {
          "id": 3,
          "text": "Enteroinvasive E.coli"
        },
        {
          "id": 4,
          "text": "Salmonella"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and peripheral smear showing <strong>helmet cells</strong> or <strong>schistocytes</strong> are suggestive of <strong>h</strong><strong>emolytic uremic syndrome </strong>(HUS)<strong>.&nbsp;</strong>This condition&nbsp;is most commonly associated with enterohemorrhagic&nbsp;<strong>Escherichia coli</strong> strain&nbsp;<strong>O157: H7&nbsp;</strong>worldwide.</p>\n<p>This strain releases<strong>&nbsp;Shiga-like toxin</strong>.&nbsp;This toxin is absorbed from the inflamed gastrointestinal mucosa into the circulation and causes <strong>endothelial</strong> <strong>dysfunction</strong>. It leads to <strong>platelet </strong>activation and <strong>aggregation</strong>. Children and older adults are at the highest risk.</p>\n<p>The image given below shows schistocytes or helmet cells seen in HUS.&nbsp;&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed110bae6299454e81bda8f6e444230fx799x600.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Differences between TTP and HUS</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>TTP</strong></p>\n</td>\n<td>\n<p><strong>HUS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Causative agent</p>\n</td>\n<td>\n<p>A deficiency of, or antibodies to the metalloprotease ADAMTS13</p>\n</td>\n<td>\n<p>E. coli (O157: H7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI prodrome</p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Age group affected</p>\n</td>\n<td>\n<p>Adults</p>\n</td>\n<td>\n<p>Children</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sex affected</p>\n</td>\n<td>\n<p>Females</p>\n</td>\n<td>\n<p>No sex predilection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relapses</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal impairment</p>\n</td>\n<td>\n<p>Usually mild</p>\n</td>\n<td>\n<p>Often severe</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe thrombocytopenia</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Pentad of TTP and triad of HUS</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f1004c9ccec548288509c1eaed783d3fx1280x1840.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9d74b8d51ae54c0b8d11fd94e1a8222d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5837",
      "difficulty": "easy"
    },
    {
      "text": "A consultant asks one of his patients to keep his fingers as shown in the image to elicit a clinical finding. Which of the following conditions are likely to cause an abnormal sign pertaining to this clinical finding?<div class='question-desc-html'><ol>\n<li aria-level=\"1\">Irritable bowel syndrome</li>\n<li aria-level=\"1\">Lung abscess</li>\n<li aria-level=\"1\">Cystic fibrosis</li>\n<li aria-level=\"1\">Aortic aneurysm</li>\n<li aria-level=\"1\">Hemiplegia</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3 and 5 only"
        },
        {
          "id": 2,
          "text": "1, 3, 4 and 5"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4 and 5"
        },
        {
          "id": 4,
          "text": "2, 3, 4, and 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The consultant, by asking the patient to keep the dorsal surfaces of his fingers opposed (<strong>Schamroth sign</strong>), is trying to elicit <strong>clubbing.</strong> Clubbing is seen in conditions like<strong> lung abscess</strong>, <strong>cystic fibrosis</strong>, <strong>aortic aneurysm</strong>, and <strong>hemiplegia</strong>, but not in irritable bowel syndrome.</p>\n<p><strong>Digital clubbing</strong> is a <strong>focal bulbous enlargement</strong> of the <strong>terminal segments</strong> of the fingers and/or toes. It occurs due to the proliferation of connective tissue between the nail matrix and the distal phalanx. Clubbed fingers are also known as watch-glass nails, drumstick fingers, and Hippocratic fingers/nails.</p>\n<p>Hypoxia causes increased release of <strong>platelet-derived growth factor</strong> (PDGF) and <strong>vascular endothelial growth factor</strong> (VEGF). This leads to increased vascularity, permeability, and connective tissue changes.</p>\n<p>The image below shows finger clubbing.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1700b4a66f3047868e2952ab61dc194ax800x600.JPEG\" alt=\"Explanation Image\"><p>Clinical methods to elicit clubbing are:</p>\n<ul>\n<li aria-level=\"1\"><strong>Schamroth sign</strong>: It is performed by placing the dorsal surfaces of terminal phalanges of corresponding right and left fingers together. <strong>Normal</strong> fingers create a <strong>diamond-shaped window</strong>, but this window is obliterated in <strong>clubbed</strong> fingers. </li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6c42326dc1564cff8a566640a8dcbebfx600x1183.JPEG\" alt=\"Explanation Image\"><ul>\n<li><strong>Lovibond's angle/Profile sign:</strong> It is the angle made by the nail as it exists from the proximal nail fold. <strong>Normally</strong>, this angle is usually <strong>less than 180°</strong>.<strong> </strong>In <strong>true clubbing</strong>, it is <strong>more than 180°</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/edb6a06a30084e68b72ff6aaa88a794ex600x861.JPEG\" alt=\"Explanation Image\"><ul>\n<li><strong>Hyponychial angle:</strong> This is constructed by drawing a line from the distal digital crease to the cuticle and another line from the cuticle to hyponychium (the thickened stratum corneum of epidermis under the free edge of the nail). The <strong>normal</strong> angle is<strong> less than 192°</strong>.</li>\n<li aria-level=\"1\"><strong>Phalangeal depth ratio:</strong> This is defined by the ratio of the digit's depth measured at the nail bed and distal interphalangeal joint. Normally, the depth at the distal interphalangeal joint is more than that at the nail bed. A <strong>phalangeal depth ratio </strong>of<strong> more than 1</strong> is indicative of <strong>clubbing</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/043370a510064036818a4c7fda2fd2dex1280x2179.JPEG\" alt=\"Explanation Image\"><ul>\n<li><strong>Digital index</strong>: This is the <strong>sum</strong> of the <strong>phalangeal depth ratios</strong> for all <strong>10 fingers</strong>. A digital index of <strong>10.2 or more</strong> is indicative of clubbing. This is <strong>more specific</strong> for clubbing than the phalangeal depth ratio.</li>\n</ul>\n<p>Causes of clubbing are:</p>\n<ul>\n<li aria-level=\"1\"><strong>Pulmonary</strong></li>\n<ul>\n<li aria-level=\"2\">Bronchogenic carcinoma</li>\n<li aria-level=\"2\">Mesothelioma</li>\n<li aria-level=\"2\">Lung abscess, empyema, bronchiectasis</li>\n<li aria-level=\"2\">Cystic fibrosis</li>\n<li aria-level=\"2\">Sarcoidosis</li>\n<li aria-level=\"2\">Diffuse pulmonary disease - pulmonary fibrosis, asbestosis</li>\n</ul>\n<li aria-level=\"1\"><strong>GI</strong></li>\n<ul>\n<li aria-level=\"2\">Inflammatory bowel disease - ulcerative colitis, Crohn's disease</li>\n<li aria-level=\"2\">Sprue, celiac disease</li>\n<li aria-level=\"2\">Gastric and colonic carcinoma</li>\n<li aria-level=\"2\">Cirrhosis</li>\n<li aria-level=\"2\">Chronic active hepatitis</li>\n</ul>\n<li aria-level=\"1\"><strong>Cardiovascular</strong></li>\n<ul>\n<li aria-level=\"2\">Cyanotic congenital heart disease</li>\n<li aria-level=\"2\">Infective endocarditis</li>\n<li aria-level=\"2\">Aortic aneurysm</li>\n<li aria-level=\"2\">Arteriovenous malformations</li>\n<li aria-level=\"2\">Atrial myxoma</li>\n</ul>\n<li aria-level=\"1\"><strong>Endocrine</strong></li>\n<ul>\n<li aria-level=\"2\">Hyperthyroidism - Grave’s disease</li>\n</ul>\n<li aria-level=\"1\"><strong>CNS</strong></li>\n<ul>\n<li aria-level=\"2\">Hemiplegia (unilateral clubbing)</li>\n</ul>\n</ul>\n<p><strong>Clubbing</strong> may occur as isolated finding, but when it occurs along with <strong>subperiosteal new bone formation</strong> in the<strong> </strong>long bones and <strong>painful joint enlargement</strong>, it is known as the syndrome of <strong>hypertrophic osteoarthropathy</strong>. This is seen in conditions like bronchogenic carcinoma, mesothelioma, bronchiectasis, and hepatic cirrhosis.</p>\n<p id=\"__p52\" class=\"p p-first\"><strong>Pseudoclubbing</strong> is <strong>asymmetrical</strong> involvement of the fingers. It is seen in conditions like chronic renal failure, subungal hemangioma, and systemic sclerosis. Radiologically, there is <strong>acro-osteolysis</strong> (resorption of the terminal tufts) due to soft-tissue collapse.</p><hr><h3>Related Pearl: Nail findings and associated systemic conditions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nail finding</strong></p>\n</td>\n<td><strong>Associated systemic condition</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Clubbing</strong></p>\n</td>\n<td>\n<ul>\n<li>Inflammatory bowel disease</li>\n<li><span>Lung cancer</span></li>\n<li>Idiopathic pulmonary fibrosis</li>\n<li><span>Complicated tuberculosis</span></li>\n<li><span>Suppurative lung disease (lung abscess, empyema, bronchiectasis, cystic fibrosis)</span></li>\n<li>Mesothelioma</li>\n<li>Cirrhosis</li>\n<li>Congenital heart disease, Endocarditis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Koilonychia</strong></p>\n</td>\n<td>\n<p>Iron-deficiency anemia, hemochromatosis, Raynaud&rsquo;s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Onycholysis</strong></p>\n</td>\n<td>\n<p>Psoriasis, onychomycosis, hyperthyroidism, sarcoidosis, trauma, amyloidosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pitting</strong></p>\n</td>\n<td>\n<p>Psoriasis, Reiter&rsquo;s syndrome, Alopecia areata</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Beau&rsquo;s lines</strong></p>\n</td>\n<td>\n<p>Any severe systemic illness that disrupts nail growth, Raynaud&rsquo;s disease, pemphigus, trauma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Yellow nail</strong></p>\n</td>\n<td>\n<p>Lymphedema, pleural effusion, immunodeficiency, bronchiectasis, sinusitis, rheumatoid arthritis, nephrotic syndrome, thyroiditis, tuberculosis, Raynaud&rsquo;s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nail Pterygium</strong></p>\n</td>\n<td>\n<p>Dorsal: Lichen Planus</p>\n<p>Ventral: trauma, systemic sclerosis, Raynaud phenomenon, lupus erythematosus</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"heading\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nail finding</strong></p>\n</td>\n<td>\n<p><strong>Associated systemic condition</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Terry&rsquo;s (white) nails</strong></p>\n</td>\n<td>\n<p>Hepatic failure, cirrhosis, diabetes mellitus, CHF, hyperthyroidism, malnutrition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Azure lunula</strong></p>\n</td>\n<td>\n<p>Hepatolenticular degeneration (Wilson&rsquo;s disease), silver poisoning, quinacrine therapy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Half-and-half nails</strong></p>\n</td>\n<td>\n<p>Specific for renal failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Muehrcke&rsquo;s lines</strong></p>\n</td>\n<td>\n<p>Specific for hypoalbuminemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mees&rsquo; lines</strong></p>\n</td>\n<td>\n<p>Arsenic poisoning, Hodgkin&rsquo;s disease, CHF, leprosy, malaria, chemotherapy, carbon monoxide poisoning, other systemic insults</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Dark longitudinal streaks</strong></p>\n</td>\n<td>\n<p>Melanoma, benign nevus, chemical staining, normal variant in darkly pigmented people</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Splinter hemorrhage</strong></p>\n</td>\n<td>\n<p>Subacute bacterial endocarditis, SLE, rheumatoid arthritis, antiphospholipid syndrome, peptic ulcer disease, malignancies, oral contraceptive use, pregnancy, psoriasis, trauma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Telangiectasia</strong></p>\n</td>\n<td>\n<p>Rheumatoid arthritis, SLE, dermatomyositis, scleroderma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c2b6c413a63b48158a0a8de913b19650.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0214",
      "difficulty": "medium"
    },
    {
      "text": "A man presented with fatigue and a mass in the left upper abdomen. On examination, there was massive splenomegaly with no lymphadenopathy. Investigations revealed pancytopenia. His peripheral blood smear is given below. Immunohistochemistry revealed tumor cells to be positive for annexin A1, CD22, CD25, and CD103. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Primary myelofibrosis"
        },
        {
          "id": 2,
          "text": "Hairy cell leukemia"
        },
        {
          "id": 3,
          "text": "Multiple myeloma"
        },
        {
          "id": 4,
          "text": "Mantle cell lymphomas"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario along with the image shows <strong>hairy cells</strong> i.e. abnormal B cells having round nuclei and pale blue cytoplasm with thread-like extensions. So the likely diagnosis is <strong>hairy cell leukemia</strong>.&nbsp;</p>\n<p>Hairy cell leukaemia is a rare type of B-cell tumour involving <strong>small lymphocytes</strong>. The specific activating <strong>point mutation</strong> is in the serine/ threonine kinase&nbsp;<strong>BRAFV600E</strong>.</p>\n<p>Symptoms occur due to infiltration of bone marrow, liver and spleen.&nbsp;<strong>Clinical features</strong> include:</p>\n<ul>\n<li><strong>Massive splenomegaly </strong>and hepatomegaly. Lymphadenopathy is rare</li>\n<li><strong>Pancytopenia</strong>&nbsp;- due to marrow involvement can also be seen</li>\n<li><strong>Monocytopenia</strong>&nbsp;-<strong>&nbsp;</strong>leads to <strong>increased&nbsp;</strong>incidence of&nbsp;<strong>atypical mycobacterial infections</strong></li>\n</ul>\n<p>Routine peripheral smear shows <strong>hairy cells</strong> (abnormal B cells) having<strong> round, oblong </strong>or<strong> reniform nuclei </strong>and <strong>pale blue cytoplasm </strong>with thread-like<strong> extensions</strong> as shown below.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d06990d003674513b0c20e51da2a71d6x800x599.JPEG\" alt=\"Explanation Image\"><p>Hairy cell leukaemia is limited to the <strong>red&nbsp;pulp</strong> of the spleen which is heavily infiltrated. This leads to <strong>obliteration </strong>of <strong>white pulp</strong> and a <strong>beefy red</strong> gross appearance.&nbsp;</p>\n<p>The pattern of<strong>&nbsp;bone marrow</strong>&nbsp;involvement on biopsy specimens is pathognomonic for hairy cell leukemia.</p>\n<ul>\n<li>Diffuse infiltration of tumor cells with&nbsp;<strong>honeycomb&nbsp;appearance</strong></li>\n<li>Individual cells have a <strong>fried egg&nbsp;appearance</strong>&nbsp;i.e. the nucleus of each hairy cell is surrounded by a halo of cytoplasm</li>\n<li><strong>Dry tap</strong>&nbsp;is obtained upon performing bone marrow aspiration due to marrow fibrosis and the interlocking cell borders of hairy cells</li>\n</ul>\n<p>The image given below shows small cells with clear cytoplasm and a round central nucleus (\"fried egg\"-like appearance).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/71cc2c9e0dd3438eb2fde12948adb2bfx1280x853.JPEG\" alt=\"Explanation Image\"><p>Tests for hairy cell leukemia include:</p>\n<ul>\n<li><strong>CD11c, CD25</strong>&nbsp;and<strong> CD103</strong>&nbsp;are the characteristic immunophenotype diagnostic markers</li>\n<li><strong>Pan-B markers</strong> such as&nbsp;<strong>CD19</strong>,<strong> CD20</strong>, and <strong>CD22</strong>&nbsp;also test positive&nbsp;</li>\n<li><strong>Annexin A1</strong> on bone marrow specimens have been shown to have 100% sensitivity and specificity in differentiating hairy cell leukemia from other B cell malignancies.</li>\n<li>Tartrate-resistant acid phosphatase <strong>(TRAP) stain</strong> is an important tool in the clinical diagnosis of hairy cell leukemia and yields positive results in&nbsp; majority of the cases.</li>\n</ul>\n<p>Management&nbsp;of hairy cell leukemia include:</p>\n<ul>\n<li><strong>Splenectomy</strong></li>\n<li><strong>Cladribine </strong>(first line agent)&nbsp;and&nbsp;<strong>deoxycoformycin</strong>&nbsp;are highly active <strong>nucleoside</strong> agents that cause durable remissions in patients.</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Primary myelofibrosis</strong> is the replacement of the marrow by fibrous tissue leading to reduced bone marrow haematopoiesis. This results in cytopenia, and extramedullary haematopoiesis (in the spleen mainly). The peripheral blood smear shows<strong> tear drop-shaped red cells</strong> (dacrocytes).</p>\n<p>Option C: <strong>Multiple myeloma</strong> is a plasma cell tumor. Patients present with lytic bone lesions, hypercalcemia, renal failure, and acquired immune abnormalities. Plasma cell tumors are positive for <strong>CD138</strong>, <strong>syndecan-1</strong> (adhesion molecule), and<strong> CD56</strong>. Bone-marrow biopsy shows <strong>mott cells</strong> (a variant of plasma cell)&nbsp;with globular inclusions called <strong>Russell bodies </strong>(if cytoplasmic) or<strong> Dutcher bodies</strong> (if nuclear).</p>\n<p>Option D:&nbsp;<strong>Mantle cell lymphomas</strong> express high levels of <strong>cyclin D1</strong>, <strong>CD19</strong>, and<strong> CD20</strong>. The tumor is usually <strong>CD5+</strong> and <strong>CD23&minus;</strong>. <strong>Painless</strong> <strong>lymphadenopathy</strong> is the most common presentation. Other organs involved are spleen and gut.&nbsp;</p><hr><h3>Related Pearl: WHO classification of Lymphoid Neoplasms</h3><table>\n<tbody>\n<tr>\n<td><strong>I. Precursor B-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>\n<p>B-cell acute lymphoblastic leukemia/lymphoma</p>\n<p>(B-ALL)</p>\n</td>\n</tr>\n<tr>\n<td><strong>II. Peripheral B-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>Chronic lymphocytic leukemia/small lymphocytic lymphoma<br />B-cell prolymphocytic leukemia<br />Lymphoplasmacytic lymphoma<br />Splenic and nodal marginal zone lymphomas<br />Extranodal marginal zone lymphoma<br />Mantle cell lymphoma<br />Follicular lymphoma<br />Marginal zone lymphoma<br />Hairy cell leukemia<br />Plasmacytoma/plasma cell myeloma<br />Diffuse large B-cell lymphoma<br />Burkitt lymphoma</td>\n</tr>\n<tr>\n<td><strong>III. Precursor T-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>\n<p>T-cell acute lymphoblastic leukemia/lymphoma</p>\n<p>(T-ALL)</p>\n</td>\n</tr>\n<tr>\n<td><strong>IV. Peripheral T-Cell and NK-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>T-cell prolymphocytic leukemia<br />Large granular lymphocytic leukemia<br />Mycosis fungoides/S&eacute;zary syndrome<br />Peripheral T-cell lymphoma, unspecified<br />Anaplastic large-cell lymphoma<br />Angioimmunoblastic T-cell lymphoma<br />Enteropathy-associated T-cell lymphoma<br />Panniculitis-like T-cell lymphoma<br />Hepatosplenic &gamma;&delta;T-cell lymphoma<br />Adult T-cell leukemia/lymphoma<br />Extranodal NK/T-cell lymphoma<br />NK-cell leukemia</td>\n</tr>\n<tr>\n<td><strong>V. Hodgkin Lymphoma</strong></td>\n</tr>\n<tr>\n<td>Nodular sclerosis<br />Mixed cellularity<br />Lymphocyte-rich<br />Lymphocyte depletion<br />Lymphocyte predominance</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Origin of leukemia / lymphoma and their immunophenotypes</h3><table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td><strong>Immunophenotype</strong></td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>&nbsp;</p>\n<p>Diffuse large B-cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79a, CD 19, CD20, CD21,CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD19, CD20, CD22, CD79a, CD10, Bcl-6</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CLL:&nbsp;Chronic lymphocytic leukemia&nbsp;</p>\n<p>SLL:&nbsp;Small lymphocytic lymphoma</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e64075adadb143d68845152048c64ccb.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4701",
      "difficulty": "easy"
    },
    {
      "text": "A 32-year-old male patient came to the casualty with severe abdominal pain. He gives a history of consumption of alcohol. On examination the following findings were observed on the abdomen. His serum amylase and lipase are elevated 3 times from the baseline. Identify the correct pair.",
      "choices": [
        {
          "id": 1,
          "text": "A-Cullen's sign, B- Sister Mary Joseph nodule"
        },
        {
          "id": 2,
          "text": "A- Cullen's sign, B-Grey Turner's sign"
        },
        {
          "id": 3,
          "text": "A-Grey turner's sign, B-Cullen's sign"
        },
        {
          "id": 4,
          "text": "A-Grey turner's sign, B- Sister Mary Joseph nodule"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Abdominal pain after consumption of alcohol, elevated lipase and amylase suggest <strong>acute pancreatitis.</strong> In necrotizing pancreatitis, there is bruising of skin seen as</p>\n<ul>\n<li>A-<strong>Grey turner's sign: Bruising in the flanks</strong></li>\n<li>B-<strong>Cullen's</strong> <strong>sign: Periumbilical bruising</strong></li>\n</ul>\n<p><strong>Sister Mary Joseph nodule</strong> also called Sister Mary Joseph sign, refers to a <strong>palpable nodule bulging into the umbilicus</strong> as a result of metastasis of malignant cancer in the pelvis or abdomen.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0358ec30a0fd43de811a571d2b324a8fx430x340.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/fb52634a740348c3968c45afc2a7b9ed.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6764",
      "difficulty": "easy"
    },
    {
      "text": "A postgraduate student, while assisting an emergency trauma surgery on an HIV-infected patient, has suffered a bleeding puncture wound in his right index finger. The post-exposure prophylaxis is given for 4 weeks. Match the drug with their daily dosages?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>A. Lamivudine</td>\n<td>1. 50mg</td>\n</tr>\n<tr>\n<td>B. Tenofovir</td>\n<td>2. 100mg</td>\n</tr>\n<tr>\n<td>C. Dolutegravir</td>\n<td>3. 300mg</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "A-2, B-3, C-1"
        },
        {
          "id": 2,
          "text": "A-1, B-2, C-1"
        },
        {
          "id": 3,
          "text": "A-3, B-3, C-1"
        },
        {
          "id": 4,
          "text": "A-1, B-2, C-3"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Recommended post-exposure prophylaxis (PEP) is a three drug regimen which includes<strong>&nbsp;lamivudine 300mg , t</strong><strong>enofovir 300mg </strong>and<strong> dolutegravir 50mg</strong>. The PEP must be <strong>initiated</strong> <strong>ideally</strong> <strong>within 2 hours</strong> and <strong>certainly within 72 hours</strong>.</p>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Most common cause of HIV in a <strong>healthcare worker</strong> is due to <strong>needle stick injuries</strong>. Exposure to needle stick injuries can be prevented by:</p>\n<ul>\n<li>Using barriers (goggles, gloves,) during performing procedures that cause exposure to blood/ body fluids</li>\n<li>Hand washing and routine disinfection of surfaces.</li>\n<li>Careful handling and disposing of sharps and needles after use.</li>\n</ul>\n</div>\n</div>\n</div>\n<p>The protocol followed after exposure is: Exposure within the past 72 hours --&gt; Assess exposed individual --&gt; Assess exposure source --&gt; Determine the risk of transmission --&gt; Counselling and support --&gt; 4 weeks prescription with drug information --&gt; routine HIV antibody testing upto 6 months after exposure.</p><hr><h3>Related Pearl: 2021 NACO Guidelines on Post-exposure Prophylaxis (PEP) for HIV</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Exposure Code</strong></p>\n</td>\n<td>\n<p><strong>HIV Source Code</strong></p>\n</td>\n<td>\n<p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PEP Recommendation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>&nbsp;1</p>\n</td>\n<td>\n<p>&nbsp;Not required</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>&nbsp;2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>&nbsp;1</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>&nbsp;2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>&nbsp;1/2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2/3</p>\n</td>\n<td>\n<p>Not known</p>\n</td>\n<td>\n<p>Consider PEP if HIV prevalence is high in the given population</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p><strong>Exposure Codes</strong></p>\n<ul>\n<li>EC1: <strong>Mild exposure:</strong> mucous membrane/non-intact skin with small volumes/eyes or mucous membrane or subcutaneous injections following small-bore needles</li>\n<li>EC2:&nbsp;<strong>Moderate exposure: </strong>mucous membrane/non-intact skin with large volumes or percutaneous superficial exposure with a solid needle</li>\n<li>EC3:&nbsp;<strong>Severe exposure: </strong>percutaneous with large volume by hollow needle, deep puncture</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p><strong>HIV Source Codes</strong></p>\n<ul>\n<li>SC 1- HIV +ve, asymptomatic, CD count high, low viral load</li>\n<li>SC 2- HIV +ve, symptomatic, CD count low, high viral load</li>\n<li>SC unknown: HIV status unknown</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">\n<p><strong>Recommended PEP regimens</strong></p>\n<p>1) <strong>Adolescents and Adults</strong> (&gt;10 years of age and &gt;30 kg weight): Tenofovir 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg</p>\n<p>2) <strong>Children&nbsp;</strong>(&gt;6 years of age and &gt;20 kg weight): Zidovudine&nbsp;(dosage as per weight band) + Lamivudine (dosage as per weight band) + Dolutegravir 50 mg</p>\n<ul>\n<li aria-level=\"1\">PEP must be initiated ideally <strong>within 2 hours</strong> and certainly within 72 hours.</li>\n<li aria-level=\"1\">Duration of PEP: <strong>28 days/4weeks</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: WHO 2018 guidelines for post exposure prophylaxis regimen in HIV</h3><div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>An HIV post-exposure prophylaxis regimen with two ARV drugs is effective, but three drugs are preferred.</p>\n<p>The recent MOHFW January 2020 guidelines on the management of PEP in HIV recommends the replacement of 2 drug regimen with 3 drug regimen referring to WHO December 2018 guidelines on PEP management protocol in HIV. This shift towards recommending a three-drug regimen for<br />everyone was based on the availability of less toxic and better-tolerated medications.</p>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>ADULTS AND ADOLESCENTS:-</strong></p>\n<p>Preferred backbone regimen -&nbsp;TDF + 3TC (or FTC)</p>\n<p>New drug - &nbsp;DTG is the preferred third drug for HIV post-exposure prophylaxis</p>\n<p>New drug -&nbsp;<span>ATV/r, DRV/r, LPV/r and RAL may be considered as alternative third drug options for post-exposure prophylaxis</span></p>\n<p><strong>CHILDREN:-</strong></p>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Preferred backbone regimen -&nbsp;AZT + 3TC</p>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ABC + 3TC or TDF + 3TC (or FTC) can be considered as alternative regimens</p>\n<p>New drug -&nbsp;DTG is the preferred third drug for HIV post-exposure prophylaxis</p>\n<p>New drug -&nbsp;<span>ATV/r, DRV/r, LPV/r and RAL may be considered as alternative third drug options for post-exposure prophylaxis</span></p>\n<p>&nbsp;</p>\n<p><span>Legend</span></p>\n<p><span>TDF - Tenofovir disoproxil fumarate&nbsp;</span></p>\n<p>3TC - Lamivudine&nbsp;</p>\n<p>FTC - Emtricitabine&nbsp;</p>\n<p>DTG - Dolutegravir&nbsp;</p>\n<p>ATV/r - Atazanavir + ritonavir&nbsp;</p>\n<p>DRV/r - Darunavir + ritonavir&nbsp;</p>\n<p>LPV/r - Lopinavir + ritonavir&nbsp;</p>\n<p>RAL - Raltegravir&nbsp;</p>\n<p>AZT - Zidovudine&nbsp;</p>\n<p>ABC - Abacavir&nbsp;</p>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3957",
      "difficulty": "medium"
    },
    {
      "text": "A 70-year-old man with a known history of DM and HTN on regular medications presents with a history of progressively worsening dyspnoea on exertion. On examination, there is elevated JVP, positive hepatojugular reflux, crackles at the lung bases, hepatomegaly, ascites, and pedal oedema​. What is your provisional diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Heart failure"
        },
        {
          "id": 2,
          "text": "Hypertrophic cardiomyopathy"
        },
        {
          "id": 3,
          "text": "Mitral regurgitation"
        },
        {
          "id": 4,
          "text": "Portal hypertension"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given symptoms and signs are suggestive of <strong>heart failure </strong>(Option A).</p>\n<p><strong>Portal hypertension</strong> (Option D) can be a result of r<strong>ight-sided heart failure,</strong> however, the presence of worsening dyspnea along with the other symptoms implies a <strong>primary cardiac condition.</strong></p>\n<p><strong>Heart failure</strong> is a common endpoint for most chronic cardiac conditions such as hypertension, valvular heart disease, and coronary heart disease.<br />The symptoms of heart failure are commonly due to <strong>volume overload </strong>with pulmonary and/or systemic venous pressures.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>RIGHT HEART FAILURE</strong></td>\n<td><strong>LEFT HEART FAILURE</strong></td>\n</tr>\n<tr>\n<td>Symptoms occur due to <strong>systemic congestion</strong></td>\n<td>Symptoms occur due to <strong>pulmonary congestion</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Raised pulsatile JVP</li>\n<li>Hepatic congestion</li>\n<li>Tender hepatomegaly</li>\n<li>Pitting pedal edema</li>\n<li aria-level=\"1\">Ascites</li>\n<li aria-level=\"1\">Early satiety</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\"1\">Shortness of breath</li>\n<li aria-level=\"1\">Orthopnea (dyspnea that occurs within 1-2 mins of lying down)</li>\n<li aria-level=\"1\">Paroxysmal nocturnal dyspnea(shortness of breath that develops after lying down for 30 mins or longer)</li>\n<li aria-level=\"1\">Pulmonary rales</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><br /></p><hr><h3>Related Pearl: Summary of Pathogenesis of Major Findings in Congestive Heart Failure</h3><p><strong>Summary of Pathogenesis of Major Findings in Congestive Heart Failure</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Abnormality</strong></p>\n</td>\n<td>\n<p><strong>Cause</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Weakness, exercise intolerance, fatigue</p>\n</td>\n<td>\n<p>Left ventricle output inadequate to perfuse muscles; especially, failure of output to rise with exercise</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ankle, sacral edema</p>\n</td>\n<td>\n<p>Increased peripheral venous pressure &rarr;increased fluid transudation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatomegaly</p>\n</td>\n<td>\n<p>Increased peripheral venous pressure &rarr;increased resistance to portal flow.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pulmonary congestion</p>\n</td>\n<td>\n<p>Increased pulmonary venous pressure &rarr;pulmonary venous distention and transudation of fluid into air spaces</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dyspnea on exertion</p>\n</td>\n<td>\n<p>Failure of left ventricular output to rise during exercise &rarr; increased pulmonary venous pressure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Paroxysmal dyspnea, pulmonary edema</p>\n</td>\n<td>\n<p>Probably a sudden failure of left heart output to keep up with the right heart output &rarr;acute rise in pulmonary venous and capillary pressure &rarr;transudation of fluid into air spaces.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Orthopnea</p>\n</td>\n<td>\n<p>Normal pooling of blood in lungs in supine position added to the already congested pulmonary vascular system; increased venous return not put out by the left ventricle. (Relieved by sitting up, raising the head of the bed, lying on extra pillows.)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiac dilation</p>\n</td>\n<td>\n<p>Greater ventricular end-diastolic volume.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0882",
      "difficulty": "easy"
    },
    {
      "text": "A man presents with headache, fever, and neck stiffness for the last 1 month. On examination, the sign shown in the image below is positive. CSF analysis reveals lymphocytic predominance with low glucose levels. A cobweb coagulum is formed when CSF is left standing. What is the therapy of choice for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Isoniazid + rifampin + pyrazinamide + ethambutol"
        },
        {
          "id": 2,
          "text": "Ceftriaxone + vancomycin"
        },
        {
          "id": 3,
          "text": "Ampicillin"
        },
        {
          "id": 4,
          "text": "Liposomal amphotericin B + flucytosine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The scenario of a&nbsp;<strong>positive Kernig's sign</strong>, as shown in the image,&nbsp;and CSF analysis findings of <strong>lymphocytic predominance</strong> with <strong>low glucose</strong>&nbsp;level and <strong>cobweb</strong> formation suggest&nbsp;<strong>tubercular meningitis</strong>. The therapy of choice for this patient is&nbsp;<strong>isoniazid + rifampin + pyrazinamide+ ethambutol</strong>.&nbsp;</p>\n<p><strong>Kernig's sign</strong> is elicited with the patient in supine position. The thigh and knee are flexed over the abdomen. The examiner then tries to passively extend the knee joint. There is severe pain during extension due to meningeal irritation.</p>\n<p><strong>Tubercular meningitis</strong> is a type of subacute meningitis. It is caused due to the hematogenous dissemination of the bacilli into the brain parenchyma. These bacilli form tubercles. The tubercles undergo caseating necrosis and release the tubercular antigens in the subarachnoid space, leading to inflammation of<strong>&nbsp;</strong>the <strong>meninges</strong>. They predominantly involve the <strong>basal portion</strong> of the brain.</p>\n<p>Symptoms include headache, <strong>neck stiffness, </strong>features of<strong> cranial nerve palsies</strong> such as facial weakness, downward and outward positioning of the eyes, diminished vision, double vision, and hearing loss. Signs include papilledema, <strong>Kernig's sign</strong>, and <strong>Brudzinki's sign</strong> of meningeal irritation.</p>\n<p>It is treated with fixed-dose combinations of isoniazid (5 mg/kg/d), rifampin (10 mg/kg/d), pyrazinamide (30 mg/kg/d), ethambutol (15 mg/kg/d), and pyridoxine (50 mg/d) for a period of <strong>6 months</strong>. It can be extended by 3-6 months in cases of tubercular meningitis. Also, in HIV-negative patients with TB meningitis, <strong>dexamethasone</strong> (12&ndash;16 mg/d) is recommended for 6 weeks. In India, tuberculosis is managed with a&nbsp;<strong>fixed-dose combination</strong> and <strong>daily dosing</strong> of medications.</p>\n<div class=\"page\" title=\"Page 1150\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Other options:</p>\n<p>Option B:<strong>&nbsp;Ceftriaxone + vancomycin</strong> is the initial treatment of choice for acute meningitis due to <strong><em>Streptococcus pneumoniae</em></strong>.</p>\n<p>Option C:<strong>&nbsp;Ampicillin</strong> is the treatment of choice for meningitis due to <strong><em>Listeria monocytogenes</em></strong> and is given for at least 3 weeks.</p>\n<p>Option D: <strong>Liposomal amphotericin B + flucytosine</strong> is used for chronic meningitis due to <strong><em>Cryptococcus neoformans</em> </strong>(in patients with no immunosuppression).</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Acute bacterial meningitis - causes and empirical treatment</h3><table>\n<tbody>\n<tr>\n<td><strong>Patient Group</strong></td>\n<td><strong>Bacterial Pathogen</strong></td>\n<td><strong>Empirical Therapy</strong></td>\n</tr>\n<tr>\n<td>Age&lt;1 month</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p>Enterobacteriacea</p>\n<p><em>Listeria monocytogenes</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin</td>\n</tr>\n<tr>\n<td>1 month - 2 years</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p><em>H. influenza</em></p>\n<p><em>S. pneumonia</em></p>\n<p><em>N. meningitidis</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin+<br />Vancomycin (if PRSP suspected)</td>\n</tr>\n<tr>\n<td>2 - 50 years and no risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><br /></td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Age &gt; 50 yrs and/or risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><em>L. monocytogenes</em><br />Group B Streptococci</td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin+<br />Ampicillin</p>\n</td>\n</tr>\n<tr>\n<td>Post-craniotomy/Head trauma/CSF Rhinorrhea</td>\n<td>Gram negative bacilli</td>\n<td>\n<p>Ceftazidime+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Post-shunt surgery/ Ommaya reservoir</td>\n<td>\n<p><em>S. aureus</em><br />Coagulase-negative staphylococci</p>\n</td>\n<td>Ceftazidime+<br />Vancomycin</td>\n</tr>\n<tr>\n<td>Immunocompromised state </td>\n<td>\n<p><em> S. pneumoniae                    </em></p>\n<p><em>N. meningitidis                    </em></p>\n<p><em>L. monocytogenes       </em></p>\n<p>Gram negative bacilli </p>\n</td>\n<td>\n<p>Vancomycin+                      Ampicillin+                         Cefepime                           </p>\n<p>                   OR </p>\n<p>Vancomycin+                      Meropenem      </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*PRSP= penicillin-resistant S pneumoniae </p><hr><h3>Related Pearl: CSF findings in meningitis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Glucose&nbsp;</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>Protein</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>WBC (per&nbsp;&mu;L)</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>40-85</td>\n<td>15-45</td>\n<td>\n<p>&lt;5</p>\n<p>60-70% lymphocytes, &le;30% monocytes / macrophages</p>\n</td>\n</tr>\n<tr>\n<td><strong>Bacterial</strong></td>\n<td>&lt;40</td>\n<td>&gt;100</td>\n<td>\n<p>&gt;1000</p>\n<p>&uarr;&uarr;PMNs (&ge;80%)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Viral</strong></td>\n<td>Normal</td>\n<td>20-80</td>\n<td>\n<p>25-500</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberculous</strong></td>\n<td>&lt;50 <br />in 75% cases</td>\n<td>100-200</td>\n<td>\n<p>25-100</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fungal</strong></td>\n<td>&darr; to normal</td>\n<td>150-300</td>\n<td>\n<p>40-600</p>\n<p>Lymphocytes or PMNs, depending on specific organism</p>\n</td>\n</tr>\n<tr>\n<td><strong>Parasitic</strong></td>\n<td>Normal</td>\n<td>50-200&nbsp;</td>\n<td>\n<p>150-2000</p>\n<p>&uarr;&uarr; Eosinophils (&ge;50%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: ATT Regimen for TB Patients</h3><p>As per the latest recommendations from <strong>National Tuberculosis Elimination Programme (NTEP)</strong>, treatment of TB is now based primarily on <strong>drug susceptibility testing</strong>. This is irrespective of new cases, previously treated cases or recurrent TB cases. <br />All cases of TB are treated with Drug Sensitive TB Regimen, as long as the patient is sensitive to isoniazid and rifampicin. (<strong>No classification into category I or II</strong>)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of TB Case</strong></td>\n<td><strong>Intensive Phase</strong></td>\n<td><strong>Continuation Phase</strong></td>\n</tr>\n<tr>\n<td>New and previously treated cases (H and R sensitive)</td>\n<td>2 months H R Z E</td>\n<td>4 months H R E</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2><strong><span>Classification based on drug resistance. </span></strong></h2>\n<p><span>The<strong> </strong>cases are classified as:</span></p>\n<ul>\n<li><strong>Mono-resistant (MR):</strong> A TB patient, who is resistant to one 1st line anti-TB drug only.</li>\n<li><strong>Poly-Drug Resistant (PDR):</strong> A TB patient, who is resistant to more than one 1st line anti-TB drug, other than Rifampicin and isoniazid. </li>\n<li><strong>Rifampicin Resistant (RR):</strong> A TB patient, who is resistant to <strong>rifampicin</strong> with or without resistance to other drugs. Patients, who have rifampicin resistance, should be managed as if they are an MDR TB case.</li>\n<li><strong>Multi-Drug Resistant (MDR):</strong> A TB patient, who is resistant to <strong>both isoniazid and rifampicin.</strong></li>\n<li><strong>Extensively Drug-Resistant (XDR):</strong> A MDR TB patient who is additionally resistant to a <strong>fluoroquinolone</strong> (ofloxacin, levofloxacin, or moxifloxacin) and at least one additional group A drug (as of 2021, these are bedaquiline and linezolid)</li>\n</ul>\n<h2><strong><span>Standard DR TB regimen</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Regimen class</strong></td>\n<td><strong>Drugs</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/ poly-drug resistant TB regimen</strong></td>\n<td>Lfx R E Z for 6 months</td>\n<td>\n<p>6 months long</p>\n<p>Oral drugs only</p>\n</td>\n</tr>\n<tr>\n<td><strong>BPaLM regime (New MDR regime by WHO)</strong></td>\n<td>Bdq Pa Lzd Mfx for 6 months</td>\n<td>\n<p>6 months long</p>\n</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter oral bedaquiline regime (Shorter MDR)</strong></td>\n<td>\n<p><strong>Intensive Phase:</strong></p>\n<p>Lfx Bdq(6 months) Cfz Z Hh E Eto for 4-6 months</p>\n<p><strong>Continuation phase:</strong></p>\n<p>Lfx Cfz Z E for 5 months</p>\n</td>\n<td>\n<p>9-11 months long totally</p>\n<p>Injectables used in Intensive phase.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Bdq(6 months or longer) Lfx Lzd Cfz Cs </td>\n<td>\n<p>18-20 months long</p>\n<p>Oral drugs only</p>\n<p>This regimen is used for XDR TB patients for 20 months.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2> </h2>\n<h2><strong><span>Criteria for patients to receive standard Drug Resistant TB regimen:</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Standard Drug Resistant TB regimen</strong></td>\n<td><strong>Inclusion criteria</strong></td>\n<td><strong>Exclusion criteria</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/poly-drug resistant TB regimen</strong></td>\n<td><strong>Isoniazid resistant</strong> TB with <strong>rifampicin sensitive</strong></td>\n<td>No specific criteria</td>\n</tr>\n<tr>\n<td><strong>BPaLM regimen (New MDR TB regimen by WHO)</strong></td>\n<td>\n<ol>\n<li><strong>MDR/RR-TB</strong> or <strong>pre-XDR-TB</strong> ( MDR/RR-TB and resistance to fluoroquinolones). </li>\n<li>Those with <strong>confirmed</strong> pulmonary TB and all forms of extrapulmonary TB (except for TB involving CNS, osteoarticular, and miliary TB).</li>\n<li>Patients <strong>&gt;14 years of age.<br /></strong></li>\n</ol>\n</td>\n<td>Pregnant and lactating women</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter MDR TB regimen</strong></td>\n<td>Patient with <strong>rifampicin resistant</strong> pulmonary or extra pulmonary TB</td>\n<td>Non drug sensitivity test based criteria:\n<ul>\n<li>Pregnancy</li>\n<li>Any extra pulmonary disease in PLHIV</li>\n<li>Disseminated meningeal or central nervous system TB</li>\n<li>Intolerance to any drug in the shorter MDR TB regimen</li>\n</ul>\nDrug sensitivity test based criteria:\n<ul>\n<li>If DST/DRT result for FQ or SLI is resistant (XDR TB)</li>\n<li>Presence of InhA mutation</li>\n<li>Resistant to Z </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Patients in whom <strong>shorter MDR TB regimen cannot be considered</strong> due to any reason</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Legend</p>\n<p>FQ: Fluoroquinolone</p>\n<p>SLI: Second Line Injectable</p>\n<p>PLHIV: People Living with HIV</p>\n<p>Lfx: Levofloxacin</p>\n<p>Pa: Pretomanid</p>\n<p>H: Isoniazid</p>\n<p>Hh: High Dose Isoniazid</p>\n<p>R: Rifampicin</p>\n<p>E: Ethambutol</p>\n<p>Z: Pyrazinamide</p>\n<p>Mfx: Moxifloxacin</p>\n<p>Km: Kanamycin</p>\n<p>Am: Amikacin</p>\n<p>Eto: Ethionamide</p>\n<p>Cfz: Clofazimine</p>\n<p>Bdq: Bedaquiline</p>\n<p>Lzd: Linezolid</p>\n<p>Cs: Cycloserine</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/05a5f9e2522e4170b8f9637264aeeed6.GIF"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4899",
      "difficulty": "easy"
    },
    {
      "text": "Match the following conditions with their usual joint predilection.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>Joint</strong></td>\n</tr>\n<tr>\n<td> 1. Rheumatoid arthritis</td>\n<td>a. Distal interphalangeal joint</td>\n</tr>\n<tr>\n<td>2. Osteoarthritis</td>\n<td>b. Metacarpophalangeal joint</td>\n</tr>\n<tr>\n<td>3. Systemic lupus erythematosus</td>\n<td>c. Proximal interphalangeal joint</td>\n</tr>\n<tr>\n<td>4. Psoriatic arthritis</td>\n<td>d. First carpometacarpal joint</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-b, 2-d, 3-a, 4-c"
        },
        {
          "id": 2,
          "text": "1-b, 2-d, 3-c, 4-a"
        },
        {
          "id": 3,
          "text": "1-b, 2-c, 3-d, 4-a"
        },
        {
          "id": 4,
          "text": "1-b, 2-c, 3-a, 4-d"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct combination of conditions with their usual joint predilection is <strong>1-b, 2-d, 3-c, 4-a</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>Joint</strong></td>\n</tr>\n<tr>\n<td>Rheumatoid arthritis</td>\n<td>Metacarpophalangeal joint</td>\n</tr>\n<tr>\n<td>Osteoarthritis</td>\n<td>First carpometacarpal joint</td>\n</tr>\n<tr>\n<td>Systemic lupus erythematosus</td>\n<td>Proximal interphalangeal joint</td>\n</tr>\n<tr>\n<td>Psoriatic arthritis</td>\n<td>Distal interphalangeal joint</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Rheumatoid arthritis </strong>(RA)<strong> </strong>is a chronic inflammatory disease of <strong>symmetric polyarthritis</strong>, mainly affecting the small joints of the hands and feet. The <strong>wrists</strong> and <strong>metacarpophalangeal</strong> and <strong>proximal interphalangeal joints</strong> are most frequently involved. Being a systemic disease, RA also causes various <strong>extraarticular manifestations</strong>, like subcutaneous nodules, lung involvement, pericarditis, peripheral neuropathy, vasculitis, and hematologic abnormalities. Testing for <strong>serum antibodies</strong> to<strong> anti-citrullinated protein antibodies</strong> and<strong> rheumatoid factor</strong> can help in the quick diagnosis and management of suspected RA.</p>\n<p><strong>Osteoarthritis </strong>(OA) is the <strong>most common</strong> type of arthritis, mainly affecting the <strong>hip</strong>, <strong>knee</strong>, and <strong>first metatarsal phalangeal</strong>,<strong> first carpometacarpal</strong>, and <strong>distal </strong>and<strong> proximal interphalangeal joints</strong>. The incidence of OA is very high in the elderly and more common in women. It is diagnosed based on structural abnormalities, like <strong>cartilage loss</strong> (seen as joint space loss on X-ray) and <strong>osteophytes</strong>, which occur due to failure of joint protective mechanisms.</p>\n<p><strong>Systemic lupus erythematosus </strong>(SLE) is an<strong> autoimmune</strong> disease characterized by autoantibody- and immune complex-mediated tissue destruction. It is a <strong>multisystem disease</strong>, resulting in musculoskeletal, cutaneous, renal, hematologic, cardiopulmonary, and neurologic symptoms and signs. Diagnostically, the most important autoantibodies are <strong>antinuclear antibodies</strong> because they are positive in &gt;95% of patients.</p>\n<p><strong>Psoriatic arthritis </strong>is an <strong>inflammatory </strong>type of arthritis mainly affecting the <strong>distal interphalangeal joints</strong>. In most cases, psoriasis precedes arthritis. Other features include <strong>nail changes</strong> (pitting, horizontal ridging, onycholysis, yellowish discoloration, hyperkeratosis), <strong>dactylitis</strong>, <strong>enthesitis</strong>, and tenosynovitis. The <strong>Classification of Psoriatic Arthritis (CASPAR) criteria</strong> are a useful tool for early diagnosis of psoriatic arthritis.</p><hr><h3>Related Pearl: Joint Involvement in Various Arthritis</h3><table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Joint Disorders</strong></td>\n<td><strong>Joints Commonly Involved</strong></td>\n<td>\n<p><strong>Joints Com</strong><strong>monly </strong><strong>Spared</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;<strong>Osteoarthritis</strong></p>\n</td>\n<td>\n<p>Cervical and lumbosacral spine, PIP, DIP,&nbsp;1st CMC, hip, knee,&nbsp;1st MTP,&nbsp;</p>\n</td>\n<td>\n<p>&nbsp;Elbow, Wrist, Ankle, MCP&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Rheumatoid Arthritis</strong></td>\n<td>Shoulder, Wrist, MCP, PIP, Knee, MTP&nbsp;</td>\n<td>DIP&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Ankylosing Spondylitis</strong></td>\n<td>Sacroiliac joint, intervertebral joints</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Psoriatic Arthritis</strong></td>\n<td>PIP,&nbsp;DIP</td>\n<td>Ray distribution*&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Ray distribution: Joint involvement tends to follow a pattern with all of the joints of one finger involved sparing the adjacent finger completely.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Diseases and Usual Joints affected</h3><table>\n<tbody>\n<tr>\n<td>Disease</td>\n<td>Joint</td>\n</tr>\n<tr>\n<td>Gout</td>\n<td>MTP of great toe</td>\n</tr>\n<tr>\n<td>Pseudogout</td>\n<td>Knee</td>\n</tr>\n<tr>\n<td>Rheumatoid arthritis</td>\n<td>Metacarpophalangeal joint</td>\n</tr>\n<tr>\n<td>Ankylosing spondylitis</td>\n<td>Sacro-iliac joint</td>\n</tr>\n<tr>\n<td>Septic arthritis</td>\n<td>Knee</td>\n</tr>\n<tr>\n<td>Syphilitic arthritis</td>\n<td>Knee</td>\n</tr>\n<tr>\n<td>Gonococcal arthritis</td>\n<td>Knee</td>\n</tr>\n<tr>\n<td>Diabetic Charcot joint</td>\n<td>Foot joint(midtarsal)</td>\n</tr>\n<tr>\n<td>Senile osteoporosis</td>\n<td>Vertebra</td>\n</tr>\n<tr>\n<td><strong>P</strong>aget's disease<strong><br /></strong></td>\n<td><strong>P</strong>elvis &gt; Femur &gt;Skull &gt;Tibia</td>\n</tr>\n<tr>\n<td>Osteochondritis dissecans</td>\n<td>Knee &gt;Elbow<br />(Most common cause of loose bodies in young)</td>\n</tr>\n<tr>\n<td>Actinomycosis</td>\n<td>Mandible</td>\n</tr>\n<tr>\n<td>Hemophilic arthritis</td>\n<td>Knee(Children-Ankle)</td>\n</tr>\n<tr>\n<td>Acute osteomyelitis</td>\n<td>Lower end of femur(Metaphysis)</td>\n</tr>\n<tr>\n<td>Brodie's abscess</td>\n<td>Upper end of tibia</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0333",
      "difficulty": "medium"
    },
    {
      "text": "A woman with hysteria who was hyperventilating developed carpo-pedal spasm. What could be the likely cause for this?",
      "choices": [
        {
          "id": 1,
          "text": "Respiratory acidosis"
        },
        {
          "id": 2,
          "text": "Metabolic acidosis"
        },
        {
          "id": 3,
          "text": "Respiratory alkalosis"
        },
        {
          "id": 4,
          "text": "Metabolic alkalosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong><span data-preserver-spaces=\"true\">Respiratory alkalosis</span></strong><span data-preserver-spaces=\"true\">, developed secondary to hyperventilation, is the likely cause of the carpopedal spasm.</span></p>\n<p><span data-preserver-spaces=\"true\">Hyperventilation leads to the washout of carbon dioxide, resulting in decreased levels of PaCO2 (</span><strong><span data-preserver-spaces=\"true\">hypocapnia</span></strong><span data-preserver-spaces=\"true\">), which in turn&nbsp;</span><strong><span data-preserver-spaces=\"true\">increases the pH </span></strong>(<strong><span data-preserver-spaces=\"true\">alkalosis</span></strong>)<span data-preserver-spaces=\"true\">. Thus, acute&nbsp;</span><strong><span data-preserver-spaces=\"true\">respiratory alkalosis</span></strong><span data-preserver-spaces=\"true\">&nbsp;occurs during hyperventilation. An increase in extracellular pH increases the binding of free calcium to albumin, lowering the ionized calcium concentration. This leads to&nbsp;</span><strong><span data-preserver-spaces=\"true\">hypocalcemia</span></strong><span data-preserver-spaces=\"true\">.</span></p>\n<p><span data-preserver-spaces=\"true\">The clinical features of hypocalcemia are:</span></p>\n<ul>\n<li><strong><span data-preserver-spaces=\"true\">Tetany:</span></strong><span data-preserver-spaces=\"true\">&nbsp;Increased peripheral neuromuscular irritability. May include perioral&nbsp;</span><strong><span data-preserver-spaces=\"true\">paresthesias</span></strong><span data-preserver-spaces=\"true\">, muscle spasms, and cramps.</span></li>\n<li><strong><span data-preserver-spaces=\"true\">Trosseau's sign</span></strong><span data-preserver-spaces=\"true\">: Induction of carpal spasm when the BP cuff is inflated 20 mm Hg over the systolic BP for three minutes or more.</span></li>\n<li><strong><span data-preserver-spaces=\"true\">Chvostek's sign</span></strong><span data-preserver-spaces=\"true\">: Contraction of the ipsilateral circumoral facial muscles when the facial nerve is tapped just anterior to the ear.</span></li>\n<li><span data-preserver-spaces=\"true\">Severe hypocalcemia can cause seizures,&nbsp;</span><strong><span data-preserver-spaces=\"true\">carpopedal</span></strong><span data-preserver-spaces=\"true\">&nbsp;</span><strong><span data-preserver-spaces=\"true\">spasm</span></strong><span data-preserver-spaces=\"true\">, bronchospasm, and laryngospasm.</span></li>\n</ul>\n<p><span data-preserver-spaces=\"true\">Treatment of the underlying condition is necessary. The patient should be reassured and&nbsp;</span><strong><span data-preserver-spaces=\"true\">rebreathing from a paper bag should</span></strong><span data-preserver-spaces=\"true\">&nbsp;be done during acute episodes.</span></p>\n<p><span data-preserver-spaces=\"true\">The image below shows</span><strong><span data-preserver-spaces=\"true\">&nbsp;Trosseau's sign.</span></strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c57748f5f0814bb382575ab1a67d4274x289x240.PNG\" alt=\"Explanation Image\"><p>The image below shows <strong>Chvostek's sign.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/212f7d34a038422299f5101d0045b087x230x277.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Causes of Acid-Base Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Metabolic acidosis</strong></p>\n</td>\n<td>\n<p><strong>Metabolic alkalosis</strong></p>\n</td>\n<td>\n<p><strong>Respiratory acidosis</strong></p>\n</td>\n<td>\n<p><strong>Respiratory alkalosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ketoacidosis</p>\n<p>Lactic acidosis</p>\n<p>Chronic renal failure</p>\n<p>Salicylate intoxication</p>\n<p>Methanol/formaldehyde intoxication</p>\n<p>Ethylene glycol intoxication</p>\n<p>Diarrhoea</p>\n<p>Renal tubular acidosis</p>\n</td>\n<td>\n<p>Vomiting</p>\n<p>Hyperaldosteronism</p>\n<p>Loop or thiazide diuretics</p>\n</td>\n<td>\n<p>Opiates, sedatives, anesthesia</p>\n<p>Guillain- Barre syndrome, Polio, ALS, multiple sclerosis</p>\n<p>Airway obstruction</p>\n<p>Adult respiratory distress syndrome, COPD</p>\n</td>\n<td>\n<p>Pneumonia, pulmonary embolism</p>\n<p>High altitude</p>\n<p>Psychogenic</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1383",
      "difficulty": "medium"
    },
    {
      "text": "A male patient with complaints of jaundice and pruritis shows elevated GGT and ALP.  ERCP revealed beading in both intrahepatic and extrahepatic biliary tree. A biopsy was done and showed concentric onion ring fibrosis. The autoantibody most likely to be positive in this condition is:",
      "choices": [
        {
          "id": 1,
          "text": "Anti soluble Liver Antigen (SLA)"
        },
        {
          "id": 2,
          "text": "Anti mitochondrial antibody (AMA)"
        },
        {
          "id": 3,
          "text": "Antineutrophil cytoplasmic antibody (pANCA)"
        },
        {
          "id": 4,
          "text": "Anti liver kidney microsomes (LKM)"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above clinical scenario and biopsy findings of onion ring fibrosis are suggestive of <strong>primary sclerosing cholangitis (PSC)</strong>. The autoantibody most likely to be positive in this condition is<strong> p-ANCA</strong>.&nbsp;</p>\n<p>The auto antibodies in the decreasing order of positivity in PSC are <strong>p-ANCA&gt;ANA&gt;AMA</strong>.</p>\n<div class=\"page\" title=\"Page 9595\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>PSC is the diffuse inflammation and fibrosis of the <strong>entire biliary tree</strong> (intrahepatic and extrahepatic). It results in <strong>chronic cholestasis</strong>, <strong>cirrhosis</strong>, portal hypertension and finally liver failure.</p>\n<p>Clinical features include&nbsp;<strong>cholestatic jaundice</strong>, pruritis, steatorrhea, fat-soluble vitamin deficiencies, and fatigue.</p>\n<p>Liver function tests show a cholestatic pattern with an&nbsp;<strong>elevation of ALP</strong>&nbsp;and<strong>&nbsp;GGT</strong>&nbsp;and smaller rises in the aminotransferases. Bilirubin values can be variable. Majority of patients with PSC are positive for perinuclear antineutrophil cytoplasmic antibody <strong>(pANCA)</strong>.</p>\n<p>Definitive diagnosis is by <strong>cholangiographic imaging&nbsp;</strong>showing multiple dilatations and strictures (<strong>beading</strong>) of both intrahepatic and extrahepatic biliary tree. Magnetic resonance cholangiopancreatography <strong>(MRCP) </strong>is the imaging of choice,&nbsp;cholangiopancreatography <strong>(ERCP) </strong>is done&nbsp;if MRCP is nondiagnostic.</p>\n<p>Currently, there is&nbsp;no known curative treatment. Surgical management involves&nbsp;<strong>biliary stenting </strong>or endoscopic dilatation of strictures. For patients with&nbsp;advanced liver disease,&nbsp;<strong>liver transplantation&nbsp;</strong>is the&nbsp;only available option for treatment.</p>\n</div>\n</div>\n</div>\n</div>\n<p>The below image shows a cholangiogram of primary sclerosing cholangitis. There is diffuse stricturing of intrahepatic and extrahepatic bile ducts with dilatation of the areas in between.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d5918515d0a439ca9858c09dee404a7x315x307.JPEG\" alt=\"Explanation Image\"><p><strong>Histopathological</strong> image showing concentric periductal fibrosis <strong>onion skin fibrosis</strong> involving the interlobular bile duct in primary sclerosing cholangitis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/31485fca0a0a479087832ceb0f3371d1x720x567.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Differences between primary sclerosing cholangitis (PSC)  and primary biliary cholangitis (PBC)</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Primary Biliary Cholangitis</strong></td>\n<td><strong>Primary Sclerosing Cholangitis</strong></td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>\n<p>Antimitochondrial antibodies positive in most patients</p>\n<p>Antinuclear antibodies positive</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 860\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Antimitochondrial antibodies /AMA typically negative</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>p-ANCA</strong>-positive</p>\n</td>\n</tr>\n<tr>\n<td>Age group</td>\n<td>40&ndash;60 years</td>\n<td>30-45 years</td>\n</tr>\n<tr>\n<td>Gender predominance</td>\n<td>Females</td>\n<td>Males</td>\n</tr>\n<tr>\n<td>Site</td>\n<td>Intrahepatic&nbsp;bile ducts only</td>\n<td>Intra- and extrahepatic bile ducts</td>\n</tr>\n<tr>\n<td>&nbsp;Associated with</td>\n<td>\n<p>Sjogren syndrome</p>\n<p>Hashimoto's thyroiditis&nbsp;</p>\n<p>CREST&nbsp;syndrome</p>\n<p>Rheumatoid arthritis</p>\n<p>Celiac disease</p>\n</td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Biopsy</td>\n<td>MRCP/ERCP-strictures&nbsp;</td>\n</tr>\n<tr>\n<td>Biopsy findings</td>\n<td>&nbsp;<strong>Florid duct lesion</strong> (granuloma)</td>\n<td>Concentric \"<strong>onion-skin\"</strong>&nbsp;fibrosis &nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>Long-term complication</td>\n<td>Cirrhosis</td>\n<td>\n<p>Cirrhosis</p>\n<p>Cholangiocarcinoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Antibodies in Hepatitis</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Antibodies </strong></td>\n<td><strong>Seen in </strong></td>\n</tr>\n<tr>\n<td>\n<p>ANA, ASMA, pANCA, anti-SLA/LP, AMA</p>\n</td>\n<td>\n<p>Autoimmune hepatitis Type 1</p>\n</td>\n</tr>\n<tr>\n<td>Anti-liver cytosol 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2&nbsp;</p>\n<p>Chronic hepatitis C</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 2</td>\n<td>Drug-induced hepatitis</td>\n</tr>\n<tr>\n<td>Anti-LKM 3</td>\n<td>\n<p>Chronic hepatitis D</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>ANA: Anti-nuclear antibodies (most common antibody in autoimmune hepatitis)</li>\n<li>LKM: Liver&ndash;kidney microsomes</li>\n<li>SLA/LP: Soluble liver antigen/liver-pancreas</li>\n<li>ASMA: Anti-smooth muscle actin</li>\n<li>pANCA: Perinuclear anti-neutrophil cytoplasmic antibodies</li>\n<li>AMA: Antimitochondrial antibodies</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1221",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old woman presented with the following deformity. She complains of joint pain and stiffness in the fingers for 5-6 years. She reports that stiffness is more in the early morning and improves on performing household activities. What is the most common extra-articular manifestation seen in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Pleuritis"
        },
        {
          "id": 2,
          "text": "Pericarditis"
        },
        {
          "id": 3,
          "text": "Subcutaneous nodules"
        },
        {
          "id": 4,
          "text": "Felty's syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above clinical scenario along with image showing&nbsp;<strong>swan neck</strong> deformity (hyperextension of the PIP joint with flexion of the DIP joint)<strong>&nbsp;</strong>is classically seen in <strong>rheumatoid arthritis</strong>. The<strong> most common </strong>extra-articular manifestation of rheumatoid arthritis is <strong>subcutaneous nodules.&nbsp;</strong></p>\n<p class=\"p1\"><strong>Subcutaneous nodules</strong> are generally <strong>firm, non-tender&nbsp;</strong>nodules&nbsp;that are adherent to the periosteum, tendons, or bursae. They develop in <strong>areas</strong> that are subjected to <strong>repeated trauma</strong> or <strong>irritation such</strong> as the <strong>forearm, sacral prominences</strong>, and Achilles tendon. Nodules can also develop in the lungs, pleura, pericardium, and peritoneum. Infection, gangrene and malignant transformation can be rarely seen with subcutaneous nodules.</p>\n<p class=\"p1\">Other extraarticular manifestations seen in rheumatoid arthritis are:</p>\n<ul>\n<li class=\"p1\"><strong>Sjogren syndrome </strong>- it presents with keratoconjunctivitis sicca or xerostomia</li>\n<li>Rheumatoid <strong>vasculitis</strong> - it&nbsp;presents as&nbsp;petechiae, purpura, digital infarcts, gangrene, livedo reticularis</li>\n<li class=\"p1\">Pulmonary -&nbsp;&nbsp;\n<ul>\n<li class=\"p1\"><strong>Pleuritis</strong>&nbsp;- most common pulmonary manifestation</li>\n<li class=\"p1\">Interstitial lung diseases</li>\n</ul>\n</li>\n<li>Cardiac -&nbsp;\n<ul>\n<li><strong>Pericarditis</strong>&nbsp;- most common cardiac manifestation</li>\n<li>Cardiomyopathy</li>\n<li>Mitral regurgitation</li>\n<li>Coronary artery disease</li>\n</ul>\n</li>\n<li>Hematologic -&nbsp;\n<ul>\n<li><strong>Normochromic normocytic anemia</strong>&nbsp;- most common hematologic abnormality&nbsp;</li>\n<li><strong>Felty's syndrome -&nbsp;</strong>is a triad of neutropenia, splenomegaly, and nodular rheumatoid arthritis. It is a rare manifestation</li>\n<li>Lymphoma</li>\n</ul>\n</li>\n</ul>\n<p>Patients developing <strong>extra-articular manifestations</strong>&nbsp;are associated with <strong>risk factors</strong> such as: History of<strong>&nbsp;</strong>smoking,&nbsp;early onset of physical disability, rheumatoid factor positive and anti-CCP antibody positive.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed5bd532fa6942d1a1c2e7a914044811x720x959.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Deformities in rheumatoid arthritis</h3><p><strong>Boutonni&egrave;re deformity: </strong>Flexion of the PIP joint with hyperextension of the DIP joint.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f0250f1148284de1bd77c8d6e470c56fx720x960.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Swan-neck deformity</strong>: Hyperextension of the PIP joint with flexion of the DIP joint.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/560c6a73ecfc46e7aed6682bc24af2a4x720x1017.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Z line deformity: </strong>Radial deviation of the wrist with ulnar deviation of digits.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c60e1966a5314bbf8fd6c20a5ed7f625x800x600.JPEG\" alt=\"Pearl Image\"><p>Eversion at hindfoot (subtalar joint), hallux valgus (shown below), hammertoe.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/798b7febef7a44699a664b1f1a5363cdx720x919.JPEG\" alt=\"Pearl Image\"><p>Windswept deformities of toes - Valgus deformities of toes in one foot and varus in the other foot.&nbsp;</p>\n<p><strong>Piano-key movement </strong>of the ulnar styloid.&nbsp;</p>\n<p><strong>Trigger finger</strong> due to flexor tendon synovitis.&nbsp;</p><hr><h3>Related Pearl: Important drugs for rheumatoid arthritis</h3><p><strong>1) NSAIDs - </strong>analgesic and anti-inflammatory, used as <strong>adjunctive</strong> for management of uncontrollable <strong>symptoms</strong> and in acute <strong>flares.</strong></p>\n<p dir=\"ltr\"><strong>2) Glucocorticoids - </strong>used in acute <strong>flare</strong> for rapid control and as <strong>initial therapy</strong> before the onset of action of DMARDs. Chronic administration of low doses is needed in patients with inadequate response to DMARDs.</p>\n<ul>\n<li dir=\"ltr\">\n<p>Prednisolone - oral</p>\n</li>\n<li dir=\"ltr\">\n<p>Triamcinolone - intraarticular<br /> </p>\n</li>\n</ul>\n<p><strong><span>3) DMARDs - </span></strong><span>disease-modifying anti-rheumatoid drugs:</span></p>\n<p> </p>\n<p><strong>- Conventional DMARDs:</strong></p>\n<ul>\n<li dir=\"ltr\">Methotrexate (MTX)- is an antifolate drug. The DMARD of <strong>choice</strong> and the anchor drug for combination therapy. Regular <strong>LFT</strong> monitoring is required.</li>\n<li dir=\"ltr\">Hydroxychloroquine- is used as <strong>monotherapy</strong> for <strong>early</strong> and <strong>mild</strong> disease and in combination with other DMARDs for severe cases.</li>\n<li dir=\"ltr\">Sulfasalazine- is a salicylate. It <strong>reduces</strong> the radiographic <strong>progression</strong> of the disease.</li>\n<li dir=\"ltr\">Leflunomide- is a pyrimidine synthase inhibitor used as an <strong>alternative</strong> to MTX.</li>\n</ul>\n<p><span><strong>- Biologicals:</strong></span></p>\n<ul>\n<li>TNF-α antagonists- used in combination with MTX. Has a risk of serious bacterial infections, opportunistic fungal infection &amp; reactivation of latent TB. The TNF-α inhibitors are <strong>adalimumab,</strong> golimumab, etanercept, infliximab, and certolizumab.</li>\n<li>Abatacept- a T-cell costimulation inhibitor, used in combination with MTX, leflunomide, etc.</li>\n<li>Rituximab- an <strong>anti-CD20</strong> antibody. Used in refractory disease in combination with MTX.</li>\n<li>Anakinra- an<strong> IL-1</strong> receptor <strong>antagonist</strong>. It should not be combined with anti-TNF alpha.</li>\n<li><strong>IL-6</strong> receptor <strong>antagonists</strong>- tocilizumab and sarilumab are used as monotherapy or combination therapy in moderate to severe disease.  </li>\n</ul>\n<p><span><strong>- Small molecules: </strong></span></p>\n<ul>\n<li>Janus kinase inhibitors: <strong>Tofacitinib</strong>, baricitinib, and upadacitinib are used as monotherapy or combination therapy.</li>\n</ul><hr><h3>Related Pearl: The 'most commons' of rheumatoid arthritis</h3><table>\n<tbody>\n<tr>\n<td><strong>Feature of RA</strong></td>\n<td><strong>Most common&nbsp;</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>Involved joints</td>\n<td>MCP, Wrist, PIP(DIP spared)&nbsp;</td>\n</tr>\n<tr>\n<td>Spine involvement</td>\n<td>Cervical spine</td>\n</tr>\n<tr>\n<td>Extra-articular manifestation</td>\n<td>Subcutaneous nodules (mostly extensor surface)</td>\n</tr>\n<tr>\n<td>Cardiac manifestation</td>\n<td>Pericarditis</td>\n</tr>\n<tr>\n<td>Valvular abnormality</td>\n<td>Mitral regurgitation</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Pleuritis</td>\n</tr>\n<tr>\n<td>Hematological manifestation</td>\n<td>Normochromic normocytic anemia</td>\n</tr>\n<tr>\n<td>Neurological manifestation</td>\n<td>Compression neuropathies (mostly carpal tunnel syndrome)</td>\n</tr>\n<tr>\n<td>Ocular manifestation</td>\n<td>&nbsp;Keratoconjunctivitis sicca</td>\n</tr>\n<tr>\n<td>Lymphoma</td>\n<td>Diffuse large B-cell lymphoma</td>\n</tr>\n<tr>\n<td>Cause of death</td>\n<td>Cardiovascular disease (coronary artery disease)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/99caca27f0ba4b199e70b07a1d27f598.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0206",
      "difficulty": "medium"
    },
    {
      "text": "An 81-year-old woman presented with gradually increasing shortness of breath over the past 6 months. Examination reveals finger clubbing and bibasilar fine inspiratory crackles. Pulmonary function test showed a restrictive defect with reduced lung volumes. HRCT is shown below. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Acute interstitial pneumonia"
        },
        {
          "id": 2,
          "text": "Respiratory bronchiolitis associated interstitial lung disease"
        },
        {
          "id": 3,
          "text": "Idiopathic pulmonary fibrosis"
        },
        {
          "id": 4,
          "text": "Desquamative interstitial pneumonia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In a patient with <strong>chronic shortness of breath</strong>, finger <strong>clubbing</strong>, and fine <strong>inspiratory</strong> <strong>crackles</strong>, spirometry showing a <strong>restrictive defect</strong> and <strong>reduced lung volumes</strong> points to a diagnosis of<strong> interstitial lung disease</strong>. In the given HRCT, there is prominent <strong>honeycombing</strong> <strong>in</strong> the <strong>lower</strong> and <strong>posterior</strong> <strong>lung zones</strong>. This is seen in <strong>idiopathic pulmonary fibrosis (IPF).</strong></p>\n<p><strong>Interstitial lung diseases</strong> are characterized by <strong>inflammation</strong> and <strong>fibrosis</strong> involving the <strong>lung parenchyma</strong>. Although there are multiple diseases under this subset, the clinical presentation for all of them is the same. The <strong>patients</strong> are usually <strong>over 60 years of age</strong> and present with <strong>progressive exertional dyspnea</strong> and <strong>dry cough</strong>. On examination, <strong>fine</strong> <strong>inspiratory, velcro crackles</strong> may be heard. <strong>Digital</strong> <strong>clubbing</strong> and <strong>cyanosis</strong> are signs of advanced disease.</p>\n<p><strong>Pulmonary function tests (PFT)</strong> will show a <strong>restrictive deficit</strong> and <strong>reduction of TLC, FEV1, </strong>and<strong> FVC</strong>. There is also a <strong>reduction</strong> in <strong>DL<sub>CO</sub></strong> and may be the <strong>first finding</strong> seen<strong> in PFT</strong>. Other laboratory tests should be undertaken if the patient has symptoms involving other systems, to rule out any connective tissue disorder which might have led to ILD.</p>\n<p><strong>IPF </strong>is the <strong>most common interstitial lung disease</strong> occurring due to an <strong>unknown cause</strong>. <strong>HRCT</strong> shows <strong>predominant</strong> <strong>subpleural</strong> and <strong>basal</strong> <strong>involvement</strong>, in the form of <strong>reticulation</strong>, <strong>honeycombing,</strong> and <strong>traction</strong> <strong>bronchiectasis</strong>. This is known as the <strong>usual interstitial pneumonia (UIP)</strong> <strong>pattern</strong>. Note that <strong>ground glass opacities</strong> are <strong>absent</strong> in this pattern.&nbsp;</p>\n<p>The <strong>treatment</strong> of IPF is with <strong>antifibrotic therapy</strong> such as <strong>pirfenidone</strong> and <strong>nintedanib</strong>.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Acute interstitial pneumonia</strong> is characterized by a <strong>sudden onset</strong> of <strong>hypoxemia</strong> and respiratory distress, following symptoms of an <strong>upper respiratory tract infection. </strong>HRCT shows patchy bilateral <strong>ground-glass opacities </strong>and<strong> consolidation </strong>of the air spaces.</p>\n<p>Options B and D: <strong>Respiratory bronchiolitis associated with ILD (RB-ILD)</strong> and <strong>desquamative interstitial pneumonia (DIP)</strong> are more commonly seen in <strong>smokers.</strong> HRCT shows prominent <strong>ground-glass opacities </strong>in both these disorders.</p><hr><h3>Related Pearl: HRCT Findings in Interstitial Lung Diseases</h3><p>Idiopathic interstitial lung diseases</p>\n<ul>\n<li aria-level=\"1\"><strong>Idiopathic pulmonary fibrosis / Usual interstitial pneumonia</strong><br />\n<ul>\n<li><strong>Honeycombing</strong></li>\n<li>Reticular shadows</li>\n<li aria-level=\"1\">Traction bronchiectasis</li>\n<li aria-level=\"1\">Complete loss of lung architecture</li>\n<li aria-level=\"1\">Absence of other nonspecific findings (ground-glass opacities, nodules, cysts, consolidations)</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4689091fe1e944fbb126cdfdbbeab7ddx246x157.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Non-specific interstitial pneumonia</strong>\n<ul>\n<li aria-level=\"1\">Extensive <strong>ground-glass opacities</strong></li>\n<li aria-level=\"1\">Sub pleural sparing (specific, but not seen always)</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c2cc0129f166436b80cdc78eadefca46x706x644.PNG\" alt=\"Pearl Image\"><ul>\n<li aria-level=\"1\"><strong>Cryptogenic organizing pneumonia (COP)</strong></li>\n<ul>\n<li aria-level=\"2\">Patchy consolidation with air bronchogram</li>\n<li aria-level=\"2\"><strong>Reverse halo</strong>/ <strong>Atoll sign</strong>: Ground glass area surrounded by peripheral consolidation (as shown below in red arrows)</li>\n</ul>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/14a2b8cf78af4d09ae90a48b8fcf2a25x598x445.PNG\" alt=\"Pearl Image\"><ul>\n<li><strong>Lymphocytic interstitial pneumonia (LIP)</strong>\n<ul>\n<li aria-level=\"1\"><strong>Thin-walled cysts</strong> (shown below in red arrows)</li>\n<li aria-level=\"1\">Centrilobular nodules&nbsp;</li>\n<li aria-level=\"1\">Ground glass opacities</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df68360574724c508e6cacf09f3feb6ex663x606.PNG\" alt=\"Pearl Image\"><ul>\n<li>&nbsp;<strong>Respiratory bronchiolitis related interstitial lung disease</strong>\n<ul>\n<li>Centrilobular ground-glass nodules</li>\n<li>Bronchial wall thickening</li>\n</ul>\n</li>\n<li><strong>Acute interstitial pneumonia</strong>\n<ul>\n<li>Diffuse patchy ground-glass opacities</li>\n</ul>\n</li>\n<li><strong>Desquamated interstitial pneumonia</strong>\n<ul>\n<li>Patchy ground-glass opacities&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p>Other forms of ILDs</p>\n<ul>\n<li><strong>Lymphangioleiomyomatosis (LAM)</strong>\n<ul>\n<li>Regular thin-walled cysts</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/57506149be7c44bfb863865b2ebefaf4x1126x962.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Pulmonary alveolar proteinosis (PAP)</strong>\n<ul>\n<li aria-level=\"1\">Ground-glass opacification with superimposed septal thickening, known as &ldquo;<strong>crazy paving</strong>&rdquo;</li>\n<li aria-level=\"1\">It is characteristic but not diagnostic</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2c5317c962f4d16b1416ece31e7f352x1279x970.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Pulmonary Langerhans cell histiocytosis (PLCH)</strong>\n<ul>\n<li aria-level=\"1\">Bilateral irregular shaped cysts with nodules, predominantly in the upper lobe.</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/31564146821e4b5faa1b5305d8445724x1280x819.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6e5393d94b9d47ed8737e37191e24cc5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7497",
      "difficulty": "medium"
    },
    {
      "text": "A young woman complains of burning sensation during micturition, increased urinary frequency, and urgency. She does not complain of fever, flank pain, or colicky abdominal pain. Which of the following is/are the first-line medications used in this condition?<div class='question-desc-html'><ol>\n<li>Nitrofurantoin</li>\n<li>Ampicillin</li>\n<li>Trimethoprim and sulfamethoxazole</li>\n<li>Ciprofloxacin</li>\n<li>Cephalosporins</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 4, and 5"
        },
        {
          "id": 2,
          "text": "2, 3, and 5"
        },
        {
          "id": 3,
          "text": "1 only"
        },
        {
          "id": 4,
          "text": "1 and 3"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical sceanrio is suggestive of<strong> uncomplicated urinary tract infection</strong>&nbsp;(UTI), and<strong> nitrofurantoin </strong>and<strong>&nbsp;trimethoprim and sulfamethoxazole</strong> are the <strong>first-line drugs</strong>&nbsp;used in this condition.</p>\n<p>UTI encompasses many clinical entities, including asymptomatic bacteriuria, cystitis, prostatitis, and pyelonephritis. When the infection is confined to the bladder, also known as <strong>acute cystitis</strong>&nbsp;(the <strong>most common</strong> manifestation), it is known as&nbsp;<strong>uncomplicated UTI</strong>. This&nbsp;is&nbsp;more prevalent among <strong>women</strong> than men. When the infection extends beyond the bladder, causing systemic symptoms and signs, it is known as&nbsp;<strong>complicated UTI</strong>.</p>\n<p>Frequent sexual intercourse, a history of UTI, diabetes, and incontinence are some of the important risk factors of UTI. It is most commonly caused by <em><strong>E. coli</strong></em>. Other species include&nbsp;<em>Staphylococcus saprophyticus, Klebsiella</em>,<em> Proteus</em>,<em> Enterococcus</em>, and <em>Citrobacter</em> species.&nbsp;</p>\n<p>Patients with <strong>cystitis</strong> typically present with&nbsp;<strong>dysuria</strong>, <strong>urinary frequency</strong>, and <strong>urgency</strong>.&nbsp;Nocturia, hesitancy, suprapubic discomfort, and gross hematuria can also be seen.&nbsp;<strong>Fever</strong> with a typical high spiking picket-fence pattern and rigors,&nbsp;<strong>flank and/or loin pain</strong>,&nbsp;nausea, and vomiting&nbsp;are seen in <strong>pyelonephritis</strong>. UTI&nbsp;can be complicated by the presence of infection, stones or foreign bodies, or delayed response to treatment.</p>\n<p>Treatment in a patient with uncomplicated cystitis is started based on history alone. However, if symptoms are not specific or history is not reliable, a <strong>urine dipstick test</strong> is performed. Emperical treatment can be started in a woman with <strong>one symptom of UTI</strong> and a <strong>positive nitrite or leukocyte esterase&nbsp;</strong>result. In case of a negative result, urine culture and pelvic examination are recommended.</p>\n<p>Antibiotic therapy include:</p>\n<ul>\n<li><strong>Trimethoprim and sulfamethoxazole </strong>(TMP-SFX)<strong>&nbsp;</strong>and&nbsp;<strong>nitrofurantoin</strong>: These are the <strong>first-line </strong>drugs for <strong>uncomplicated cystitis</strong>. However, TMP-SFX show high rates of resistance and adversely affect the normal flora in the body. Pivmecillinam, fosfomycin, and nitrofurantoin can be used instead.&nbsp;</li>\n<li><strong>Beta-lactam antibiotics</strong>: These are the <strong>second-line</strong> agents due to high rates of relapse and lower pathogen clearance.</li>\n<li><strong>Fluoroquinolones&nbsp;</strong>(ciprofloxacin): These&nbsp;are used for uncomplicated cystitis only if no other alternatives are available due to high rates of resistance and side effects like increased risk of Achilles tendon rupture and irreversible neuropathy. However, they are the <strong>first-line</strong> drugs for <strong>pyelonephritis</strong>.</li>\n<li><strong>Ampicillin</strong> and <strong>cephalosporins</strong>: These are drugs of choice in <strong>pregnancy</strong>.</li>\n</ul><hr><h3>Related Pearl: Risk Factors of UTI</h3><p><strong>Risk Factors for Urinary Tract Infection</strong></p>\n<p><strong>Demographic factors</strong></p>\n<ul>\n<li>Female Gender</li>\n<li>Male infants (UTI is Males&gt;females during infancy alone)</li>\n</ul>\n<p><strong>Structural</strong> factors - Any anatomical hindrance to drainage</p>\n<ul>\n<li>Vesicoureteral reflux (for pyelonephritis)</li>\n<li>Neuropathic Bladder</li>\n<li>Pregnancy</li>\n<li>Constipation</li>\n<li>Obstructive uropathy</li>\n<li>Uncircumcised male</li>\n</ul>\n<p><strong>Practices &amp; Procedures</strong>:</p>\n<ul>\n<li>Toilet training</li>\n<li>Voiding dysfunction</li>\n<li>Wiping from back to front in Females (not males)</li>\n<li>Tight clothing (underwear)</li>\n<li>Urethral instrumentation</li>\n</ul>\n<p><strong>Infective Factors</strong></p>\n<ul>\n<li>Pinworm infestation</li>\n<li>Infection of Bacteria with P fimbriae</li>\n</ul><hr><h3>Related Pearl: Asymptomatic bacteriuria</h3><div class=\"topbullet\">&nbsp;</div>\n<div class=\"topbullet\"><strong>Asymptomatic bacteriuria: </strong>Urinary tract infection without any symptoms. Criteria for diagnosis are as follows:</div>\n<div class=\"topbullet\">&nbsp;</div>\n<table>\n<tbody>\n<tr>\n<td>Type of specimen</td>\n<td>Number of samples required&nbsp;</td>\n<td>Minimum colony-forming units (cfu)/mL required for diagnosis of UTI</td>\n</tr>\n<tr>\n<td>Midstream clean-catch urine specimen</td>\n<td>\n<p>For women: 2 consecutive samples</p>\n<p>For men: single sample</p>\n</td>\n<td><strong><strong>1,00,000&nbsp;</strong></strong>of the same bacterial species&nbsp;</td>\n</tr>\n<tr>\n<td>Catheterized urine specimen&nbsp;</td>\n<td>Single sample</td>\n<td>\n<p><strong><strong>100 </strong></strong>for&nbsp;asymptomatic bacteriuria (CA-ASB)</p>\n<p><strong>1000</strong> for catheter-associated urinary tract infection&nbsp;(CA-UTI)</p>\n</td>\n</tr>\n<tr>\n<td>Suprapubic aspirate</td>\n<td>Single sample</td>\n<td><strong>Any growth of microorganisms</strong> in the culture&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9432",
      "difficulty": "medium"
    },
    {
      "text": "The ascitic fluid analysis of a patient shows SAAG >1.1 g/dL and ascitic protein <2.5 g/dL. The most likely etiology of ascites in this patient is",
      "choices": [
        {
          "id": 1,
          "text": "Nephrotic syndrome"
        },
        {
          "id": 2,
          "text": "Cirrhosis"
        },
        {
          "id": 3,
          "text": "Tuberculosis"
        },
        {
          "id": 4,
          "text": "Constrictive pericarditis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given patient, serum ascites albumin gradient <strong>(SAAG)</strong>&nbsp;<strong>&gt;1.1 g/dl</strong> and <strong>ascitic protein</strong> <strong>&lt;2.5 g/dl</strong>. So the most likely etiology of ascities in this patient is&nbsp;<strong>cirrhosis</strong>.</p>\n<p>Ascitic fluid is extracted&nbsp;percutaneously from the peritoneum of a patient, by means of a procedure called as&nbsp;<strong>paracentesis.&nbsp;</strong>This fluid must be examined for total protien levels, albumin levels, cell counts and differential counts. A serum albumin level should be measured simultaneously for calculating&nbsp;SAAG.</p><hr><h3>Related Pearl: Serum Ascites Albumin Gradient  (SAAG)</h3><p>The serum ascites albumin gradient is calculated as follows:</p>\n<p>SAAG = Serum albumin - Ascitic fluid albumin</p>\n<p>It can be used to determine the cause of ascites following ascitic fluid analysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08ad7499e5e74b398f3c98a430c6af02x1200x1361.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0309",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old male patient came with back pain and stiffness. He was found to have sacroiliitis on imaging and was diagnosed with ankylosing spondylitis. He is positive for an HLA marker. This marker positivity is also seen in _____.<div class='question-desc-html'><ol>\n<li>Psoriatic spondylitis</li>\n<li>Reactive arthritis due to Shigella</li>\n<li>Rheumatoid arthritis</li>\n<li>Behcet’s disease</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 4 only"
        },
        {
          "id": 2,
          "text": "1, 2, and 3"
        },
        {
          "id": 3,
          "text": "1, 2 and 4"
        },
        {
          "id": 4,
          "text": "1 and 2 only"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the above clinical scenario of <strong>ankylosing spondylitis (AS)</strong>, there will be positivity for <strong>HLA-B27</strong>. This marker positivity is also seen in <strong>psoriatic</strong> <strong>spondylitis (1)</strong> and <strong>reactive arthritis (2) due to <em>Shigella</em></strong>.</p>\n<p><strong>HLA-B27 </strong>is also found to be positive in the following conditions:</p>\n<ul>\n<li><strong>Psoriatic spondylitis</strong>: Some patients with psoriatic arthritis have axial joint involvement without peripheral involvement, which presents similarly to AS.</li>\n<li><strong>Reactive arthritis</strong>: Acute non-purulent arthritis occurs a few days after a systemic infection or an infection elsewhere in the body. It is usually seen following enteric or urogenital infection. Organisms causing these infections are <em>Shigella, Salmonella, Yersinia, </em>and<em> Chlamydia.</em></li>\n</ul>\n<p><strong>Ankylosing spondylitis</strong> is a chronic inflammatory disease affecting the spine and sacroiliac joint. It is more common in <strong>young males</strong> and strongly associates with <strong>HLA-B27</strong>.</p>\n<p>Clinically, patients present with <strong>recurring backache,</strong> which <strong>worsens </strong>in the<strong> early morning </strong>or<strong> </strong>with<strong> inactivity</strong> and improves with exercise. Later, they develop fatigue, pain, joint swellings, and heel pain.</p>\n<p><strong>Extra-articular manifestations</strong> include uveitis<em>,</em> aortic incompetence, carditis, and apical lobe fibrosis.</p>\n<p>X-ray findings:</p>\n<ul>\n<li>Erosion of sacroiliac joints - <strong>sacroiliitis</strong></li>\n<li>Squaring of vertebrae and bamboo spine appearance</li>\n</ul>\n<p>Other options:</p>\n<ul>\n<li><strong>Behcet's disease</strong> - HLA-B51 positive</li>\n<li><strong>Rheumatoid arthritis</strong> - HLA DR4 positive</li>\n</ul><hr><h3>Related Pearl: HLA association with diseases</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Autoimmune Gut and Skin</strong> <strong>Diseases and HLA associations</strong></td>\n</tr>\n<tr>\n<td>Gluten-sensitive enteropathy (celiac disease)</td>\n<td>DQ2 , DQ8</td>\n</tr>\n<tr>\n<td>Chronic active hepatitis</td>\n<td>DR3</td>\n</tr>\n<tr>\n<td>Dermatitis herpetiformis</td>\n<td>DR3</td>\n</tr>\n<tr>\n<td>SLE(white)</td>\n<td>DR3</td>\n</tr>\n<tr>\n<td>Sjogren&rsquo;s syndrome</td>\n<td>DR3</td>\n</tr>\n<tr>\n<td>Psoriasis vulgaris</td>\n<td>Cw6</td>\n</tr>\n<tr>\n<td>Pemphigus vulgaris</td>\n<td>DR4, DQ1</td>\n</tr>\n<tr>\n<td>Bullous pemphigoid variant</td>\n<td>DQ7</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><table>\n<tbody>\n<tr>\n<td><strong>Autoimmune Endocrine</strong> <strong>Diseases and HLA associations</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Type 1 diabetes mellitus</td>\n<td>DQ8, DR4, DR3, DR2</td>\n</tr>\n<tr>\n<td>Hyperthyroidism (Graves&rsquo;)</td>\n<td>B8, DR3</td>\n</tr>\n<tr>\n<td>Hyperthyroidism (Japanese)</td>\n<td>B35</td>\n</tr>\n<tr>\n<td>Adrenal insufficiency</td>\n<td>DR3</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><table>\n<tbody>\n<tr>\n<td><strong>Autoimmune Neurologic</strong> <strong>Diseases and HLA associations</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Myasthenia gravis</td>\n<td>B8</td>\n</tr>\n<tr>\n<td>Multiple sclerosis</td>\n<td>B16, DR2</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Other Important Diseases and their HLA Associations</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Ankylosing Spondylitis</p>\n</td>\n<td>B27</td>\n</tr>\n<tr>\n<td>\n<p>Reactive Arthritis</p>\n</td>\n<td>B27</td>\n</tr>\n<tr>\n<td>\n<p>Psoriatic Arthritis</p>\n</td>\n<td>B27</td>\n</tr>\n<tr>\n<td>Behcet&rsquo;s disease</td>\n<td>B51</td>\n</tr>\n<tr>\n<td>Congenital adrenal hyperplasia</td>\n<td>B47</td>\n</tr>\n<tr>\n<td>Narcolepsy</td>\n<td>DR2 (<strong>DQB1*06:02)</strong></td>\n</tr>\n<tr>\n<td>Goodpasture&rsquo;s syndrome (anti-GBM)</td>\n<td>DR2</td>\n</tr>\n<tr>\n<td>Abacavir hypersensitivity</td>\n<td>B57 <strong>(</strong><strong>B*57:01)</strong></td>\n</tr>\n<tr>\n<td>Hemochromatosis</td>\n<td>A3</td>\n</tr>\n<tr>\n<td>Narcolepsy</td>\n<td>Q1</td>\n</tr>\n<tr>\n<td>Rheumatoid arthritis</td>\n<td>DR4</td>\n</tr>\n<tr>\n<td>\n<p>Pernicious anemia</p>\n</td>\n<td>DR5&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;Hashimoto thyroiditis</td>\n<td>DR3, DR5</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5990",
      "difficulty": "medium"
    },
    {
      "text": "A 20-year-old female patient came to the emergency room stating that she passed blood instead of urine. Labs revealed Hb 6.5 g/dL, leukocyte count 3500/mm3, platelet count 65000/mm3, reticulocytosis, and elevated LDH levels. Flow cytometry showed CD55- and CD59-negative RBCs. Which of the following drugs is used for the treatment of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Eculizumab"
        },
        {
          "id": 2,
          "text": "Ocrelizumab"
        },
        {
          "id": 3,
          "text": "Tocilizumab"
        },
        {
          "id": 4,
          "text": "Durvalumab"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>paroxysmal nocturnal hemoglobinuria </strong>(PNH), and the drug used to treat this condition is <strong>Eculizumab</strong>.</p>\n<p>PNH is an <strong>acquired chronic hemolytic anaemia </strong>characterized by a triad of <strong>intravascular</strong> <strong>hemolysis</strong>,<strong> pancytopenia</strong>, and the tendency for <strong>venous thrombosis</strong>. </p>\n<p>Clinical features include:</p>\n<ul>\n<li>Symptoms of anaemia (may also be discovered incidentally)</li>\n<li>Increased susceptibility to infections (due to severe neutropenia)</li>\n<li>Hemorrhage (due to severe thrombocytopenia)</li>\n<li>Recurrent attacks of severe abdominal pain (due to abdominal vein thrombosis or intravascular hemolysis)</li>\n<li>Budd-Chiari syndrome, presenting as acute hepatomegaly and ascites (due to hepatic vein thrombosis)</li>\n</ul>\n<p>Lab investigations reveal:</p>\n<ul>\n<li><strong>Anaemia</strong>: Normo-macrocytic; can become microcytic due to chronic iron loss</li>\n<li><strong>Hemoglobinuria</strong>: Resulting in chronic iron loss</li>\n<li>High MCV: May occur due to marked reticulocytosis </li>\n<li>Elevated unconjugated bilirubin</li>\n<li><strong>Markedly elevated LDH</strong></li>\n<li><strong>Cellular bone marrow</strong> with marked erythroid hyperplasia, progressing to a hypocellular or aplastic bone marrow</li>\n<li><strong>Increased susceptibility of RBCs to complement </strong>(C): Occurs due to deficiency of surface proteins CD59 and CD55. This definitive diagnosis is performed via <strong>flow cytometry</strong> (high sensitivity). A bimodal distribution of cells is seen, with a substantial population of <strong>CD59- </strong>and<strong> CD55-negative cells</strong>.</li>\n</ul>\n<p>Treatment involves anti-complement therapy with drugs such as<strong> eculizumab</strong> (administered IV every 2 weeks) and <strong>ravulizumab </strong>(administered every 8 weeks). </p>\n<p>However, since these drugs are expensive, supportive treatment is exceedingly important:</p>\n<ul>\n<li>Folic acid supplements (at least 3 mg/d)</li>\n<li>Periodic monitoring of serum iron, iron supplements, and blood transfusions whenever necessary</li>\n<li>Regular anticoagulant prophylaxis for patients with venous thrombosis or thrombophilia</li>\n<li>Thrombolytic treatment with tissue plasminogen activator for patients with thrombotic complications</li>\n</ul>\n<p><strong>Bone marrow transplant</strong> or immunosuppressive therapy should be considered in very young patients with severe PNH and possible bone marrow failure.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Ocrelizumab</strong> is an anti-CD20 monoclonal antibody used to treat patients with <strong>relapsing</strong> and <strong>primary progressive multiple sclerosis</strong>. It depletes circulating B cells through antibody- and complement-dependent cytotoxicity.</p>\n<p>Option C: <strong>Tocilizumab</strong> is an anti-IL-6 monoclonal antibody used in the treatment of <strong>giant cell arteritis</strong>, <strong>rheumatoid arthritis</strong>, <strong>cytokine release syndrome</strong>, <strong>COVID-19 infection</strong>, and <strong>systemic sclerosis</strong>.</p>\n<p>Option D: <strong>Durvalumab</strong> is an immune checkpoint inhibitor of the programmed death-ligand 1 pathway used to treat patients with <strong>stage III non-small cell lung carcinoma</strong> and <strong>limited-stage small cell lung carcinoma</strong>.</p><hr><h3>Related Pearl: FDA approved drugs in 2017</h3><p>The following is the list of drugs approved by FDA in 2017, organized into specialities based on their indication.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Indication</strong></td>\n</tr>\n<tr>\n<td><strong>A. Cardiology/Vascular Diseases</strong></td>\n</tr>\n<tr>\n<td>1.&nbsp;&nbsp;&nbsp; Betrixaban</td>\n<td>It is a Factor Xa (FXa) inhibitor used or the prophylaxis of <strong>venous thromboembolism (VTE)</strong> in adult patients hospitalized for an acute medical illness</td>\n</tr>\n<tr>\n<td><strong>B. Hematology</strong></td>\n</tr>\n<tr>\n<td>2.&nbsp;&nbsp;&nbsp; Copanlisib</td>\n<td>Kinase inhibitor used to treat adults with relapsed <strong>follicular lymphoma</strong> who have received at least two prior systemic therapies</td>\n</tr>\n<tr>\n<td>3.&nbsp;&nbsp;&nbsp; Inotuzumab ozogamicin</td>\n<td>CD22-directed antibody-drug conjugate (ADC) to treat adults with relapsed or refractory B-cell precursor <strong>Acute</strong> <strong>Lymphoblastic leukemia (ALL).</strong></td>\n</tr>\n<tr>\n<td>4.&nbsp;&nbsp;&nbsp; Acalabrutinib</td>\n<td>Kinase inhibitor used to treat adults with <strong>mantle cell lymphoma (MCL)</strong> who have received at least one prior therapy</td>\n</tr>\n<tr>\n<td>5.&nbsp;&nbsp;&nbsp; L-glutamine oral powder</td>\n<td>An N amino acid used to reduce the acute complications of <strong>sickle cell disease</strong> in adult and pediatric patients 5 years of age and older.</td>\n</tr>\n<tr>\n<td>6.&nbsp;&nbsp;&nbsp; Emicizumab-kxwh</td>\n<td>Bispecific factor IXa- and factor X-directed antibody used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with <strong>Hemophilia A</strong> (congenital factor VIII deficiency) with factor VIII inhibitors</td>\n</tr>\n<tr>\n<td>7.&nbsp;&nbsp;&nbsp; Enasidenib</td>\n<td>Isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory <strong>acute myeloid leukemia</strong> <strong>(AML) </strong>with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA approved test.</td>\n</tr>\n<tr>\n<td>8.&nbsp;&nbsp;&nbsp; Midostaurin</td>\n<td>Kinase inhibitor used in newly diagnosed cases of <strong>acute myeloid leukemia (AML)</strong> that is FLT3 mutation positive as detected by an FDA-approved test, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation.&nbsp;Also used in aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).&nbsp;</td>\n</tr>\n<tr>\n<td><strong>C. Gastroenterology</strong></td>\n</tr>\n<tr>\n<td>9.&nbsp;&nbsp;&nbsp; Naldemedine</td>\n<td>An opioid antagonist indicated for the treatment of <strong>opioid-induced constipation</strong></td>\n</tr>\n<tr>\n<td>10.Plecanatide</td>\n<td>Guanylate cyclase-C agonist to treat <strong>Chronic Idiopathic Constipation (CIC)</strong> in adult patients.</td>\n</tr>\n<tr>\n<td>11.Telotristat ethyl</td>\n<td>Tryptophan hydroxylase inhibitor, to treat <strong>carcinoid syndrome diarrhea</strong></td>\n</tr>\n<tr>\n<td><strong>D. Endocrinology</strong></td>\n</tr>\n<tr>\n<td>12.Semaglutide</td>\n<td>Glucagon-like peptide 1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with <strong>type 2 diabetes mellitus</strong></td>\n</tr>\n<tr>\n<td>13.Dapagliflozin and saxagliptin</td>\n<td>Sodium-glucose cotransporter 2 (SGLT-2) inhibitor and a dipeptidyl peptidase-4 (DPP-4) inhibitor combination, indicated as an adjunct to diet and exercise to improve glycemic control in adults with <strong>type 2 Diabetes mellitus</strong> (T2DM) who have inadequate control with dapagliflozin or who are already treated with dapagliflozin and saxagliptin.</td>\n</tr>\n<tr>\n<td><strong>E. Hepatology</strong></td>\n</tr>\n<tr>\n<td>14.Hepatitis B vaccine (recombinant), Adjuvanted</td>\n<td>Indicated for prevention of infection caused by all known subtypes of <strong>hepatitis b virus</strong>. It isApproved for use in adults 18 years of age and older.</td>\n</tr>\n<tr>\n<td>15.Glecaprevir and Pibrentasvir</td>\n<td>Fixed-dose combination of glecaprevir, a hepatitis C virus (HCV) NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor indicated for the treatment of patients with <strong>chronic HCV</strong> genotype (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis and with compensated cirrhosis (Child-Pugh A)</td>\n</tr>\n<tr>\n<td>16.Sofosbuvir, Velpatasvir and Voxilaprevir</td>\n<td>Fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, velpatasvir, an HCV NS5A inhibitor, and voxilaprevir, an HCV NS3/4A protease inhibitor indicated for the treatment of adult patients with <strong>chronic HCV</strong> infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have (1, 2.2, 14).</td>\n</tr>\n<tr>\n<td><strong>F. Nephrology</strong></td>\n</tr>\n<tr>\n<td>17.Etelcalcetide</td>\n<td>Calcium-sensing receptor agonist to treat <strong>secondary hyperparathyroidism</strong> in adult patients with <strong>chronic kidney disease</strong> undergoing dialysis</td>\n</tr>\n<tr>\n<td>18.Meropenem and Vaborbactam</td>\n<td>Combination of meropenem, a penem antibacterial, and vaborbactam, a beta-lactamase inhibitor to treat adults with <strong>complicated urinary tract infections</strong> including <strong>pyelonephritis</strong> caused by designated susceptible bacteria</td>\n</tr>\n<tr>\n<td><strong>G. Neurology</strong></td>\n</tr>\n<tr>\n<td>19.Deutetrabenazine</td>\n<td>Vesicular monoamine transporter 2 (VMAT2) inhibitor for the treatment of <strong>chorea</strong> associated with <strong>Huntington&rsquo;s disease</strong> and <strong>tardive dyskinesia</strong> in adults</td>\n</tr>\n<tr>\n<td>20.Valbenazine</td>\n<td>Vesicular monoamine transporter 2 (VMAT2) inhibitor to treat adults with <strong>tardive dyskinesia</strong></td>\n</tr>\n<tr>\n<td>21.Edaravone</td>\n<td>Member of the substituted 2-pyrazolin-5-oneclass used to treat patients with <strong>amyotrophic lateral sclerosis (ALS)</strong></td>\n</tr>\n<tr>\n<td>22.Safinamide</td>\n<td>Monoamine oxidase type B (MAO-B) inhibitor indicated as an adjunctive treatment to levodopa/carbidopa in patients with <strong>Parkinson&rsquo;s Disease (PD)</strong> experiencing &ldquo;off&rdquo; episodes</td>\n</tr>\n<tr>\n<td><strong>H. Rheumatology</strong></td>\n</tr>\n<tr>\n<td>23.Sarilumab</td>\n<td>Interleukin-6 (IL-6) receptor antagonist to treat adult <strong>rheumatoid arthritis</strong></td>\n</tr>\n<tr>\n<td>24.Ocrelizumab</td>\n<td>CD20-directed cytolytic antibody to treat patients with relapsing and primary progressive forms of <strong>multiple sclerosis</strong></td>\n</tr>\n<tr>\n<td><strong>I. Oncology</strong></td>\n</tr>\n<tr>\n<td>25.Abemaciclib</td>\n<td>Kinase inhibitor to treat certain advanced or <strong>metastatic breast cancers</strong></td>\n</tr>\n<tr>\n<td>26.Neratinib maleate</td>\n<td>Kinase inhibitor indicated for extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified <strong>breast cancer.</strong></td>\n</tr>\n<tr>\n<td>27.Ribociclib</td>\n<td>Kinase inhibitor used to treat postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic <strong>breast cancer</strong>.</td>\n</tr>\n<tr>\n<td>28.Durvalumab</td>\n<td>Programmed death-ligand 1 (PD-L1) blocking antibody to treat patients with locally advanced or metastatic <strong>urothelial carcinoma.</strong></td>\n</tr>\n<tr>\n<td>29.Brigatinib</td>\n<td>Kinase inhibitor to treat patients with anaplastic lymphoma kinase (ALK)-positive metastatic <strong>Non-small cell lung cancer (NSCLC)</strong> who have progressed on or are intolerant to crizotinib.</td>\n</tr>\n<tr>\n<td>30.Niraparib <strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></td>\n<td>Poly (ADP-ribose) polymerase (PARP) inhibitor indicated for the maintenance treatment for <strong>recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers </strong>who are in a complete or partial response to platinum-based chemotherapy.</td>\n</tr>\n<tr>\n<td><strong>J. Pulmonology</strong></td>\n</tr>\n<tr>\n<td>31.Benralizumab</td>\n<td>Interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) for add-on maintenance treatment of patients with <strong>severe asthma</strong> aged 12 years and older, and with an eosinophilic phenotype.</td>\n</tr>\n<tr>\n<td><strong>K. Internal medicine</strong></td>\n</tr>\n<tr>\n<td>32.Letermovir</td>\n<td>CMV DNA terminase complex inhibitor indicated for the prevention of <strong>cytomegalovirus</strong> <strong>infection</strong> following allogenic <strong>hematopoietic stem cell transplant.</strong></td>\n</tr>\n<tr>\n<td><strong>L. Dermatology</strong></td>\n</tr>\n<tr>\n<td>33.Avelumab</td>\n<td>Programmed death ligand-1 (PD-L1) blocking antibody to treat metastatic <strong>Merkel cell carcinoma</strong></td>\n</tr>\n<tr>\n<td>34.Delafloxacin</td>\n<td>Fluoroquinolone antibacterial to treat patients with <strong>acute</strong> <strong>bacterial skin infections</strong></td>\n</tr>\n<tr>\n<td>35.Dupilumab</td>\n<td>Interleukin-4 receptor alpha antagonist to treat adults with moderate-to-severe eczema (<strong>atopic</strong> <strong>dermatitis</strong>)</td>\n</tr>\n<tr>\n<td>36.Brodalumab</td>\n<td>Human interleukin-17 receptor A (IL-17RA) antagonist to treat adults with moderate-to-severe <strong>plaque psoriasis</strong></td>\n</tr>\n<tr>\n<td>37.Guselkumab</td>\n<td>Interleukin-23 blocker for the treatment of adult patients with moderate-to-severe <strong>plaque psoriasis</strong></td>\n</tr>\n<tr>\n<td>38.Ozenoxacin</td>\n<td>A quinolone antimicrobial indicated to treat <strong>impetigo</strong></td>\n</tr>\n<tr>\n<td><strong>M. Pediatrics</strong></td>\n</tr>\n<tr>\n<td>39.Vestronidase alfavjbk</td>\n<td>Recombinant human lysosomal beta glucuronidase indicated to treat pediatric and adult patients with an inherited metabolic condition called <strong>mucopolysaccharidosis type VII (MPS VII),</strong> also known as <strong>sly syndrome.</strong></td>\n</tr>\n<tr>\n<td>40.Benznidazole</td>\n<td>Nitroimidazole antimicrobial indicated to treat children ages 2 to 12 years old with <strong>chagas</strong> <strong>disease</strong></td>\n</tr>\n<tr>\n<td>41.Deflazacort</td>\n<td>Corticosteroid used to treat patients age 5 years and older with <strong>duchenne muscular dystrophy</strong> (<strong>DMD</strong>)</td>\n</tr>\n<tr>\n<td>42.Cerliponase alfa</td>\n<td>Hydrolytic lysosomal N-terminal tripeptidyl peptidase indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late <strong>infantile neuronal ceroid lipofuscinosis type 2 (CLN2</strong>), also known as tripeptidyl peptidase 1 (TPP1) deficiency.</td>\n</tr>\n<tr>\n<td><strong>N. Obstetrics &amp; Gynecology</strong></td>\n</tr>\n<tr>\n<td>43.Secnidazole</td>\n<td>Nitroimidazole antimicrobial used for the treatment of <strong>bacterial vaginosis</strong></td>\n</tr>\n<tr>\n<td>44.Abaloparatide</td>\n<td>Human parathyroid hormone related peptide [PTHrP(1-34)] analog for the treatment of <strong>osteoporosis</strong> <strong>in postmenopausal women</strong> at high risk of fracture or those who have failed other therapies.</td>\n</tr>\n<tr>\n<td><strong>O. Ophthalmology</strong></td>\n</tr>\n<tr>\n<td>45.Latanoprostene Bunod ophthalmic solution</td>\n<td>Prostaglandin analog to treat <strong>intraocular pressure</strong> in patients with <strong>open-angle glaucoma or ocular hypertension.</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Complement deficiency and associated diseases</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Complement protein</td>\n<td>Effects of deficiency</td>\n</tr>\n<tr>\n<td>C1, C2, C4</td>\n<td>Immune- complex disease (SLE)</td>\n</tr>\n<tr>\n<td>C3, Factor I</td>\n<td>Susceptibility to capsulated bacteria</td>\n</tr>\n<tr>\n<td>C5-C9</td>\n<td>Susceptibility to Neisseria</td>\n</tr>\n<tr>\n<td>Factor D. properdin (factor P)</td>\n<td>Susceptibility to capsulated bacteria and Neisseria.</td>\n</tr>\n<tr>\n<td>\n<p>DAF (Decay accelerating factor)</p>\n<p>CD 59</p>\n</td>\n<td>Paroxysmal nocturnal hemoglobinuria</td>\n</tr>\n<tr>\n<td>C1-inhibitor</td>\n<td>Hereditary angioneurotic edema</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Classification of Hemolytic Anemias</h3><p>Hemolytic anemias can be classified in 2 ways:</p>\n<p>1. Based on the <strong>type of defect</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type </strong></td>\n<td><strong>Intracorpuscular Defects</strong></td>\n<td><strong>Extracorpuscular Factors</strong></td>\n</tr>\n<tr>\n<td>Hereditary</td>\n<td>\n<p>Hemoglobinopathies</p>\n<p>Enzymopathies</p>\n<p>Membrane-cytoskeletal defects</p>\n</td>\n<td>Familial (atypical) hemolytic uremic syndrome</td>\n</tr>\n<tr>\n<td>Acquired</td>\n<td>Paroxysmal nocturnal hemoglobinuria (PNH)</td>\n<td>\n<p>Mechanical destruction (microangiopathic)</p>\n<p>Toxic agents</p>\n<p>Drugs</p>\n<p>Infectious</p>\n<p>Autoimmune</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>2. Based on the <strong>sites</strong> of <strong>hemolysis:</strong></p>\n<p><strong>Intravascular </strong>hemolysis<strong>:</strong></p>\n<ul>\n<li><span class=\"TextRun SCXW225898103\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW225898103\">Mechanical injury</span></span>\n<ul>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Trauma caused by cardiac valves </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Microangiopathic hemolytic anaemias (hemolytic uremic syndrome, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura) </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"2\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Repetitive physical trauma</li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW46333709\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW46333709\">Complement fixation (antibody-mediated destruction)</span></span>\n<ul>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Hemolytic disease of the newborn- ABO incompatibility </li>\n<li data-leveltext=\"%1.\" data-font=\"Calibri, sans-serif\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Transfusion reaction  </li>\n<li data-leveltext=\"%1.\" data-font=\"\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Drug-induced </li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Infections of red blood cells </span></span>\n<ul>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Malaria</span></span></li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">B</span></span><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW127641793\">abesiosis</span></span></li>\n</ul>\n</li>\n<li><span class=\"EOP SCXW127641793\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\">Exogenous toxic factors - c</span></span></span><span class=\"EOP SCXW127641793\" data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"SpellingError SCXW261552469\">lostridial</span></span><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\"> sepsis</span></span></span></li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\"><strong>Extravascular </strong>hemolysis<strong>:</strong></p>\n<ul>\n<li>Hereditary spherocytosis</li>\n<li>Thalassemia</li>\n<li>Sickle cell anemia</li>\n<li>Hemolytic disease of the newborn- Rh incompatibility</li>\n</ul>\n<p><strong>Both</strong> intravascular and extravascular hemolysis:</p>\n<ul>\n<li>G6PD deficiency</li>\n<li>Autoimmune hemolytic anemia</li>\n</ul>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7895",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following disorders of bilirubin metabolism leads to predominantly conjugated hyperbilirubinemia?<div class='question-desc-html'><ol>\n<li>Dubin-Johnson syndrome</li>\n<li>Gilbert syndrome</li>\n<li>Rotor syndrome</li>\n<li>Byler disease</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 2"
        },
        {
          "id": 2,
          "text": "1, 3, 4"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 4,
          "text": "1 and 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Dubin-Johnson syndrome, Rotor syndrome</strong>, and <strong>Byler disease</strong> are the disorders of bilirubin metabolism which lead to predominant conjugated hyperbilirubinemia.</p>\n<p><strong>Unconjugated hyperbilirubinemia:</strong> It occurs<strong>&nbsp;</strong>either due to a <strong>hemolytic process</strong> producing excess bilirubin or due to a <strong>impaired uptake/ conjugation</strong> of bilirubin causing inadequate conjugation.</p>\n<p>Causes of unconjugated hyperbilirubinemia include:&nbsp;</p>\n<ul>\n<li>Increased bilirubin production due to hemolysis\n<ul>\n<li>Inherited -&nbsp;sickle cell anemia, thalassemia, G6PD deficiency</li>\n<li>Acquired -&nbsp;paroxysmal nocturnal hemoglobinuria</li>\n</ul>\n</li>\n<li>Increased bilirubin due to ineffective erythropoiesis\n<ul>\n<li>Iron, cobalamine, and folate deficiency</li>\n</ul>\n</li>\n<li>Drugs - Rifampicin, probenecid.</li>\n<li>Hereditary defects in conjugation -<strong>&nbsp;</strong>\n<ul>\n<li><strong>Criggler-Najjar syndrome </strong>(<strong>type I </strong>and<strong> II</strong>)</li>\n<li><strong>Gilbert syndrome</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Mixed </strong>or <strong>predominantly conjugated hyperbilirubinemia:&nbsp;</strong>It occurs either due to <strong>impaired excretion</strong> of conjugated bilirubin into the bile ductules or due to backward leakage of the bile.&nbsp;</p>\n<p>Familial defects in hepatic excretory function include:</p>\n<ul>\n<li><strong>Dubin-Johnson syndrome</strong></li>\n<li><strong>Rotor syndrome</strong></li>\n<li>Benign recurrent intrahepatic cholestasis (BRIC)</li>\n<li>Progressive familial intrahepatic cholestasis (FIC)\n<ul>\n<li>Type 1 - is called <strong>Byler disease</strong></li>\n</ul>\n</li>\n</ul>\n<p>Note: <strong>Byler disease</strong> is a cholestatic disease that presents episodically from infancy. It is due to <strong>FIC1 mutation</strong> and it can lead to malnutrition, growth retardation, and end stage liver disease during childhood.</p><hr><h3>Related Pearl: Hereditary Hyperbilirubinemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Defects in bilirubin metabolism</strong></td>\n<td><strong>Clinical course</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Unconjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type I</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Absent UGT1A1 activity</p>\n</td>\n<td>\n<p>Fatal in the neonatal period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type II</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Generally mild,</p>\n<p>occasional kernicterus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>\n<p>AR (common)</p>\n<p>AD (occasional)</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Conjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Dubin-Johnson syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Impaired biliary excretion of bilirubin glucuronides due to a mutation in canalicular multidrug resistance protein 2 (MRP2)</p>\n</td>\n<td>\n<p>Innocuous with black pigmentation of liver</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotor syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased hepatic uptake and storage</p>\n<p>Decreased biliary excretion</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Hyperbilirubinemia- Causes</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Predominantly Unconjugated Hyperbilirubinemia&nbsp;</strong></td>\n<td><strong>Conjugated hyperbilirubinemia</strong></td>\n</tr>\n<tr>\n<td>\n<p>Excess production of bilirubin</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hemolytic anemias</p>\n</td>\n<td>\n<p>Biliary tract obstruction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resorption of blood from internal hemorrhage (e.g., alimentary tract bleeding, hematomas)</p>\n</td>\n<td>\n<p>&nbsp;Biliary tract diseases like primary biliary cirrhosis and primary sclerosing cholangitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ineffective erythropoiesis (e.g., pernicious anemia, thalassemia)</p>\n</td>\n<td>\n<p>Dubin Johnson syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reduced hepatic uptake</p>\n</td>\n<td>\n<p>Rotor syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Drug interference with membrane carrier systems</p>\n</td>\n<td>Benign recurrent intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td>\n<p>Some cases of Gilbert syndrome</p>\n</td>\n<td>Progressive familial intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td>\n<p>Impaired bilirubin conjugation</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Physiologic jaundice of the newborn (decreased UGT1A1 activity, decreased excretion)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Breast milk jaundice (&beta;-glucuronidases in milk)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Genetic deficiency of UGT1A1 activity (Crigler-Najjar syndrome types I and II)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse hepatocellular disease (e.g., viral or drug-induced hepatitis, cirrhosis)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9894",
      "difficulty": "easy"
    },
    {
      "text": "Match the following:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td colspan=\"2\">&nbsp;<strong>Disease</strong></td>\n<td colspan=\"2\"><strong>Gene</strong></td>\n</tr>\n<tr>\n<td>1.&nbsp;</td>\n<td>Medullary cystic kidney disease-1 (MCKD-1) &nbsp;</td>\n<td>a.</td>\n<td>UMOD</td>\n</tr>\n<tr>\n<td>2.&nbsp;</td>\n<td>Medullary cystic kidney disease-2 (MCKD 2) &nbsp;</td>\n<td>b.</td>\n<td>PKHD1</td>\n</tr>\n<tr>\n<td>3.&nbsp;</td>\n<td>Adolescent nephronophthisis &nbsp;</td>\n<td>c.</td>\n<td>MUC1</td>\n</tr>\n<tr>\n<td>4.</td>\n<td>Autosomal recessive polycystic kidney disease (ARPKD) &nbsp;&nbsp;</td>\n<td>d.</td>\n<td>NPHP2&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-d, 2-b, 3-c, 4-a"
        },
        {
          "id": 2,
          "text": "1-b, 2-d, 3-a, 4-c"
        },
        {
          "id": 3,
          "text": "1-c, 2-a, 3-d, 4-b"
        },
        {
          "id": 4,
          "text": "1-a, 2-c, 3-b, 4-d"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The gene mutations causing the following cystic disorders are:</p>\n<ul>\n<li>Medullary cystic kidney disease-1 (<strong>MCKD-1</strong>) -&nbsp;<strong>MUC1 </strong></li>\n<li>Medullary cystic kidney disease-2 (<strong>MCKD-2</strong>) - <strong>UMOD</strong></li>\n<li>Autosomal recessive polycystic kidney disease (<strong>ARPKD</strong>) - <strong>PKHD1&nbsp;</strong></li>\n<li>Adolescent <strong>nephronophthisis</strong> - <strong>NPHP</strong> 1-20</li>\n</ul>\n<p>Medullary cystic kidney disease (<strong>MCKD</strong>) is an <strong>autosomal dominant</strong> disorder. It presents with a late-onset, slowly progressive renal failure. Renal cysts are not common but can be seen occasionally. Medullary cystic kidney diseases are of two types, MCKD1 and MCKD2.</p>\n<p><strong>MCKD1</strong> is due to a defect in the&nbsp;<strong>mucin 1</strong> (MUC1) gene. The mutated gene codes for a large protein fragment that has a toxic effect on the tubules. It is not associated with elevated uric acid levels and gout.</p>\n<p><strong>MCKD2</strong> is due to a defect in the UMOD gene, which codes for the protein <strong>uromodulin</strong>. It is associated with <strong>hyperuricemia </strong>and<strong> gout</strong>.</p><hr><h3>Related Pearl: Cystic Diseases of the Kidney</h3><table>\n<tbody>\n<tr>\n<td><strong>Features&nbsp;</strong></td>\n<td><strong>Adult PKD</strong></td>\n<td><strong>Childhood PKD</strong></td>\n</tr>\n<tr>\n<td><strong>Mode of inheritance</strong></td>\n<td>Autosomal dominant</td>\n<td>Autosomal recessive</td>\n</tr>\n<tr>\n<td><strong>Mutation in genes</strong></td>\n<td>PKD1, PKD2</td>\n<td>PKHD1</td>\n</tr>\n<tr>\n<td><strong>Proteins produced</strong></td>\n<td>Polycystin 1, polycystin 2</td>\n<td>Fibrocystin</td>\n</tr>\n<tr>\n<td><strong>Chromosomes involved</strong></td>\n<td>16p, 4q</td>\n<td>6p</td>\n</tr>\n<tr>\n<td><strong>Extrarenal manifestations&nbsp;</strong></td>\n<td>\n<p>Multiple cysts in the <strong>liver</strong> (most common), pancreas, spleen</p>\n<p>Berry aneurysms in the circle of Willis - SAH</p>\n<p>Colonic diverticuli</p>\n<p>Mitral valve prolapse</p>\n</td>\n<td><strong>Congenital hepatic fibrosis</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Other cystic diseases:</p>\n<p><strong>Medullary sponge kidney</strong> -&nbsp;</p>\n<ul>\n<li aria-level=\"1\">Sporadic in origin</li>\n<li aria-level=\"1\">Characterized by medullary cysts</li>\n<li aria-level=\"1\">Associated with hematuria, recurrent renal stones, and normal renal function</li>\n</ul>\n<p><strong>Multicystic renal dysplasia</strong> -&nbsp;</p>\n<ul>\n<li aria-level=\"1\">Characterized by irregular, enlarged, multicystic kidneys</li>\n<li aria-level=\"1\">Associated with ureteropelvic obstruction, ureteral agenesis, or atresia&nbsp;</li>\n<li aria-level=\"1\">Bilateral multicystic renal dysplasia&nbsp; is associated with renal failure</li>\n</ul>\n<p><strong>Simple renal cysts</strong> -&nbsp;</p>\n<ul>\n<li aria-level=\"1\">Characterized by single or multiple cysts with normal-sized kidney</li>\n<li aria-level=\"1\">Associated with microscopic hematuria</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0672",
      "difficulty": "easy"
    },
    {
      "text": "A postpartum woman developed a severe headache and lactational failure. MRI revealed enlarged pituitary with a hemorrhagic infarct. She does not have any visual disturbance, ophthalmoplegia, or impaired consciousness. What is the most-likely management in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Surgical decompression"
        },
        {
          "id": 2,
          "text": "High dose glucocorticoids"
        },
        {
          "id": 3,
          "text": "Wait and watch"
        },
        {
          "id": 4,
          "text": "IV mannitol"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario and MRI findings is suggestive of <strong>pituitary apoplexy</strong> in a post-partum woman.&nbsp;Since there is no evidence of visual loss or impaired consciousness, the most likely management in this case would be&nbsp;<strong>high-dose glucocorticoids.</strong></p>\n<p>Pituitary apoplexy is damage to the pituitary gland and the surrounding structures as a result of acute <strong>intrapituitary hemorrhagic vascular events</strong>. It occurs spontaneously, as in pre-existing adenoma or in <strong>postpartum cases (Sheehan's syndrome)</strong>&nbsp;or&nbsp;in association with other systemic diseases like diabetes mellitus, systemic hypertension, sickle cell anemia, and acute shock.&nbsp;</p>\n<p><strong>Postpartum apoplexy</strong>&nbsp;is due to the hyperplastic enlargement of the pituitary gland (occuring normally in pregnant woman), which poses an increased risk for haemorrhage. Clinical features include:</p>\n<ul>\n<li>Headache with signs of meningeal irritation</li>\n<li>Lactational failure</li>\n<li>Bilateral visual changes</li>\n<li>Ophthalmoplegia</li>\n<li>Cardiovascular collapse (shock)&nbsp;</li>\n<li>Hypoglycemia or diabetes mellitus</li>\n<li>Loss of consciousness</li>\n</ul>\n<p>Investigation of choice:&nbsp;<strong>MRI</strong>&nbsp;or <strong>CT</strong> shows signs of intratumoral or sellar hemorrhage, with pituitary stalk deviation and compression of pituitary tissue.</p>\n<p>Treatment :</p>\n<ul>\n<li><strong>No signs</strong> of visual disturbances or loss of consciousness - <strong>high dose glucocorticoids</strong></li>\n<li>Signs of<strong>&nbsp;</strong>progressive visual loss, cranial nerve palsy, or loss of consciousness present - <strong>urgent surgical decompression</strong></li>\n</ul>\n<p><strong>Note:&nbsp;</strong>Hypopituitarism follows pituitary apoplexy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4661",
      "difficulty": "medium"
    },
    {
      "text": "An elderly man who is a known case of hypertension and uncontrolled diabetes mellitus presents with decreased urine output and facial puffiness. His estimated glomerular filtration rate was 20 mL/min/1.73 sq. m. According to the KDIGO classification, what is the stage of his chronic kidney disease?",
      "choices": [
        {
          "id": 1,
          "text": "G3a"
        },
        {
          "id": 2,
          "text": "G3b"
        },
        {
          "id": 3,
          "text": "G4"
        },
        {
          "id": 4,
          "text": "G5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>According to the KDIGO classification, the stage of this patient's chronic kidney disease (CKD) is&nbsp;<strong>G4.</strong></p>\n<p>CKD is a spectrum of pathophysiological processes resulting in abnormal kidney function, with a <strong>progressive decline</strong> in <strong>glomerular filtration rate</strong> (GFR). According to the <strong>Kidney Disease Improving Global Outcome (KDIGO)</strong> classification, CKD can be stratified using both <strong>GFR</strong> and <strong>albuminuria&nbsp;</strong>to predict the risk of progression of CKD:</p>\n<p>Stages of CKD based on GFR (mL/min/1.73 sq.m):</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>GFR&nbsp;</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>G1</td>\n<td><span class=\"ILfuVd yZ8quc\">&ge;90</span></td>\n<td>Normal or high</td>\n</tr>\n<tr>\n<td>G2</td>\n<td>60-89</td>\n<td>Mildly decreased</td>\n</tr>\n<tr>\n<td>G3a</td>\n<td>45-59</td>\n<td>\n<p class=\"p1\">Mildly to moderately decreased</p>\n</td>\n</tr>\n<tr>\n<td>G3b</td>\n<td>30-44</td>\n<td>Moderately to severely decreased</td>\n</tr>\n<tr>\n<td>G4</td>\n<td>15-29</td>\n<td>Severely decreased</td>\n</tr>\n<tr>\n<td>G5</td>\n<td>&lt;15</td>\n<td>Kidney failure</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Stages of CKD based on albuminuria (mg/g):</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Albuminuria</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>A1</td>\n<td>&lt;30</td>\n<td>Normal to mildly increased</td>\n</tr>\n<tr>\n<td>A2</td>\n<td>30-300</td>\n<td>Moderately increased</td>\n</tr>\n<tr>\n<td>A3</td>\n<td>&gt;300</td>\n<td>Severely increased</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9342",
      "difficulty": "medium"
    },
    {
      "text": "A 36-year-old female patient has hyperparathyroidism, pituitary adenoma, and gastrinoma with cutaneous angiofibromas. What is the likely diagnosis?<div class='question-desc-html'><p>MEN - Multiple endocrine neoplasia</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "MEN 1"
        },
        {
          "id": 2,
          "text": "MEN 2"
        },
        {
          "id": 3,
          "text": "MEN 3"
        },
        {
          "id": 4,
          "text": "MEN 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario suggests a diagnosis of <strong>MEN 1 syndrome</strong>.</p>\n<p><strong>Multiple endocrine neoplasia</strong> (MEN) syndromes are characterized by tumors of two or more endocrine glands. There are <strong>four major types</strong> of MEN (MEN 1–4), and they either show an <strong>autosomal dominant</strong> pattern of inheritance or occur sporadically. </p>\n<p><strong>MEN 1</strong>, also known as <strong>Wermer’s syndrome</strong>, is characterized by the triad of <strong>parathyroid</strong>, <strong>pancreatic islet cell</strong>, and <strong>anterior pituitary </strong><strong>tumors</strong>. Adrenal cortical tumors, carcinoid tumors, facial angiofibromas, collagenomas, thyroid tumors, and lipomas may also occur. MEN 1-associated tumors are usually multiple, larger, and more aggressive, resulting in resistance to treatment and poor patient outcomes.</p>\n<ol>\n<li><strong>Parathyroid tumors-</strong> <strong>primary hyperparathyroidism</strong> is the <strong>most common</strong> feature of MEN 1. <strong>Hypercalcemia</strong> with or without symptoms (polyuria, polydipsia, constipation, dyspepsia), nephrolithiasis, and osteitis fibrosa cystica may also occur. All four parathyroid glands are usually affected with multiple adenomas or hyperplasia. </li>\n<li><strong>Pancreatic islet cell tumors-</strong> these are <strong>neuroendocrine tumors</strong>, including:\n<ul>\n<li><strong>Gastrinoma</strong> (gastrin-secreting tumors)- associated with increased gastric acid secretion and multiple peptic ulcers (Zollinger-Ellison syndrome). Patients may present with diarrhea and steatorrhea. Gastrinomas are the<strong> major cause</strong> of <strong>mortality</strong> and morbidity. </li>\n<li><strong>Insulinoma</strong> (insulin-secreting tumors)- patients present with <strong>hypoglycemic symptoms</strong> (weakness, headaches, sweating, seizures, weight gain) that develop after fasting or exertion and improve after glucose intake. Along with increased plasma insulin levels and hypoglycemia, increased C peptide and proinsulin levels help in diagnosing the condition.</li>\n<li><strong>Glucagonoma</strong> (glucagon-secreting tumors)- may be associated with necrolytic migratory erythema, weight loss, anemia, and stomatitis. </li>\n<li><strong>VIPomas</strong> (Vasoactive intestinal peptide [VIP]-secreting tumors): The VIPoma syndrome, also known as Verner-Morrison syndrome, is characterized by watery diarrhea, hypokalemia, and achlorhydria. These are mostly located in the <strong>tail</strong> of the <strong>pancreas</strong>.</li>\n<li><strong>PPomas</strong> (Pancreatic polypeptide-secreting tumors) and <strong>nonfunctioning pancreatic tumors-</strong> are associated with a <strong>worse prognosis</strong> as they often go undiagnosed due to the absence of both clinical features and biochemical abnormalities.</li>\n</ul>\n</li>\n<li><strong>Pituitary tumors-</strong> manifestations depend on the hormone secreted (symptoms of hyperprolactinemia, acromegaly, or Cushing’s disease) and tumor size (visual disturbances or hypopituitarism due to compression of the optic chiasm or normal pituitary tissue). </li>\n</ol>\n<p><strong>Surgical excision</strong> of the nonmetastatic tumor after localization is the <strong>curative treatment</strong>. Appropriate medical therapy can be used for some tumors when surgery is contraindicated or unsuccessful (calcimemetics for parathyroid tumors, parietal cell H<sup>+</sup>-K<sup>+</sup>-ATPase inhibitors for gastrinomas). In case of metastasis, chemotherapy, hormonal therapy, radiation therapy, and artery embolization may be successful.</p>\n<p>MEN 1 occurs due to a mutation in the <em>MEN1 </em>gene located on <strong>chromosome 11q13</strong>. Mutational genetic analysis is necessary to confirm the clinical diagnosis and identify family members who harbor the mutation and require screening for tumor detection and early treatment.</p>\n<p>Other options:</p>\n<p>Options B and C: <strong>MEN 2</strong>, also called <strong>Sipple’s syndrome</strong>, is characterized by medullary thyroid carcinoma (MTC), pheochromocytomas, and parathyroid tumors. This occurs due to mutations of the <strong>rearranged during transfection (RET) protooncogene</strong>. There are three clinical variants -</p>\n<ol>\n<li><strong>MEN 2A</strong> (most common): MTC is associated with pheochromocytomas in 50% of patients and parathyroid tumors in 20% of patients. MEN 2A may also be associated with Hirschsprung’s disease and cutaneous lichen amyloidosis.</li>\n<li>MEN 2B<strong> (MEN</strong> <strong>3</strong>): MTC is associated with pheochromocytoma, along with Marfanoid habitus; mucosal neuromas of the lips, tongue, and eyelids; medullated corneal fibers; and intestinal autonomic ganglion dysfunction leading to multiple diverticulae and megacolon. Parathyroid tumors are usually absent.</li>\n<li><strong>MTC only </strong>(FMTC): MTC is the only manifestation.</li>\n</ol>\n<p>Option D: <strong>MEN 4 </strong>is characterized by a combination of <strong>MEN 1–associated tumors</strong> and <strong><em>CDKN1B</em> mutation-related tumors</strong> (gonadal, adrenal, renal, and thyroid tumors).</p><hr><h3>Related Pearl: MEN 1 Syndrome Features</h3><p>Chromosome <strong>11q13 / MEN1 </strong>gene</p>\n<p>Also known as <strong>Wermer&rsquo;s syndrome</strong></p>\n<p>Characteristic tumors seen in:</p>\n<ul>\n<li>Parathyroid adenoma &ndash; 90 % - Most common overall</li>\n<li>Entero pancreatic tumors - Most common functioning tumor is gastrinoma (most common site is duodenum)</li>\n<li>Pituitary adenoma &ndash; Most common is prolactinoma</li>\n<li><strong>Mnemonic</strong> &ndash; Par Pan Pit &ndash; in decreasing order of frequency</li>\n</ul>\n<p>Associated tumors are:</p>\n<ul>\n<li>Angiofibroma</li>\n<li>Collagenomas</li>\n<li>Adrenal cortical tumors</li>\n<li>Lipoma</li>\n<li>Neuroendocrine tumors - gastric, thymic, lungs</li>\n<li>Meningioma</li>\n<li>Pheochromocytoma</li>\n<li>Carcinoid tumors, usually of the foregut</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95f7c4eac7794f728806926c4f50bbb2x1280x1061.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Cancer Predisposition Syndromes and Associated Genes</h3><table>\n<tbody>\n<tr>\n<td><strong>Syndrome </strong></td>\n<td><strong>Gene</strong></td>\n<td><strong>Chromosome</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Tumors</strong></td>\n</tr>\n<tr>\n<td>Ataxia telangiectasia</td>\n<td>ATM</td>\n<td>11q22-q23</td>\n<td>AR</td>\n<td>Breast</td>\n</tr>\n<tr>\n<td>Bloom syndrome</td>\n<td>BLM</td>\n<td>15q26.1</td>\n<td>AR</td>\n<td>Several types</td>\n</tr>\n<tr>\n<td>Cowden syndrome</td>\n<td>PTEN</td>\n<td>10q23</td>\n<td>AD</td>\n<td>Breast, thyroid</td>\n</tr>\n<tr>\n<td>Autoimmune lymphoproliferative syndrome</td>\n<td>FASFASL&nbsp;</td>\n<td>10q24 1q23</td>\n<td>AD</td>\n<td>Lymphomas</td>\n</tr>\n<tr>\n<td>Familial adenomatous polyposis&nbsp;</td>\n<td>APC</td>\n<td>5q21</td>\n<td>AD</td>\n<td>Intestinal adenoma, colorectal</td>\n</tr>\n<tr>\n<td>Familial melanoma 1</td>\n<td>p16INK4</td>\n<td>9p2</td>\n<td>AD</td>\n<td>Melanoma, pancreatic</td>\n</tr>\n<tr>\n<td>Familial Wilms&rsquo; tumor</td>\n<td>WT1</td>\n<td>11p13</td>\n<td>AD</td>\n<td>Kidney (pediatric)</td>\n</tr>\n<tr>\n<td>Hereditary breast/ovarian cancer &nbsp;</td>\n<td>BRCA1BRCA2&nbsp;</td>\n<td>17q2113q12.3&nbsp;</td>\n<td>AD</td>\n<td>Breast, ovarian, colon, prostate</td>\n</tr>\n<tr>\n<td>Hereditary diffuse gastric cancer</td>\n<td>CDH1</td>\n<td>16q22</td>\n<td>AD</td>\n<td>Stomach</td>\n</tr>\n<tr>\n<td>Hereditary multiple exostoses</td>\n<td>EXT1EXT2&nbsp;</td>\n<td>8q2411p11-12&nbsp;</td>\n<td>AD</td>\n<td>Exostoses, chondrosarcoma</td>\n</tr>\n<tr>\n<td>Hereditary prostate cancer</td>\n<td>HPC1</td>\n<td>1q24-25</td>\n<td>AD</td>\n<td>Prostate</td>\n</tr>\n<tr>\n<td>Hereditary retinoblastoma</td>\n<td>RB1</td>\n<td>13q14.2</td>\n<td>AD</td>\n<td>Retinoblastoma, osteosarcoma</td>\n</tr>\n<tr>\n<td>Hereditary nonpolyposis colon cancer (HNPCC)&nbsp;</td>\n<td>MSH2MLH1MSH6PMS2&nbsp;</td>\n<td>2p163p21.32p167p22&nbsp;</td>\n<td>AD</td>\n<td>Colon, endometrial, ovarian, stomach, smallbowel, ureter carcinoma</td>\n</tr>\n<tr>\n<td>Hereditary papillary renal carcinoma&nbsp;</td>\n<td>MET</td>\n<td>7q31</td>\n<td>AD</td>\n<td>Papillary kidney</td>\n</tr>\n<tr>\n<td>Juvenile polyposis&nbsp;</td>\n<td>SMAD4</td>\n<td>18q21</td>\n<td>AD</td>\n<td>Gastrointestinal, pancreatic</td>\n</tr>\n<tr>\n<td>Li-Fraumeni</td>\n<td>TP53</td>\n<td>17p13.1</td>\n<td>AD</td>\n<td>Sarcoma, breast</td>\n</tr>\n<tr>\n<td>Multiple endocrine neoplasia type 1</td>\n<td>MEN1</td>\n<td>11q13</td>\n<td>AD</td>\n<td>Parathyroid, endocrine, pancreas, and pituitary</td>\n</tr>\n<tr>\n<td>Multiple endocrine neoplasia type 2a &nbsp;</td>\n<td>RET</td>\n<td>10q11.2</td>\n<td>AD</td>\n<td>Medullary thyroid carcinoma,pheochromocytoma</td>\n</tr>\n<tr>\n<td>Neurofibromatosis type 1 &nbsp;</td>\n<td>NF1</td>\n<td>17q11.2</td>\n<td>AD</td>\n<td>Neurofibroma, neurofibrosarcoma, brain</td>\n</tr>\n<tr>\n<td>Neurofibromatosis type 2</td>\n<td>NF2</td>\n<td>22q12.2</td>\n<td>AD</td>\n<td>Vestibular schwannoma, meningioma, spine</td>\n</tr>\n<tr>\n<td>Nevoid basal cell carcinoma syndrome(Gorlin&rsquo;s syndrome)&nbsp;</td>\n<td>PTCH</td>\n<td>9q22.3</td>\n<td>AD</td>\n<td>Basal cell carcinoma, medulloblastoma,jaw cysts&nbsp;</td>\n</tr>\n<tr>\n<td>Tuberous sclerosis</td>\n<td>TSC1TSC2&nbsp;</td>\n<td>9q3416p13.3&nbsp;</td>\n<td>AD</td>\n<td>Angiofibroma, renal angiomyolipoma&nbsp;</td>\n</tr>\n<tr>\n<td>von Hippel&ndash;Lindau</td>\n<td>VHL</td>\n<td>3p25-26</td>\n<td>AD</td>\n<td>Kidney, cerebellum, pheochromocytoma</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5988",
      "difficulty": "medium"
    },
    {
      "text": "A elderly hypertensive man presented with unilateral weakness of upper limbs and slurring of speech. NCCT scan was done to reveal the following sign. What is the name of the sign?<div class='question-desc-html'><p>NCCT - Non-contrast computed tomography</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "String sign of Kantor"
        },
        {
          "id": 2,
          "text": "Eye of tiger sign"
        },
        {
          "id": 3,
          "text": "Hyperdense MCA sign"
        },
        {
          "id": 4,
          "text": "Dural tail sign"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario of<strong>&nbsp;unilateral weakness</strong> of <strong>upper limbs</strong> and<strong> slurring</strong> of <strong>speech</strong> in a&nbsp;<strong>hypertensive</strong> man is suggestive of <strong>stroke</strong>. The NCCT image is showing&nbsp;<strong>hyperdense MCA sign&nbsp;</strong>i.e. occlusion of middle cerebral artery (<strong>MCA</strong>) due to a <strong>hyperdense</strong> <strong>embolus. </strong>This sign is<strong>&nbsp;</strong>indicative of <strong>ischemic stroke.&nbsp;</strong></p>\n<div class=\"page\" title=\"Page 12128\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>After the clinical diagnosis of stroke is made, an emergency evaluation should be made to check patient&rsquo;s airway, breathing, and circulation (ABCs), hypoglycemia/ hyperglycemia. The main goal is to distinguish it as either an <strong>ischemic stroke</strong> <strong>or hemorrhagic stroke</strong> with the help of an emergency <strong>noncontrast head CT</strong>.&nbsp;</p>\n<div class=\"page\" title=\"Page 542\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The following signs of <strong>acute ischemia</strong> can be seen on<strong> CT</strong>:</p>\n<ul>\n<li><strong>Blurring of the gray/white junction</strong> and effacement of the sulci due to ischemic swelling of the tissues.</li>\n<li>Blurring of the margins of the gray matter structures</li>\n<li>In cases of internal carotid artery occlusion or middle cerebral artery main segment (M1) occlusion, <strong>intraluminal clot</strong> may be seen as a <strong>focal hyperdensity</strong>, known as the <strong>hyperdense MCA sign</strong>&nbsp;or <strong>hyperdense dot sign</strong>.</li>\n</ul>\n<p>Management includes:</p>\n<ul>\n<li>Reduction of blood pressure when: BP &gt;220/120 mmHg, presence of malignant hypertension or concomitant myocardial ischemia, or if blood pressure is &gt;185/110 mmHg in a patient planned for intravenous thrombolysis.</li>\n<li>Serum glucose maintained between&nbsp;<strong>60&nbsp;mg/dL and 180 mg/dL.</strong></li>\n<li><strong>IV mannitol</strong> and <strong>water restriction</strong>&nbsp;may be required to reduce edema which can lead to a mass effect.</li>\n<li><strong>Intravenous thrombolysis&nbsp;</strong>with recombinant tissue plasminogen activator (rTPA),&nbsp;<strong>alteplase</strong>&nbsp;(0.9 mg/kg), tenecteplase (0.25 mg/kg) should be immediately administered to patients with ischemic stroke who arrive in the window period (within 4.5 hours of symptom onset).</li>\n<li><strong>Endovascular mechanical thrombectomy</strong>&nbsp;is done in patients who not respond to thrombolytic therapy or in whom thrombolysis is contraindicated.</li>\n<li><strong>Oral aspirin</strong>&nbsp;with an&nbsp;<strong>initial dose of 300 mg</strong>&nbsp;should be started within 48 hours of acute ischemic stroke.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p>Other options:</p>\n</div>\n</div>\n</div>\n</div>\n<p>Option A:<strong> String sign of Kantor</strong> is seen in <strong>Crohn's disease</strong>. It&nbsp;refers to the string like appearance of a contrast filled bowel loop due to luminal narrowing.</p>\n<p>Option B:<strong> Eye of tiger sign</strong> is seen due to T2 hypointensity in the globus pallidus with a longitudinal stripe of high intensity. It is commonly seen in <strong>pantothenate kinase-associated neurodegeneration (PKAN)</strong> but is not pathognomic of the condition. It can be seen in Wilson's disease, atypical parkinsonism and organophosphate poisoning.</p>\n<p>Option D: The <strong>dural tail sign</strong> is seen in <strong>meningioma</strong>&nbsp;due to thickening and enhancement of dura.</p><hr><h3>Related Pearl: Target BP in hypertensive patients- European Society of Cardiology guidelines 2018</h3><table>\n<tbody>\n<tr>\n<td><strong>Age group</strong></td>\n<td><strong>Hypertension</strong></td>\n<td><strong>Coexisting diabetes</strong></td>\n<td><strong>Coexisting chronic kidney disease</strong></td>\n<td><strong>Coexisting coronary artery disease</strong></td>\n<td><strong>Coexisting stroke/ TIA</strong></td>\n</tr>\n<tr>\n<td>\n<p>18-65 years</p>\n<p>(Target systolic range- if tolerated)</p>\n</td>\n<td>\n<p class=\"p1\">120-130 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">120-130 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-140 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">120-130 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">120-130 mmHg</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>65-79 years</p>\n<p>(Target systolic range- if tolerated)</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n</tr>\n<tr>\n<td>Office diastolic measurement</td>\n<td>70-79mmHg</td>\n<td>70-79mmHg</td>\n<td>70-79mmHg</td>\n<td>&nbsp;70-79mmHg</td>\n<td>&nbsp;70-79mmHg</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Indications and Contraindications of thrombolysis in Ischemic Stroke</h3><p><strong>Indications for thrombolysis in stroke</strong>&nbsp;</p>\n<ul>\n<li>Clinical diagnosis of stroke</li>\n<li>Onset of symptoms to time of drug administration &lt;3 hours/<strong>4.5</strong> hours</li>\n<li>Age &ge; 18 years</li>\n<li>CT scan showing no haemorrhage or edema of &gt;1/3<sup>rd</sup> of the MCA territory&nbsp;</li>\n</ul>\n<p><strong>Contraindications of thrombolysis in stroke&nbsp;</strong></p>\n<ul>\n<li>Sustained BP &gt;185/110 mmHg despite treatment</li>\n<li>Bleeding diathesis</li>\n<li>Recent head injury or Intracerebral hemorrhage</li>\n<li>Major surgery in preceding 14 days</li>\n<li>Minor stroke symptoms</li>\n<li>Gastrointestinal bleeding in preceding 21 days</li>\n<li>Recent myocardial infarction</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dbce6a4bda9347c98c708d19c3370983.png"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7751",
      "difficulty": "easy"
    },
    {
      "text": "A young man with a history of a respiratory tract infection 4 weeks ago, is unable to stand or walk for the past 2 weeks. His weakness began in the toes and ankles and progressed to involve his knee and hip joints. His upper limbs are not affected and cranial nerves are intact. On examination, there is an absent knee jerk. Which of the following would you consider as the initial therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Intravenous immune globulin (IVIg)"
        },
        {
          "id": 2,
          "text": "Mechanical ventilation"
        },
        {
          "id": 3,
          "text": "Corticosteroid administration"
        },
        {
          "id": 4,
          "text": "Antibiotic administration"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario depicting&nbsp;<strong>progressive, ascending, symmetrical weakness</strong> following a respiratory infection is suggestive of <strong>Guillain Barre syndrome</strong> (GBS). <strong>Intravenous immune globulin</strong> (IVIg) would be considered as the initial therapy in this patient.</p>\n<p>GBS is an acute, fulminant <strong>polyradiculoneuropathy</strong> that is <strong>autoimmune</strong> in nature. Most of the cases occur after a <strong>respiratory or gastrointestinal infection</strong>. GBS is caused when immune response/antibodies are produced against external antigens like infections (Campylobacter jejuni, Mycoplasma pneumoniae, HHV) and vaccines (Influenza). These autoantibodies target similar proteins present in the person's nervous tissue (called&nbsp;<strong>molecular mimicry</strong>).</p>\n<p>GBS manifests as a rapidly evolving<strong>&nbsp;motor paralysis</strong>&nbsp;with areflexia (or hyporeflexia) with or without sensory disturbance. It is an ascending paralysis that affects the lower limbs more than the upper limbs. It can also affect the cranial nerves leading the bulbar paralysis like difficulty articulating words and excessive drooling.</p>\n<p>igh-dose<strong> intravenous immune globulin</strong> (IVIg) or <strong>plasmapheresis</strong>&nbsp;are <strong>equally effective</strong> for typical GBS.&nbsp;IVIg is the <strong>initial therapy</strong> chosen because of its <strong>ease</strong> of administration and <strong>good safety</strong> record.&nbsp;It contains&nbsp;anti-idiotypic antibodies against autoantibodies. It is administered as five daily infusions for a total dose of 2 g/kg body weight.</p>\n<p>Other options:&nbsp;</p>\n<p>Option B - <strong>Mechanical ventilation</strong> is reserved for those who develop respiratory insufficiency or patients who develop early bulbar weakness. This patient has no bulbar weakness (normal cranial nerves).</p>\n<p>Option C - <strong>Corticosteroid administration</strong> has not been shown to provide many benefits in GBS.&nbsp;</p>\n<p>Option D - <strong>Antibiotic administration</strong> would not be useful in GBS as the pathophysiology involves axonal degeneration due to a immune cause, not infective.&nbsp;</p><hr><h3>Related Pearl: Mechanism of Immunopathogenesis of Guillain-Barre Syndrome</h3><p>The following sequence of events, takes into consideration, the development of Guillain-Barre syndrome (GBS) associated with <em>Campylobacter jejuni</em><strong> infection</strong>.</p>\n<ol>\n<li><strong>B cells</strong> recognize glycoconjugates on <strong> jejuni (Cj)</strong> that cross-react with <strong>ganglioside</strong> present on <strong>Schwann cell surface</strong> and <strong>subjacent peripheral nerve myelin</strong>.</li>\n<li>Most of the B cells are activated via a partially T cell&ndash;dependent route and secrete primarily <strong>IgG autoantibodies</strong>. Some B cells, activated via a T cell&ndash;independent mechanism, secrete primarily IgM</li>\n<li><strong>The</strong> <strong>activated B cells</strong> escape from Peyer&rsquo;s patches into regional lymph nodes.</li>\n<li><strong>Activated T cells</strong> also function to assist in the opening of the blood-nerve barrier, facilitating penetration of pathogenic autoantibodies.</li>\n<li>The earliest changes in myelin consist of <strong>edema between myelin lamellae</strong> and <strong>vesicular disruption</strong> of the outermost myelin layers.</li>\n<li>These effects are associated with activation of the <strong>C5b-C9 membrane attack complex</strong> and mediated by <strong>calcium entry</strong>; it is possible that the macrophage cytokine tumor necrosis factor (TNF) also participates in <strong>myelin damage</strong>.</li>\n</ol><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b40cb513616a452c90a928eb9e4fc6d7x1280x1987.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Sensory Loss In peripheral Neuropathies</h3><p>Symmetrical Sensory Loss</p>\n<ul>\n<li>Cryptogenic or idiopathic sensory polyneuropathy (CSPN)</li>\n<li>Diabetes mellitus and other metabolic disorders</li>\n<li>Drugs and toxins</li>\n<li>Familial (HSAN), CMT, amyloidosis</li>\n<li>Inflammatory demyelinating polyneuropathy (GBS and CIDP)&nbsp;</li>\n</ul>\n<p>Asymmetrical Sensory Loss</p>\n<ul>\n<li>Cancer (paraneoplastic)</li>\n<li>Sjögren&rsquo;s syndrome</li>\n<li>Idiopathic sensory neuronopathy (possible GBS variant)</li>\n<li>Cisplatin and other chemotherapeutic agents</li>\n<li>Vitamin B6 toxicity</li>\n<li>Multifocal CIDP, vasculitis, cryoglobulinemia, amyloidosis, sarcoid, infectious (leprosy, Lyme, hepatitis B, C, or E, HIV, CMV), tumor infiltration&nbsp;</li>\n<li>Compressive mononeuropathy, plexopathy, or radiculopathy</li>\n<li>Polyradiculopathy or plexopathy due to diabetes mellitus</li>\n<li>Cryptogenic or idiopathic sensory polyneuropathy (CSPN)</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7141",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged man presented with pain and swelling of his right knee for one week. It started progressing to the ankle joints and feet for the past 2 days. He gives a history of diarrhea and burning micturition 4 weeks ago. On examination, his soles showed the following lesions. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Syphilitic arthritis"
        },
        {
          "id": 2,
          "text": "Enteropathic arthritis"
        },
        {
          "id": 3,
          "text": "Psoriatic arthritis"
        },
        {
          "id": 4,
          "text": "Reactive arthritis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario of acute arthritis following a <strong>recent infection</strong> and&nbsp;<strong>additive pattern</strong>&nbsp;(involvement of new joints within few days) and examination finding of&nbsp;<strong>keratoderma blennorrhagica</strong>&nbsp;(image) are suggestive of&nbsp;<strong>reactive arthritis</strong>.&nbsp;</p>\n<p>Keratoderma blennorrhagica is a <strong>mucocutaneous manifestation</strong> of reactive arthritis. It presents as&nbsp;vesicles and pustules that lead to hyperkeratotic lesions or crusting on the <strong>palms </strong>and<strong> soles</strong>.</p>\n<p>Other mucocutaneous manifestations of reactive arthritis include:</p>\n<ul>\n<li><strong>Oral ulcers </strong>-<strong>&nbsp;</strong>superficial, transient, and often asymptomatic</li>\n<li><strong>Circinate balanitis </strong>-&nbsp;consists of vesicles that rupture to form painless superficial erosions on the glans penis</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d76ecdc80eab4a1690982f5a4da0438b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6410",
      "difficulty": "medium"
    },
    {
      "text": "A 70-year-old man is brought to the emergency department with altered mental status. Lab workup shows serum sodium of 110 mEq/L and negative alcohol and toxicology screens. An opacity in the left lower lung is seen on the chest X-Ray. What is the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Fluid restriction"
        },
        {
          "id": 2,
          "text": "Demeclocycline"
        },
        {
          "id": 3,
          "text": "3% saline"
        },
        {
          "id": 4,
          "text": "Conivaptan"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>syndrome of inappropriate antidiuretic hormone&nbsp;</strong>(SIADH) with&nbsp;<strong>altered mental status</strong>, and the management in this patient is&nbsp;<strong>3% saline</strong>.</p>\n<p>SIADH occurs due to <strong>excessive production</strong> of <strong>ADH</strong> (or vasopressin). The most common cause are neuroendocrine neoplasms like <strong>small cell lung carcinoma</strong>&nbsp;(at least half the cases) and carcinoids.</p>\n<p>Symptoms include decreased thirst, lethargy, nausea, confusion, depressed mental status, and seizures. However, most patients are asymptomatic and are diagnosed incidentally due to the presence of <strong>hyponatremia</strong>. The severity of symptoms indicates the severity of hyponatremia. Hyponatremia occurs with <strong>decreased serum osmolality</strong> and <strong>normal</strong> or <strong>increased urine osmolality</strong>.</p>\n<p>Management includes <strong>correction of hyponatremia</strong> and treatment of the underlying malignancy. Since hyponatremia develops over several weeks to months, it should be corrected <strong>gradually</strong> at a rate of 0.5&ndash;1 meq/L/h to prevent brain dehydration and central pontine myelinolysis (an acute life-threatening neurological syndrome characterized by quadriparesis, ataxia, and abnormal extraocular movements).</p>\n<ul>\n<li><strong>Hypervolemic hyponatremia</strong>:\n<ul>\n<li><strong>Fluid restriction</strong> to less than urine output, plus insensible losses, with strict monitoring of fluid intake in mild cases</li>\n<li><strong>Vasopressin receptor antagonists</strong>, like conivaptan and tolvaptan, in severe cases</li>\n</ul>\n</li>\n<li><strong>Hypovolemic hyponatremia</strong> and/or <strong>altered mental status&nbsp;</strong>(indicating severe hyponatremia of &lt;115 mEq/L): <strong>Hypertonic (3%) </strong>or <strong>isotonic saline</strong> infusion</li>\n</ul>\n<p><strong>Demeclocycline</strong>, an inhibitor of vasopressin, is not preferred due to its relatively <strong>slower onset</strong> of action (1&ndash;2 weeks).</p><hr><h3>Related Pearl: Causes of SIADH</h3><p><strong>Neoplasms</strong></p>\n<p><strong>Carcinomas</strong></p>\n<ul>\n<li>Lung</li>\n<li>Duodenum</li>\n<li>Pancreas</li>\n<li>Ovary</li>\n<li>Bladder, ureter</li>\n</ul>\n<p><strong>Other neoplasms</strong></p>\n<ul>\n<li>Thymoma</li>\n<li>Mesothelioma</li>\n<li>Bronchial adenoma</li>\n<li>Carcinoid</li>\n<li>Gangliocytoma</li>\n<li>Ewing&rsquo;s sarcoma</li>\n</ul>\n<p><strong>Head trauma</strong> (closed and penetrating)</p>\n<p><strong>Infections</strong></p>\n<ul>\n<li>Pneumonia</li>\n<li>Abscess</li>\n<li>Cavitation (aspergillosis)</li>\n<li>Tuberculosis</li>\n<li>Meningitis, Encephalitis</li>\n<li>AIDS</li>\n</ul>\n<p><strong>Vascular</strong></p>\n<ul>\n<li>Cerebrovascular occlusions, haemorrhage</li>\n<li>Cavernous sinus thrombosis</li>\n</ul>\n<p><strong>Neurologic</strong></p>\n<ul>\n<li>Guillain-Barre syndrome</li>\n<li>Multiple sclerosis</li>\n<li>Delirium tremens</li>\n<li>Amyotrophic lateral sclerosis</li>\n<li>Hydrocephalus</li>\n<li>Psychosis</li>\n<li>Peripheral neuropathy</li>\n</ul>\n<p><strong>Congenital malformations</strong></p>\n<p><strong>Metabolic</strong></p>\n<ul>\n<li>Acute intermittent porphyria</li>\n</ul>\n<p><strong>Respiratory</strong></p>\n<ul>\n<li>Asthma</li>\n<li>Pneumothorax</li>\n<li>Positive-pressure respiration</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li>Vasopressin or desmopressin</li>\n<li>Serotonin reuptake inhibitors</li>\n<li>Oxytocin (high dose)</li>\n<li>Vincristine</li>\n<li>Carbamazepine</li>\n<li>Nicotine</li>\n<li>Phenothiazines</li>\n<li>Cyclophosphamide</li>\n<li>Tricyclic antidepressants</li>\n<li>Monoamine oxidase inhibitors</li>\n</ul><hr><h3>Related Pearl: Distribution of body fluids</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Example</strong></p>\n</td>\n<td>\n<p><strong>ECF volume</strong></p>\n</td>\n<td>\n<p><strong>ICF volume</strong></p>\n</td>\n<td>\n<p><strong>Osmolarity</strong></p>\n</td>\n<td>\n<p><strong>Hematocrit</strong></p>\n</td>\n<td>\n<p><strong>Plasma proteins</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isosmotic volume contraction</p>\n</td>\n<td>\n<p>Diarrhea,</p>\n<p>Burns</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperosmotic volume contraction</p>\n</td>\n<td>\n<p>Sweating,</p>\n<p>Fever,</p>\n<p>Diabetes insipidus</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyposmotic volume contraction</p>\n</td>\n<td>\n<p>Adrenal insufficiency</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isosmotic volume expansion</p>\n</td>\n<td>\n<p>Infusion of isotonic NaCl</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperosmotic volume expansion</p>\n</td>\n<td>\n<p>High NaCl intake</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyposmotic volume expansion</p>\n</td>\n<td>\n<p>SIADH</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7317",
      "difficulty": "medium"
    },
    {
      "text": "A 70-year-old man with a history of ischemic heart disease presents with palpitations for the last 3 days. A transesophageal echo shows a thrombus in the left atrium. His ECG is shown below. Which of the following should be done to treat his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Initiate anticoagulation"
        },
        {
          "id": 2,
          "text": "Initiate beta blockers"
        },
        {
          "id": 3,
          "text": "Initiate digoxin"
        },
        {
          "id": 4,
          "text": "Initiate cardioversion"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above clinical scenario along with ECG showing  <strong>irregular RR intervals </strong>with <strong>absent P waves</strong> is suggestive of <strong>atrial fibrillation</strong>. His <strong>CHA2DS2-VASc</strong> score is <strong>2</strong> (history of ischemic heart disease and age of 70), he is symptomatic for &gt; 48 hours, and there is presence of a left atrial thrombus thus requiring <strong>initiation</strong> <strong>of</strong> <strong>anticoagulation</strong>.  </p>\n<div class=\"page\" title=\"Page 7041\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The major source of <strong>thromboembolism</strong> and <strong>stroke</strong> in AF is the formation of <strong>thrombus</strong> in the <strong>left atrial appendage</strong> due to stagnant flow. Hence thromboembolism must be prevented by giving anticoagulants, along with an appropriate rate/rhythm control strategy with the help of electrical or pharmacologic cardioversion. </p>\n</div>\n</div>\n</div>\n</div>\n<p>The treatment of atrial fibrillation depends on three things: the duration of symptoms, the severity of symptoms, and the risk of stroke. The patients who present <strong>within 48 hours</strong> of the onset of symptoms have a lower risk of an existing atrial thrombus and can be safely cardioverted. Those who present with unknown or known onset of <strong>more than 48 hours</strong> should ideally be <strong>anticoagulated before cardioversion</strong>. This can be done in 2 ways as shown below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d2aabb966631485da12618f45b0bdc8fx1280x2207.JPEG\" alt=\"Explanation Image\"><p>The <strong>severity of atrial fibrillation</strong> refers to the presence of symptoms such as <strong>hypotension</strong>, <strong>pulmonary edema</strong>, or <strong>angina</strong> that are reflective of the cardiac health prior to the onset of fibrillation, and requires emergency cardioversion.</p>\n<p>For long-term treatment of patients, the <strong>risk of stroke </strong>is calculated using the <strong>CHA2DS2-VASc score,</strong> and anticoagulation is given to<strong> </strong>those with a <strong>score of 1 or more</strong>.</p>\n<p>Note: Electrical cardioversion is contraindicated in this patient due to the presence of a left atrial thrombus and therefore high risk of stroke.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/65affbb2429a470b9d5ebb1469a0b9f0x1280x2221.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: CHADS2 VASc Score (Risk of stroke in AF)</h3><table>\n<tbody>\n<tr>\n<td><strong>RISK FACTOR</strong></td>\n<td><strong>POINTS</strong></td>\n</tr>\n<tr>\n<td><strong>C</strong>- Congestive Heart Failure</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>H</strong>- Hypertension</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>A<sub>2</sub></strong><sub>-&nbsp;</sub>Age &gt;= 75 years</td>\n<td>2</td>\n</tr>\n<tr>\n<td><strong>D</strong>- Diabetes</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>S<sub>2</sub></strong>- Prior stroke or TIA</td>\n<td>2</td>\n</tr>\n<tr>\n<td><strong>V</strong>-&nbsp;Vascular disease&nbsp;</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td><strong>A</strong>-&nbsp;Age 65&ndash;74 years</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td><strong>S<sub>c</sub></strong>- Sex category (Female sex)</td>\n<td>&nbsp;1</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>CHA<sub>2</sub>DS<sub>2</sub>-VASc Score</strong></td>\n<td><strong>Stroke rate per 100 Patient Years</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>0</td>\n</tr>\n<tr>\n<td>1</td>\n<td>1.3</td>\n</tr>\n<tr>\n<td>2</td>\n<td>2.2</td>\n</tr>\n<tr>\n<td>3</td>\n<td>3.2</td>\n</tr>\n<tr>\n<td>4</td>\n<td>4.0</td>\n</tr>\n<tr>\n<td>5</td>\n<td>6.7</td>\n</tr>\n<tr>\n<td>6</td>\n<td>9.8</td>\n</tr>\n<tr>\n<td>7</td>\n<td>\n<p>9.6</p>\n</td>\n</tr>\n<tr>\n<td>8</td>\n<td>6.7</td>\n</tr>\n<tr>\n<td>9</td>\n<td>15.2</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d195546260114ee681acc883c2f8514b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1975",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old male patient presents to the OPD with incoordination, tremors, and impaired concentration. On examination, the abdomen is distended and the liver is palpable 3 cm below the right costal margin. The ophthalmic examination is shown in the picture.  Which of the following is the gold standard test for the diagnosis of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Liver biopsy"
        },
        {
          "id": 2,
          "text": "24 hour urine analysis"
        },
        {
          "id": 3,
          "text": "DNA testing"
        },
        {
          "id": 4,
          "text": "Histochemical stains"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><span data-preserver-spaces=\"true\">The given clinical scenario is suggestive of <strong>Wilson's disease </strong>with the ophthalmic examination showing a typical <strong>sunflower cataract</strong> and the <strong>gold standard test</strong> for the diagnosis of this patient is <strong>liver biopsy</strong>.</span></p>\n<p><span data-preserver-spaces=\"true\">Wilson's disease is an </span><strong><span data-preserver-spaces=\"true\">autosomal recessive</span></strong><span data-preserver-spaces=\"true\"> disorder of <strong>copper transport</strong>, primarily affecting the <strong>liver</strong> and <strong>brain</strong> (hence, it is also known as <strong>hepatolenticular disease</strong>). It occurs due to a loss-of-function mutation in the <strong>ATP7B gene</strong>. This gene encodes</span> <strong>ATP7B</strong>,<strong> </strong>a copper-transporting ATPase, which is responsible for biliary copper excretion and incorporation of copper into <strong>ceruloplasmin</strong>.</p>\n<p><span data-preserver-spaces=\"true\">Clinical features of Wilson's disease are:</span></p>\n<ul>\n<li><strong><span data-preserver-spaces=\"true\">Hepatic</span></strong>:<span data-preserver-spaces=\"true\"> Hepatomegaly, jaundice, ascites, cirrhosis, anorexia</span></li>\n<li><strong><span data-preserver-spaces=\"true\">Neurologic</span></strong><span data-preserver-spaces=\"true\">: Dystonia, dysarthria, dysphagia, rigidity, tremors, abnormal gait, uncoordinated handwriting</span></li>\n<li><span data-preserver-spaces=\"true\"><strong>Psychiatric</strong>: Decreased scholastic performance, irritability, depression, and anxiety</span></li>\n<li><span data-preserver-spaces=\"true\"><strong>Ophthalmic</strong>:</span></li>\n<ul>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\"><span data-preserver-spaces=\"true\"><strong>Kayser-Fleischer rings</strong>: These are golden-brown rings formed due to the deposition of copper in descemet’s membrane of the cornea. </span></span>They are present in 95% of patients with neurologic/psychiatric symptoms and 65% of patients with hepatic symptoms.</li>\n<li class=\"ql-indent-1\"><span data-preserver-spaces=\"true\"><strong>Sunflower</strong> <strong>cataracts</strong>:<strong> </strong>These are<strong> </strong>formed due to the deposition of copper in the lens.</span></li>\n</ul>\n<li><strong>Autonomic</strong>: Orthostatic hypotension; sweating; bowel, bladder, and sexual dysfunction</li>\n<li><strong>Endocrine</strong>: Delayed puberty, amenorrhea</li>\n<li><span data-preserver-spaces=\"true\"><span data-preserver-spaces=\"true\">Hemolytic anemia (due to the release of </span></span>copper from necrosed hepatocytes into the bloodstream)</li>\n<li>Osteoporosis and rickets</li>\n<li><span data-preserver-spaces=\"true\">Renal Fanconi syndrome</span></li>\n</ul>\n<p>Laboratory findings show <strong>low serum copper</strong> and <strong>ceruloplasmin</strong> levels and elevated hepatic enzymes. <strong>Increased urinary excretion </strong>of <strong>copper</strong> (&gt;100 μg/24 h) is also an important diagnostic test. However, <strong>percutaneous needle liver biopsy</strong> to measure hepatic copper remains the <strong>gold standard</strong>. Hepatic copper values <strong>&gt;200 μg/g of dry weight</strong> indicate Wilson’s disease.  DNA testing for mutations in ATP7B can be done and can make a definitive diagnosis in about 50–75% of patients.</p>\n<p>Treatment of Wilson's disease includes:</p>\n<ul>\n<li><strong>Copper chelation</strong>:\n<ul>\n<li><strong>D-penicillamine</strong>: It increases urinary excretion of copper and prevents copper overload. Pyridoxine (vitamin B6 ) is administered along with it to counter pyridoxine deficiency that occurs due to penicillamine.</li>\n<li><strong>Triethylenetetramine dihydrochloride</strong>: This chelating agent is given in patients intolerant to D-penicillamine and those with severe neurologic manifestations (D-penicillamine worsens neurological status).</li>\n<li><strong>Tetrathiomolybdate</strong>: This fast-acting agent decreases copper absorption and circulating free copper. It is currently under clinical trials.</li>\n</ul>\n</li>\n<li><strong>Zinc acetate</strong>: This is used to reduce copper absorption. Zinc is beneficial in <strong>pregnancy</strong> (lower teratogenic effects) and as a <strong>maintenance therapy</strong>.</li>\n<li><strong>Liver</strong><strong> transplantation</strong>: This is considered in advanced stages of irreversible hepatic damage or poor compliance with medical therapy.</li>\n</ul>\n<div class=\"page\" title=\"Page 3030\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p> </p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Diseases and Associated Cataracts - Images</h3><p><strong>Wilson's Disease/Chalcosis: Sunflower Cataract</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f38ae9ec7610483cb46270495dbc44b0x826x499.JPEG\" alt=\"Pearl Image\"><p><strong>Diabetes mellitus</strong>:<strong> &nbsp;Snowflake cataract </strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0235d6510b5145419c408792a18dde31x595x395.PNG\" alt=\"Pearl Image\"><p><strong>Blunt trauma</strong>: May present as rosette-shaped cataract</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f66a5f456ef84776a83894d96c1f9b96x381x394.PNG\" alt=\"Pearl Image\"><p><strong>Myotonic dystrophy</strong> - Christmas tree cataract</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c10ec0ef6d6948249f32b3325209b9bcx720x677.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Nazer’s Prognostic Index</h3><p><strong>Nazer&rsquo;s prognostic index</strong> for <strong>Wilson&rsquo;s disease</strong></p>\n<ul>\n<li>Serum bilirubin</li>\n<li>Serum aspartate aminotransferase (AST)</li>\n<li>Prolongation of prothrombin time (sec)</li>\n</ul>\n<p>Interpretation of Scores :</p>\n<ul>\n<li>&lt; 7 &ndash; Medical therapy</li>\n<li>7&ndash;9 &ndash; Clinical judgement, Either medical / surgical treatment</li>\n<li>&gt; 9 &ndash; Liver transplantation</li>\n</ul><hr><h3>Related Pearl: Principal Serum Enzymes Used in Clinical Diagnosis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Serum Enzyme</strong></td>\n<td><strong>Major Diagnostic Use/Location</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">Aminotransferases&nbsp;</td>\n</tr>\n<tr>\n<td>Aspartate aminotransferase (AST/SGOT)</td>\n<td>Liver function</td>\n</tr>\n<tr>\n<td>Alanine aminotransferase (ALT/SGPT)</td>\n<td>Viral hepatitis</td>\n</tr>\n<tr>\n<td colspan=\"2\">Creatine kinase</td>\n</tr>\n<tr>\n<td>CK-MM</td>\n<td>Skeletal muscle,&nbsp;Muscle disorders</td>\n</tr>\n<tr>\n<td>CK-BB</td>\n<td>Brain,&nbsp;Brain injury, meningitis, abnormal cell growth, severe shock, stroke, hypothermia, or restricted blood flow to the bowel.</td>\n</tr>\n<tr>\n<td>CK-MB</td>\n<td>Heart and skeletal muscle, Myocardial Infarction, Muscular dystrophy</td>\n</tr>\n<tr>\n<td colspan=\"2\">Lactate dehydrogenase (LDH)</td>\n</tr>\n<tr>\n<td>HHHH (I<sub>1</sub>)/LDH-1</td>\n<td>Heart &amp; RBC;Myocardial infarction</td>\n</tr>\n<tr>\n<td>HHHM(I<sub>2</sub>)/LDH-2</td>\n<td>Reticuloendothelial system</td>\n</tr>\n<tr>\n<td>HHMM(I<sub>3</sub>)/LDH-3</td>\n<td>Lungs</td>\n</tr>\n<tr>\n<td>HMMM(I<sub>4</sub>)/LDH-4</td>\n<td>Liver &amp; Skeletal Muscles</td>\n</tr>\n<tr>\n<td>MMMM(I<sub>5</sub>)/LDH-5</td>\n<td>Liver &amp; Skeletal Muscles; Liver diseases</td>\n</tr>\n<tr>\n<td colspan=\"2\">Others</td>\n</tr>\n<tr>\n<td>Amylase, Lipase and Acid Phosphatase</td>\n<td>Acute pancreatitis</td>\n</tr>\n<tr>\n<td>Ceruloplasmin</td>\n<td>Hepatolenticular degeneration (Wilson disease)</td>\n</tr>\n<tr>\n<td>&gamma;-Glutamyl transferase</td>\n<td>Liver diseases (Alcoholic Liver Disease)</td>\n</tr>\n<tr>\n<td>&beta;-Glucocerebrosidase</td>\n<td>Gaucher disease</td>\n</tr>\n<tr>\n<td>Alkaline Phosphatase (isozymes)</td>\n<td>Bone disorders, obstructive liver diseases</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/861d1c20b67f4735ba6390e0ad75e3a9.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME6411",
      "difficulty": "easy"
    },
    {
      "text": "A known type 1 diabetic patient presented to the emergency with abdominal pain, vomiting, and nausea. He reports having missed his insulin dose. DKA is suspected in him. So an ABG is taken and a fluid infusion is started. Insulin administration is not given until ABG reports are available. What could be the possible reason for delaying insulin?<div class='question-desc-html'><p>DKA: Diabetic ketoacidosis</p>\n<p>ABG: Arterial blood gas analysis</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Insulin worsens hypoglycemia in DKA"
        },
        {
          "id": 2,
          "text": "Insulin may worsen hypokalemia"
        },
        {
          "id": 3,
          "text": "Insulin causes metabolic acidosis"
        },
        {
          "id": 4,
          "text": "Insulin alters the values in ABG analysis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario points towards a likely diagnosis of <strong>diabetic ketoacidosis</strong> (DKA) that could be associated with hypokalemia.<strong>&nbsp;</strong>Insulin causes <strong>potassium uptake by activating Na-K+ ATPases&nbsp;</strong>which&nbsp;may worsen&nbsp;<strong>hypokalemia.</strong></p>\n<p>DKA is an acute, severe, <strong>hyperglycemic</strong> <strong>disorder</strong>, which was considered a hallmark of type 1 diabetes, but can occur in type 2 diabetes as well. Inadequate administration of insulin (especially during times of physiologic stress like infections) may precipitate DKA.</p>\n<p>Features of DKA include:</p>\n<ul>\n<li>Nausea, vomiting, and severe abdominal pain</li>\n<li>Hypotension and tachycardia</li>\n<li>Hyperglycemia, glycosuria, and ketosis</li>\n<li>High anion gap metabolic acidosis (HAGMA)</li>\n</ul>\n<p>As a physiologic response to acidosis, the body loses potassium and <strong>there is total body potassium deficit</strong>. Serum potassium might be normal or elevated, despite total body potassium deficit.</p>\n<p>The <strong>initial</strong>&nbsp;treatment in DKA is <strong>fluid administration</strong> (first normal saline, then half-normal saline, then dextrose+ half- normal saline). <strong>Insulin</strong> has to be given <strong>once potassium status is known</strong>. If insulin is administered prior to potassium correction, it would worsen the preexisting hypokalemia.</p>\n<p>Management for DKA is as follows:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a778f21e6512431f81837973149498e3x1280x2705.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Comparative Features of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>DKA</strong></p>\n</td>\n<td>\n<p><strong>HHS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Seen in </strong></p>\n</td>\n<td>\n<p>Type 1 DM</p>\n</td>\n<td>\n<p>Type 2 DM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n<td>\n<p>Abdominal pain</p>\n<p>Kussmaul respiration</p>\n<p>Fruity odour of breath</p>\n</td>\n<td>\n<p>Altered sensorium</p>\n<p>Coma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucose (mg/dL)</strong></p>\n</td>\n<td>\n<p>250&ndash;600</p>\n</td>\n<td>\n<p>600&ndash;1200</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sodium</strong></p>\n</td>\n<td>\n<p>120&ndash;125</p>\n</td>\n<td>\n<p>135&ndash;145</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Osmolality </strong></p>\n</td>\n<td>\n<p>300&ndash;320</p>\n</td>\n<td>\n<p>330&ndash;380</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasma Ketones</strong></p>\n</td>\n<td>\n<p>++++</p>\n</td>\n<td>\n<p>+/-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum Bicarbonate</strong></p>\n</td>\n<td>\n<p>&lt; 15 meq/ L</p>\n</td>\n<td>\n<p>Normal to slightly &darr;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pH </strong></p>\n</td>\n<td>\n<p>6.8&ndash;7.3</p>\n</td>\n<td>\n<p>&gt;7.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pCO<sub>2 </sub>(mmHg)</strong></p>\n</td>\n<td>\n<p>20&ndash;30</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anion Gap</strong></p>\n</td>\n<td>\n<p><strong>&uarr;</strong></p>\n</td>\n<td>\n<p>Normal to slightly &uarr;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Factors affecting K+ distribution between ECF and ICF concentration</h3><table>\n<tbody>\n<tr>\n<td><strong>Shift of K+ into the cell&nbsp;&rarr; &darr; ECF K+</strong></td>\n<td><strong>&nbsp;Shift of K+ out of the cell&rarr;&uarr;ECF K+</strong></td>\n</tr>\n<tr>\n<td>Insulin</td>\n<td>Insulin deficiency(DM)</td>\n</tr>\n<tr>\n<td>Aldosterone</td>\n<td>Aldosterone deficiency (Addison's disease)</td>\n</tr>\n<tr>\n<td>Metabolic alkalosis</td>\n<td>Hypertonicity (eg: hyperglycemia)</td>\n</tr>\n<tr>\n<td>Diarrhoea</td>\n<td>&beta;-blockers</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Cell lysis Eg: intravascular hemolysis, tumour lysis syndrome, rhabdomyolysis</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Strenous exercise</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4703",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged woman presents with excruciating pain in her lips, gums, and cheeks for the past 6 months. The pain is usually triggered by talking and brushing her teeth. Each pain episode lasts for 1-2 minutes. On examination, there is no sensory loss over the face. Which of the following is the first-line management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Surgical microvascular decompression"
        },
        {
          "id": 2,
          "text": "Lamotrigine"
        },
        {
          "id": 3,
          "text": "Carbamazepine"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of<strong> trigeminal neuralgia</strong>.&nbsp;The first-line management of this patient is <strong>carbamazepine.</strong></p>\n<p><strong>Trigeminal&nbsp;</strong>neuralgia is a condition characterized by excruciating paroxysmal pain in the&nbsp;<strong>lips, gums, cheek, </strong>or&nbsp;<strong>chin</strong> and, rarely ophthalmic division of the trigeminal nerve. It is also known as <strong>t</strong><strong>ic douloureux</strong>&nbsp;(a painful condition of the face).&nbsp;It is commonly seen in <strong>middle-aged</strong> and <strong>elderly women</strong>.&nbsp;</p>\n<p>The <strong>large myelinated fibers</strong> of the trigeminal nerve carry<strong> tactile stimuli</strong> from the face and do not carry pain fibers themselves. In trigeminal neuralgia, due to <strong>compression</strong> or other pathologies, the large fibers undergo <strong>demyelination</strong>. These demyelinated large fibers become <strong>hyperexcitable</strong> and&nbsp;<strong>electrically coupled</strong> with the surrounding <strong>smaller unmyelinated pain fibers</strong>&nbsp;of the trigeminal nerve. This explains why <strong>tactile stimulation of trigger zones</strong> (lips, gums, cheek, or chin)&nbsp;<strong>leads to pain</strong> paroxysms. Symptoms occur due to ectopic generation of action potentials in pain-sensitive afferent fibers of the trigeminal nerve root just before entering the pons.</p>\n<p>The pain may occur spontaneously or after movements like <strong>chewing, speaking, smiling, </strong>washing the face, brushing teeth, or exposure to wind. On examination, the physician will <strong>not find</strong> any <strong>sensory loss over</strong> the area. The pain usually lasts for <strong>seconds</strong> or <strong>minutes</strong>. The intensity of pain is&nbsp;severe, so much so that the patient winces. Therefore it is called a&nbsp;'<strong>tic</strong>'.</p>\n<p><strong>Carbamazepine</strong>&nbsp;is the<strong>&nbsp;</strong>first-line drug in the management of patients with trigeminal neuralgia. Lamotrigine, Phenytoin, Topiramate, or Gabapentin are other options that may be tried if Carbamazepine is ineffective. <strong>Microvascular decompression</strong> of the trigeminal nerve can be done if medical therapies fail.</p>\n<p>Differential diagnoses of trigeminal neuralgia include:</p>\n<ul>\n<li><strong>Migraine</strong> and <strong>cluster headaches</strong> - They tend to have <strong>deep-seated</strong> and <strong>continuous</strong> pain while trigeminal neuralgia has more of a superficial stabbing quality pain and is episodic.&nbsp;</li>\n<li><strong>Short-lasting unilateral headache with conjunctival tearing (SUNCT)</strong> - It will typically present with <strong>unilateral conjunctival congestion, tearing,</strong> and nasal stuffiness.&nbsp;</li>\n<li><strong>Temporal arteritis</strong> - It will usually be accompanied by <strong>myalgias</strong> and signs of systemic inflammation. <strong>ESR</strong> and <strong>CRP</strong> will be elevated.</li>\n<li>If trigeminal neuralgia develops in a <strong>young patient</strong> or is <strong>bilateral</strong>, a diagnosis of <strong>multiple sclerosis</strong> should be considered. In such cases, the cause of the pain is a demyelinating plaque near the entry point of the trigeminal nerve in the pons.&nbsp;</li>\n</ul><hr><h3>Related Pearl: Trigeminal Autonomic Cephalalgia</h3><p><strong>Types of trigeminal autonomic cephalalgia:</strong></p>\n<ul>\n<li>Cluster headache</li>\n<li>Paroxysmal hemicranias</li>\n<li>Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT)</li>\n<li>Short-lasting unilateral neuralgiform&nbsp;<em>headache</em>&nbsp;attacks with cranial autonomic features (SUNA)</li>\n<li>Hemicrania continua</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>&nbsp;Cluster headache</strong></td>\n<td><strong>Paroxysmal hemicrania&nbsp;</strong></td>\n<td><strong>&nbsp;SUNCT/SUNA</strong></td>\n</tr>\n<tr>\n<td>Gender&nbsp;</td>\n<td>Males&gt;females</td>\n<td>Female=Males</td>\n<td>Female=Males</td>\n</tr>\n<tr>\n<td>Character of pain&nbsp;</td>\n<td>Stabbing /boring</td>\n<td>Throbbing pain&nbsp;/stabbing /boring</td>\n<td>Burning /stabbing/sharp</td>\n</tr>\n<tr>\n<td>Severity of pain&nbsp;</td>\n<td>Excruciating&nbsp;</td>\n<td>Excruciating</td>\n<td>Severe to excruciating</td>\n</tr>\n<tr>\n<td>Site of pain&nbsp;</td>\n<td>Orbit, temple</td>\n<td>Orbit, temple</td>\n<td>Periorbital</td>\n</tr>\n<tr>\n<td>Attack frequency&nbsp;</td>\n<td>1-8 /day</td>\n<td>1-20/day</td>\n<td>3-200/day</td>\n</tr>\n<tr>\n<td>Duration</td>\n<td>15min-3 hours</td>\n<td>2-30 min</td>\n<td>5-240seconds</td>\n</tr>\n<tr>\n<td>Migraneous feature&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Alcohol trigger&nbsp;</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Cutaneous trigger</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Response to indomethacin</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Abortive treatment</td>\n<td>\n<p>100% oxygen</p>\n<p>Sumatriptan injection</p>\n</td>\n<td>\n<p>No effective treatment</p>\n</td>\n<td>\n<p>IV lidocaine&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Prophylaxis</td>\n<td>\n<p>Chronic cluster</p>\n<ul>\n<li>Lithium</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n<p>Episodic cluster&nbsp;</p>\n<ul>\n<li>Steroids&nbsp;</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Indomethacin</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n<li>Topiramate</li>\n<li>Gabapentin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Indomethacin</strong> is effective in paroxysmal hemicrania,hemicrania continuum, and primary sexual/ exercise headache</li>\n<li>Cutaneous trigger is also seen in trigeminal neuralgia, however, <strong>trigeminal neuralgia</strong> is a <strong>separate entity </strong>and not a part of trigeminal autonomic cephalalgia&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9293",
      "difficulty": "easy"
    },
    {
      "text": "Laboratory reports of a patient revealed an elevated serum potassium level. What is the classical sequence of ECG changes seen in this patient?<div class='question-desc-html'><ol>\n<li>Tall peaked T wave</li>\n<li>Loss of P wave</li>\n<li>Widened QRS complex</li>\n<li>Sine wave pattern</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 1, 3, 4"
        },
        {
          "id": 2,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 3,
          "text": "1, 3, 2, 4"
        },
        {
          "id": 4,
          "text": "2, 3, 1, 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Elevated serum potassium level is called <strong>hyperkalemia</strong>. The classical sequence of ECG changes seen with increasing severity of hyperkalemia is <strong>option B - 1, 2, 3, 4.</strong></p>\n<p>Hyperkalemia is defined by <strong>serum K<sup>+&nbsp;</sup>&gt; 5.5mM</strong>. It usually manifests as a medical emergency with cardiac arrhythmias such as sinus bradycardia, sinus arrest, slow idioventricular rhythms, ventricular tachycardia and ventricular fibrillation.</p>\n<p><strong>Note</strong>: These changes are particularly insensitive in patients with CKD.</p>\n<p>Image showing different sequential changes at increasing levels of potassium.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9a186e989d72408db69ea0e6104ed187x1280x1585.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6457",
      "difficulty": "hard"
    },
    {
      "text": "An elderly man presented with a painful and swollen right knee, and difficulty in walking. After examining the knee joint, aspiration is done. The following image is seen on the examination of synovial fluid using compensated polarized microscopy. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Osteoarthritis"
        },
        {
          "id": 2,
          "text": "Pseudogout"
        },
        {
          "id": 3,
          "text": "Gout"
        },
        {
          "id": 4,
          "text": "Psoriatic arthritis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario and the image&nbsp;of&nbsp;<strong>weakly positive birefringent, rhomboid-shaped crystals&nbsp;</strong>are suggestive of&nbsp;<strong>pseudogout</strong>.</p>\n<p><strong>Pseudogout</strong> is a condition that occurs due to the deposition of <strong>calcium pyrophosphate crystals (CPPD)</strong>. It presents with features similar to acute gout and&nbsp;predominantly affects the <strong>elderly</strong>. This is attributable to the increased levels of inorganic pyrophosphate in diseased or aging cartilage which promotes CPP crystal nucleation and their deposition.</p>\n<p><strong>Acute attacks of CPPD</strong> presents with joint swelling and pain, affecting the<strong> knee</strong> (most common), wrist, shoulders, elbows, and hands. It also has&nbsp;<strong>systemic</strong> <strong>features</strong> of inflammation including fever, chills, and elevated CRP.&nbsp;<strong>Chronic CPPD</strong> commonly presents as polyarticular arthritis resembling osteoarthritis (<strong>pseudo-osteoarthritis</strong>). It affects atypical joints such as metacarpophalangeal, wrist, elbow, and ankle joints causing severe damage.</p>\n<div class=\"page\" title=\"Page 10439\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>X-ray or ultrasonography of the joint shows <strong>chondrocalcinosis</strong>, which is punctate or linear radiodense deposits in the joint menisci or articular cartilage. Detection of <strong>rod-like</strong> or <strong>rhomboid crystals</strong> in <strong>synovial fluid</strong> or articular cartilage is <strong>diagnostic</strong> of pseudogout.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Other options :</p>\n<p>Option A:<strong>&nbsp;Osteoarthritis</strong>&nbsp;also affects the elderly. Commonly involved joints are the hip, knee, and first metatarsal phalangeal joint (MTP). The synovial fluid in osteoarthritis is<strong> non-inflammatory</strong>.&nbsp;If the synovial fluid white blood cell count is &gt;1000/&mu;L, it is likely to be due to inflammatory arthritis, gout, or pseudogout.</p>\n<p>Option C:<strong>&nbsp;Gouty&nbsp;arthritis</strong>&nbsp;is caused by the deposition of <strong>monosodium urate crystals (MSU</strong>) crystals which are <strong>needle-shaped</strong> and <strong>negatively birefringent</strong>. They appear <strong>yellowish</strong> when observed under polarized light. Below image shows <strong>needle-shaped,</strong> <strong>monosodium urate</strong> crystal in gout.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a34ee3e4fee94fcc9945b25258b5ff7ax777x599.JPEG\" alt=\"Explanation Image\"><p>Option D:<strong>&nbsp;Psoriatic arthritis </strong>usually occurs after the development of skin lesions in a patient with <strong>psoriasis</strong>. It usually presents with <strong>dactylitis</strong> (involving the <strong>distal interphalangeal joint</strong>) and <strong>enthesitis</strong>. It is diagnosed by <strong>X-ray features</strong> of <strong>pencil-in-cup deformity</strong>, marginal erosions with adjacent bony proliferation (whiskering) and&nbsp;<strong>telescoping</strong> of digits.</p><hr><h3>Related Pearl: Difference between Gout and Pseudo-gout</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Gout</strong></p>\n</td>\n<td>\n<p><strong>Pseudogout</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crystal composition</p>\n</td>\n<td>\n<p>Monosodium urate</p>\n</td>\n<td>\n<p>Calcium pyrophosphate</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shape</p>\n</td>\n<td>\n<p>Needle like</p>\n</td>\n<td>\n<p>Rhomboid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Birefringence pattern</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Weak positive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Most commonly affected joint</p>\n</td>\n<td>\n<p>1<sup>st</sup> MTP</p>\n</td>\n<td>\n<p>Knee</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>X-ray findings</p>\n</td>\n<td>\n<p>Periarticular erosions with overhanging margins</p>\n</td>\n<td>\n<p>Chondrocalcinosis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/762077766ef749698d14495fa0205202.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4664",
      "difficulty": "medium"
    },
    {
      "text": "A 46-year-old male patient came to the emergency department with fever and severe constrictive chest pain that worsened with deep inspiration and on lying down. He had a myocardial infarction 2 weeks back. A pericardial friction sound was audible at the lower left sternal border. The electrocardiogram is given below.  Which of the following is not true regarding this condition?",
      "choices": [
        {
          "id": 1,
          "text": "It occurs 1 to 8 weeks post-MI"
        },
        {
          "id": 2,
          "text": "It is due to an infection in the pericardium"
        },
        {
          "id": 3,
          "text": "Aspirin is given as first line treatment"
        },
        {
          "id": 4,
          "text": "Colchicine can be used in treatment"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><span data-preserver-spaces=\"true\">The clinical scenario of a post-myocardial infarction (MI) patient presenting with pleuritic chest pain, fever, malaise, pericardial rub on auscultation, and the ECG given above showing diffuse ST-segment elevation with upward concavity are suggestive of </span><strong><span data-preserver-spaces=\"true\">Dressler syndrome. </span></strong></p>\n<p>Dressler syndrome/post-myocardial infarction syndrome is an <strong>autoimmune</strong> condition (option B) with inflammation of the pericardium. It presents as <strong>pleuritic chest pain</strong>, fever, malaise, and sometimes a pleuritic rub and effusion. The ECG findings include <strong>PR segment depression </strong>or<strong> ST-segment elevation. </strong>It commonly occurs<strong> 1–8 weeks</strong> after MI (option A). However, it can recur over months.</p>\n<p>Treatment:</p>\n<ul>\n<li>First-line therapy consists of<strong> aspirin 650 mg </strong>(option C)<strong> </strong>every 4 hours with <strong>NSAIDs</strong> like Ibuprofen or Indomethacin</li>\n<li><strong>Colchicine </strong>(option D)<strong> </strong>enhances the response to NSAIDs and prevents recurrence</li>\n<li>Glucocorticosteroids and NSAIDs are best avoided in patients with Dressler syndrome within 4 weeks of STEMI as they may impair infarct healing, cause ventricular rupture, and increase coronary vascular resistance</li>\n</ul><p>Complications of myocardial infarction:</p>\n<ul>\n<li>Myocardial rupture</li>\n<li>Contractile dysfunction</li>\n<li>Arrhythmia: Ventricular fibrillation is the most common arrhythmia within one hour of MI</li>\n<li>Supraventricular tachycardia</li>\n<li>Heart block</li>\n<li>Pericarditis: occur even 48 hours after MI</li>\n<li>Dressler syndrome or post-MI syndrome: 2-3 weeks after a transmural MI</li>\n<li>Ventricular aneurysm</li>\n<li>Progressive late heart failure (chronic IHD)</li>\n<li>Infarct expansion associated with mural thrombus</li>\n<li>Papillary muscle dysfunction</li>\n</ul>\n<p><strong>Myocardial rupture: </strong>Various forms of cardiac rupture typically occur when there is transmural necrosis of a ventricle. </p>\n<table>\n<tbody>\n<tr>\n<td>Rupture of the <strong>left ventricular free wall</strong></td>\n<td>\n<ul>\n<li>Most common</li>\n<li>3-7 days after MI</li>\n<li>Hemopericardium and cardiac tamponade</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Rupture of the<strong> ventricular septum</strong></td>\n<td>\n<ul>\n<li>Less common</li>\n<li>Acute ventricular septal defect (VSD) and left-to-right shunting</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Papillary muscle </strong>rupture</td>\n<td>\n<ul>\n<li>Least common</li>\n<li>Severe mitral regurgitation</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Pericarditis10.JPG/800px-Pericarditis10.JPG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0213",
      "difficulty": "medium"
    },
    {
      "text": "A female patient presented to the emergency room with right-sided flank pain radiating to the groin for 1 day. Urinalysis shows crystals, as seen below. What are these crystals made up of?",
      "choices": [
        {
          "id": 1,
          "text": "Ammonium magnesium phosphate"
        },
        {
          "id": 2,
          "text": "Uric acid"
        },
        {
          "id": 3,
          "text": "Cystine"
        },
        {
          "id": 4,
          "text": "Calcium oxalate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Dumbbell-shaped </strong>and<strong> envelope-shaped </strong>crystals in this patient are indicative of <strong>calcium oxalate</strong> stones.</p>\n<p>The classic presentation for a patient with <strong>nephrolithiasis</strong> (renal calculi) is <strong>acute renal colic,</strong> which is the sudden onset of severe pain originating in the flank and radiating inferiorly and anteriorly <strong>(loin to groin). </strong>It is usually accompanied by nausea, vomiting, and hematuria. Urinalysis showing <strong>dumbbell </strong>and<strong> envelope-shaped crystals</strong> confirm that the kidney stones are made up of <strong>calcium oxalate</strong>. </p>\n<p>Risk factors for <strong>calcium oxalate stones</strong>:</p>\n<ul>\n<li><strong>Hyperparathyroidism</strong> (Causes hypercalcemia)</li>\n<li>Hypercalciuria with normal serum calcium:\n<ul>\n<li>Hyperabsorption of calcium from the intestine (<strong>absorptive hypercalciuria</strong>)</li>\n<li>Intrinsic impairment in renal tubular reabsorption of calcium (<strong>renal hypercalciuria</strong>)</li>\n<li><strong>Idiopathic</strong> fasting hypercalciuria with normal parathyroid function</li>\n</ul>\n</li>\n<li><strong>Hyperoxaluria</strong>: Hereditary or acquired (intestinal malabsorption syndromes or excess intake of oxalate)</li>\n<li><strong>Hyperuricosuria</strong></li>\n<li><strong>Hypocitraturia</strong>: Due to idiopathic causes, acidosis or chronic diarrhea.</li>\n</ul>\n<div class=\"page\" title=\"Page 949\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>There are four main types of calculi</p>\n<ul>\n<li><strong>Calcium stones</strong> (most common): composed of calcium oxalate or calcium oxalate mixed with calcium phosphate</li>\n<li><strong>Triple stones</strong> or struvite stones: composed of magnesium ammonium phosphate</li>\n<li><strong>Uric acid stones</strong> </li>\n<li><strong>Cystine</strong></li>\n</ul>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Microscopic Appearance of Various Stones</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/15e48f770c514c65b97b1eefea14db50x1280x2927.JPEG\" alt=\"Pearl Image\"><p>Xanthine, indinavir, and triamterene stones are <strong>radiolucent</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f68b368336a343f086744ca1ed22cf46.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7979",
      "difficulty": "easy"
    },
    {
      "text": "A male patient came with complaints of fatigue, weakness, and irritability for a few weeks.  He was on antitubercular drugs for the past 1 month. The laboratory investigations are given below. The most likely diagnosis is :<div class='question-desc-html'><ul>\n<li>Hemoglobin - Reduced</li>\n<li>Mean corpuscular hemoglobin (MCH) - Reduced</li>\n<li>Mean corpuscular volume (MCV) - Raised</li>\n<li>Serum ferritin - Raised</li>\n<li>Serum iron - Raised</li>\n<li>Total iron-binding capacity (TIBC) - Normal </li>\n</ul></div>",
      "choices": [
        {
          "id": 1,
          "text": "Anemia in chronic infection"
        },
        {
          "id": 2,
          "text": "Sideroblastic anemia"
        },
        {
          "id": 3,
          "text": "Iron deficiency anemia"
        },
        {
          "id": 4,
          "text": "Thalassemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most likely diagnosis is<strong> sideroblastic anemia</strong>. </p>\n<p>The following are the points given in the question pointing to this diagnosis: </p>\n<ul>\n<li>Symptoms of anemia - fatigue, weakness</li>\n<li>History of taking <strong>anti-tubercular drugs</strong> (<strong>isoniazid</strong>)</li>\n<li>Laboratory investigations showing - <strong>reduced MCH</strong>, <strong>raised MCV</strong>, <strong>raised serum iron</strong>, raised serum ferritin, and normal TIBC </li>\n</ul>\n<p>Isoniazid has a <strong>pyridoxine antagonistic</strong> action, which results in <strong>defective heme</strong> synthesis. Pyridoxine acts as a cofactor of the <strong>aminolevulinic acid (ALA) synthetase</strong> enzyme, which is the rate-limiting enzyme in heme synthesis. Isoniazid-induced sideroblastic anemia is a rare condition due to defective heme synthesis.</p>\n<p><strong>Sideroblastic anemia</strong> is a group of disorders characterized by the presence of sideroblasts. <strong>Sideroblasts</strong> are <strong>nucleated red cells</strong> (normoblasts) containing non-heme siderotic granules and stain <strong>Prussian blue</strong> positive. Based on etiology, sideroblastic anemia is classified into hereditary and acquired types.</p>\n<p><strong>Hereditary</strong> <strong>sideroblastic anemia</strong>: </p>\n<p>It is an <strong>X-linked </strong>disorder caused by a <strong>defect</strong> in the <strong>activity</strong> of <strong>ALA synthetase</strong> required for heme synthesis. Affected females act as carriers, but males have moderate to marked anemia, which manifests in childhood or early adulthood.</p>\n<p><strong>Acquired sideroblastic anemia</strong>: This is further divided into - </p>\n<p>1) <strong>Primary acquired/idiopathic/refractory </strong>-<strong> </strong>it is regarded as a <strong>myelodysplastic disorder</strong> in the FAB classification. It occurs in <strong>middle-aged </strong>and<strong> elderly individuals</strong> of both sexes. This occurs due to the <strong>reduced activity</strong> of the <strong>ALA synthetase</strong> enzyme. This furthermore causes disturbed growth and maturation of the erythroid precursors (hematopoietic stem cells). Anaemia is <strong>moderate to severe </strong>and appears gradually.</p>\n<p>2) <strong>Secondary Acquired </strong>- may occur secondary to - </p>\n<ul>\n<li><strong>Drugs</strong>,<strong> chemicals</strong>, and<strong> toxins </strong>-<strong> </strong>isoniazid, alcohol, and lead</li>\n<li><strong>Hematological disorders </strong>- myelofibrosis, acute leukemia, lymphoma, and hemolytic anemia.</li>\n<li><strong>Miscellaneous </strong>- inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus.</li>\n</ul>\n<p>Peripheral smear in sideroblastic anemia shows <strong>h</strong><strong>ypochromic microcytic</strong> (sometimes normocytic) anemia. <strong>MCH</strong> and <strong>MCV </strong>are <strong>reduced</strong> in the <strong>hereditary</strong> <strong>type</strong> and <strong>raised </strong>in the <strong>acquired type</strong>. Serum ferritin and<strong> serum iron</strong> are <strong>r</strong><strong>aised</strong>, and<strong> </strong>TIBC shows complete saturation. Bone marrow examination shows <strong>e</strong><strong>rythroid hyperplasia</strong> with pathognomonic <strong>ring sideroblasts,</strong> as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ff00d7fd5ef142f4b7787d10ce2aaf17x501x353.JPEG\" alt=\"Explanation Image\"><p><strong>Pyridoxine </strong>for 2-3 months is administered routinely to all cases of sideroblastic anemia. Blood transfusion and other supportive therapy may be required. In cases of secondary sideroblastic anemia, the primary focus is the removal of the offending agent. </p><hr><h3>Related Pearl: Features of Peripheral Blood Smear in Different Anemias</h3><p><strong>Type of anemia </strong></p>\n<p><strong>Microcytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thalassemia trait</p>\n</td>\n<td>\n<p>Basophilic stippling, target cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron-deficiency</p>\n</td>\n<td>\n<p>Elliptocytes, target cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sideroblastic anemia</p>\n</td>\n<td>\n<p>Pappenheimer bodies, RBC dimorphism, ringed sideroblasts (Perl&rsquo;s stain)&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Macrocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myelodysplastic syndrome</p>\n</td>\n<td>\n<p>Hypogranular or hypolobulated neutrophils, blast cells, giant or hypogranular platelets, Pappenheimer bodies</p>\n<p>Minor population of hypochromic / microcytic cells (dimorphic), poikilocytosis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Megaloblastic anemia</p>\n</td>\n<td>\n<p>Hypersegmented neutrophils (&gt;5 lobes), ovalocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemolysis</p>\n</td>\n<td>\n<p>Polychromasia (purple reticulocyte) +/- spherocytes&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic liver disease</p>\n</td>\n<td>\n<p>Target cells&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Normocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemolytic anemia&nbsp;</p>\n</td>\n<td>\n<p>Anisocytosis, poikilocytosis, polychromasia, nucleated red cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hereditary spherocytosis</p>\n</td>\n<td>\n<p>RBC lack central zone of pallor, reticulocytosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency&nbsp;</p>\n</td>\n<td>\n<p>Heinz bodies (revealed by special staining),&lsquo;Bite&rsquo; cells</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1742",
      "difficulty": "medium"
    },
    {
      "text": "An elderly diabetic patient with COVID-19 who was on invasive ventilation was given 40 mg of methylprednisolone for 7 days. After recovery, he developed facial pain and swelling. The tissue obtained from the sinuses showed the following finding.  If amphotericin B is not available, which other drug can be given to this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Voriconazole"
        },
        {
          "id": 2,
          "text": "Isavuconazole"
        },
        {
          "id": 3,
          "text": "Itraconazole"
        },
        {
          "id": 4,
          "text": "Flucytosine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above clinical scenario and the image showing ribbon-like, irregular, aseptate hyphae is suggestive of <strong>mucormycosis</strong><strong>. </strong>Intravenous administration of<strong> amphotericin B </strong>is the first line of treatment. If Amphotericin B is not available,&nbsp;<strong>isavuconazole</strong> can be given to this patient.</p>\n<p><strong>Mucormycosis</strong> is a group of highly invasive, progressive, even life-threatening infections caused by fungi of the order <strong>Mucorales</strong>. Important fungi are rhizopus, mucor, actinomucor, etc.</p>\n<p>These mucorales are present almost everywhere in the environment and humans are constantly exposed. But, infection is usually seen in immunocompromised states such as&nbsp;<strong>diabetes mellitus, glucocorticoid treatment</strong>, solid organ or hematopoietic stem cell transplantation (HSCT) and prolonged neutropenia. Recently, there was a rise in incidence of mucormycosis (which was alredy hyper-endemic in india) during the Covid 19 pandemic.&nbsp;</p>\n<p class=\"p1\">It can presentin five forms: Rhino-orbital-cerebral, pulmonary, cutaneous, gastrointestinal, or disseminated disease.&nbsp;<strong>Rhino-orbital-cerebral mucormycosis&nbsp;</strong>is the&nbsp;<strong>most common form</strong>. The initial presentation is nonspecific with eye or facial pain and facial numbness followed by conjunctival suffusion and dimunition of vision. If untreated it can spread from the sinuses to the orbit, and to the frontal lobe, and may also cause cavernous sinus thrombosis. On examination, sinuses may look normal in initial stages, and may need blind bipsy. In later stages, there is erythema (with or without edema), followed by a necrotic eschar.</p>\n<p>Diagnosis is made by&nbsp;<strong>culturing</strong>&nbsp;the organisms from the sterile sites like needle aspirate, pleural fluid, or a tissue biopsy specimen. The&nbsp;<strong>biopsy</strong>&nbsp;is most sensitive. It reveals characteristic&nbsp;<strong>wide, thick-walled, ribbon-like, aseptate hyphal</strong>&nbsp;elements that branch at right angles.</p>\n<p>Management:</p>\n<ul>\n<li><strong>Amphotericin B</strong>&nbsp;is the first line, antifungal agent. The dose of liposomal amphotericin formulation is <strong>5-10mg/kg/day.&nbsp;</strong>Other antifungal agents used are&nbsp;<strong>isavuconazole </strong>and<strong> posaconazole</strong></li>\n<li>Treatment of the&nbsp;underlying risk factors</li>\n<li><strong>Surgical debridement</strong></li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9465671aad8344c5a5789817753b4f02.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9346",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old man is diagnosed with type 2 diabetes mellitus for the first time. When should he visit an ophthalmologist?",
      "choices": [
        {
          "id": 1,
          "text": "Within 1 year of diagnosis"
        },
        {
          "id": 2,
          "text": "At the time of diagnosis"
        },
        {
          "id": 3,
          "text": "After 5 years of diagnosis"
        },
        {
          "id": 4,
          "text": "When symptoms of loss of vision begin to appear"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A patient with<strong> type II diabetes mellitus </strong>should visit the ophthalmologist <strong>at the time of diagnosis</strong> of diabetes. </p>\n<p><strong>American Diabetes Association </strong>recommends: </p>\n<ul>\n<li>For <strong>type 2 diabetes mellitus - immediate </strong>comprehensive eye examination just after the diagnosis of diabetes </li>\n<li>For<strong> type 1 diabetes mellitus - </strong>comprehensive eye examination within<strong> 5 years </strong>of<strong> diabetes </strong>onset.</li>\n<li>For women with preexisting type 1 or type 2 diabetes who become pregnant or are planning pregnancy - comprehensive eye examination <strong>before pregnancy </strong>or in the <strong>first trimester</strong>. Furthermore, these patients should be monitored <strong>every trimester</strong> and for 1 year postpartum.</li>\n</ul>\n<p>After the initial examination in both type 1 and type 2 DM,</p>\n<ul>\n<li><strong>Annual examination </strong>of fundus is recommended therafter.</li>\n<li>If there is no significant abnormality, the fundus should be examined every 2 years.</li>\n</ul>\n<div class=\"page\" title=\"Page 1\">Severe vision loss is a microvascular complication of DM primarily due to progressive <strong>diabetic retinopathy</strong>, characterised by macular edema and new blood vessel formation. Diabetic retinopathy is classified into <strong>two stages</strong>:</div>\n<div class=\"page\" title=\"Page 11370\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Nonproliferative diabetic retinopathy : Usually presents in the 1st decade of hyperglycemia</li>\n<li>Proliferative diabetic retinopathy</li>\n</ul>\n<div class=\"page\" title=\"Page 11372\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The most effective therapy for diabetic retinopathy is <strong>prevention</strong>. Hence, intensive glycemic and blood pressure control and routine screening becomes essential. </p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Early treatment diabetic retinopathy study (ETDRS) classification</h3><p>Non-proliferative diabetic retinopathy (NPDR):</p>\n<ul>\n<li>Mild NPDR\n<ul>\n<li>At least one microaneurysm must be present</li>\n</ul>\n</li>\n<li>Moderate NPDR\n<ul>\n<li>Microaneurysms/intraretinal hemorrhage in 2 or 3 quadrants</li>\n<li>Early mild intraretinal microvascular abnormalities (IRMA)</li>\n<li>Hard exudates and cotton-wool spots may or may not be present</li>\n</ul>\n</li>\n<li>Severe NPDR - any one of the following (4-2-1 rule)\n<ul>\n<li>4 quadrants of microaneurysms and extensive intraretinal hemorrhages</li>\n<li>2 quadrants of venous beading</li>\n<li>1 quadrant of IRMA changes</li>\n</ul>\n</li>\n<li>Very severe NPDR - any two of the following (4-2-1)\n<ul>\n<li>4 quadrants of microaneurysms and extensive intraretinal hemorrhages</li>\n<li>2 quadrants of venous beading</li>\n<li>1 quadrant of IRMA changes</li>\n</ul>\n</li>\n</ul>\n<p>Proliferative diabetic retinopathy (PDR):</p>\n<ul>\n<li>PDR without high-risk characteristics (Early PDR)\n<ul>\n<li>Early neovascularization at the optic disc (NVD) or neovascularization elsewhere (NVE)</li>\n</ul>\n</li>\n<li>PDR with high-risk characteristics as follows\n<ul>\n<li>NVD &lt; 1/4 disc area with vitreous hemorrhage (VH) or preretinal hemorrhage (PRH)</li>\n<li>NVD 1/4 to 1/3 of disc area with or without VH&nbsp;or PRH</li>\n<li>NVE &gt; 1/2 disc area with VH or PRH</li>\n</ul>\n</li>\n</ul>\n<p>Clinically significant macular edema: 1&nbsp;of the following 3 criteria are present on&nbsp;slit-lamp examination with 90D lens</p>\n<ul>\n<li>Thickening of the retina at or within 500 micron of&nbsp;the center of the fovea.</li>\n<li>Hard exudates at or within 500 micron of the&nbsp;centre of fovea associated with adjacent retinal&nbsp;thickening.</li>\n<li>Development of a zone of retinal thickening one disc&nbsp;diameter or larger in size. At least a part of this should be within one disc diameter of the foveal center.</li>\n</ul>\n<p>Advanced diabetic eye disease:</p>\n<ul>\n<li>Persistent vitreous hemorrhage</li>\n<li>Tractional retinal detachment</li>\n<li>Neovascular glaucoma</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/92933781eb3d4b00998e69c7e0d4dcb9x1280x1359.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3796",
      "difficulty": "easy"
    },
    {
      "text": "A patient comes with complaints of non-pulsatile headache of tightening quality on both sides of his forehead. He describes it as wearing a tight cap. He has no nausea, photophobia, or phonophobia.  All of the following drugs can be used in the treatment of this condition except",
      "choices": [
        {
          "id": 1,
          "text": "Aspirin"
        },
        {
          "id": 2,
          "text": "Sumatriptan"
        },
        {
          "id": 3,
          "text": "Acetaminophen"
        },
        {
          "id": 4,
          "text": "Naproxen"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A bilateral, non-pulsatile headache of tightening quality without any nausea or photophobia suggests a diagnosis of <strong>tension-type headache </strong>(TTH). Triptans are not&nbsp;useful in the treatment of this condition. They are useful when the patient has a migraine headache.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Tension-type headache</strong></td>\n<td><strong>Migraine&nbsp;</strong></td>\n<td><strong>Cluster headache</strong></td>\n</tr>\n<tr>\n<td>\n<p>Treatment</p>\n</td>\n<td>\n<p>Analgesics</p>\n<p>NSAIDs</p>\n<p>Acetaminophen</p>\n</td>\n<td>\n<p>NSAIDs</p>\n<p>Triptans</p>\n<p>Dihydroergotamine</p>\n</td>\n<td>\n<p>100% oxygen</p>\n<p>Sumatriptan</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Prophylaxis</td>\n<td>Amitriptyline</td>\n<td>&nbsp;\n<ul>\n<li>Lifestyle changes(eg, sleep,exercise, diet)</li>\n<li>&beta;-blockers</li>\n<li>Calcium channel blockers</li>\n<li>Amitriptyline, topiramate, valproate</li>\n<li>CGRP antagonists - erenumab, fremanezumab, galcanezumab, eptinezumab</li>\n</ul>\n</td>\n<td>Verapamil&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7842",
      "difficulty": "easy"
    },
    {
      "text": "A young boy from Africa comes with complains of fever, night sweats and a swelling over the jaw. On biopsy of the lesion, histopathology showed a starry sky appearance. Cytogenetics revealed a t (8;14) translocation. What is the likely diagnosis of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Follicular lymphoma"
        },
        {
          "id": 2,
          "text": "Mantle cell lymphoma"
        },
        {
          "id": 3,
          "text": "Burkitt's lymphoma"
        },
        {
          "id": 4,
          "text": "Small lymphocytic lymphoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario along with the biopsy findings of <strong>starry sky appearance</strong> and cytogenetics showing&nbsp;<strong>t(8;14) translocation </strong>point to a&nbsp;likely diagnosis of <strong>Burkitt's lymphoma</strong>.&nbsp;</p>\n<p><span data-preserver-spaces=\"true\">Burkitt's lymphoma is a type of <strong>non-hodgkin's lymphoma</strong><strong>.&nbsp;</strong>It&nbsp;arises from&nbsp;</span><strong>mature&nbsp;germinal center B-cells</strong> that express surface IgM, CD19, CD20, CD10, and BCL6. It is one of the fastest growing tumors, with a high doubling time.</p>\n<p>It can occur in 3 forms mainly preseting in <strong>children</strong> or young adults:</p>\n<ul>\n<li><strong>African (endemic)</strong> Burkitt lymphoma - it often presents as a mass involving the mandible. It may also involve the abdominal viscera, particularly the kidneys, ovaries, and adrenal glands.&nbsp;</li>\n<li><strong>Sporadic (non-endemic) </strong>Burkitt lymphoma - it most often appears as a mass involving the ileocecum and peritoneum</li>\n<li>Aggressive lymphoma or acute leukemia - it is seen in immunocompromised individuals</li>\n</ul>\n<div class=\"page\" title=\"Page 606\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>All forms of Burkitt lymphoma are associated with<strong> increased MYC protein</strong> levels due to translocations of the <strong>MYC gene</strong> on chromosome 8. Depending in the translocation partner common&nbsp;chromosomal abnormalities are:</p>\n<ul>\n<li><strong>t (8;14) </strong>causing&nbsp;MYC-IGH fusion - <strong>most common&nbsp;</strong></li>\n<li>t (8;22) causing MYC-Kappa fusion</li>\n<li>t (2;8) causing MYC-Lambda fusion</li>\n</ul>\n<p>The tumor shows a&nbsp;<strong>high mitotic index</strong>&nbsp;with numerous&nbsp;<strong>apoptotic cells.</strong>&nbsp;The nuclear remnants of these apoptotic cells are phagocytosed by interspersed benign macrophages. The phagocytes have abundant clear cytoplasm, creating a characteristic&nbsp;<strong>starry sky pattern</strong>.</p>\n<p>Despite being an aggressive tumor, it responds well to <strong>intensive chemotherapy.</strong> Chemotherapy with&nbsp;<strong>EPOCH-R</strong> (rituximab, infusional etoposide/vincristine/doxorubicin, cyclophosphamide, prednisone) is highly effective.</p>\n<p>The image below shows the starry sky appearance seen in Burkitt's lymphoma.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/087811036a1942db81d8d9a6dab453b6x1280x853.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Malignancies, Translocations and Affected Genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4106",
      "difficulty": "easy"
    },
    {
      "text": "Which among these pairs are the correctly matched conditions with their mode of inheritance?<div class='question-desc-html'><ol>\n<li>Factor V deficiency - X-linked recessive</li>\n<li>Factor VII deficiency - Autosomal recessive</li>\n<li>Factor VIII deficiency - X-linked recessive</li>\n<li>Factor IX deficiency - X-linked recessive</li>\n<li>Factor X deficiency - Autosomal dominant</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "3 and 4"
        },
        {
          "id": 2,
          "text": "1, 4, and 5"
        },
        {
          "id": 3,
          "text": "2, 3, and 4"
        },
        {
          "id": 4,
          "text": "2, 3, and 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correctly matched conditions with their mode of inheritance are&nbsp;<strong>2, 3, and 4</strong>.</p>\n<p>Factors<strong>&nbsp;</strong><strong>VIII</strong>&nbsp;and <strong>IX</strong><strong>&nbsp;</strong>deficiencies<strong>&nbsp;</strong>are inherited as&nbsp;<strong>X-linked recessive </strong>traits, whereas&nbsp;factors<strong> V</strong>, <strong>VII</strong>, and&nbsp;<strong>X </strong>deficiencies<strong>&nbsp;</strong>are inherited as <strong>autosomal recessive</strong> traits.</p>\n<p>Factors<strong>&nbsp;</strong><strong>VIII</strong>&nbsp;and <strong>IX</strong><strong>&nbsp;</strong>deficiencies are also known as <strong>hemophilia A </strong>and<strong> B</strong>, respectively.</p>\n<p>Clinically, hemophilia A and B are indistinguishable. <strong>Mild disease</strong> usually presents as <strong>bleeding</strong> following<strong> major trauma</strong>. <strong>Moderate</strong> to <strong>severe disease</strong> presents as <strong>bleeding</strong> into the joints (hemarthrosis), soft tissues, and muscles after <strong>minor trauma</strong> or <strong>spontaneously</strong>.</p>\n<p>These patients usually have a normal bleeding time and platelet counts. The diagnosis can be made only after specific determination of <strong>FVIII</strong> or<strong> FIX clotting activity</strong>.</p>\n<div class=\"page\" title=\"Page 877\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\"><strong>Factor replacement therapy</strong> is the treatment of choice either after a bleeding episode or prophylactically.</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Characteristics of Inherited Coagulation Disorders</h3><table>\n<thead>\n<tr>\n<td rowspan=\"2\">\n<p><strong>Clotting Factor Deficiency</strong></p>\n</td>\n<td rowspan=\"2\">\n<p><strong>Inheritance</strong></p>\n</td>\n<td colspan=\"3\">\n<p><strong>Laboratory Abnormality&nbsp;</strong></p>\n</td>\n<td rowspan=\"2\">\n<p><strong>Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>aPTT</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>TT</strong></p>\n</td>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>\n<p>Fibrinogen</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>Cryoprecipitate</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prothrombin</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor V</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+/&ndash;</p>\n</td>\n<td>\n<p>+/&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor VII</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor VIII</p>\n</td>\n<td>\n<p>X-linked</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FVIII concentrates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor IX</p>\n</td>\n<td>\n<p>X-linked</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FIX concentrates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor X</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+/&ndash;</p>\n</td>\n<td>\n<p>+/&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor XI</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>FFP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor XII</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p>&ndash;</p>\n</td>\n<td>\n<p><strong>No </strong>risk of bleeding; treatment not indicated</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*FFP: Fresh frozen plasma</p>\n<p>PCC: Prothrombin complex concentrate</p><hr><h3>Related Pearl: Coagulation Pathways and its Abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fedd76b578148fc8ed55da37e66574cx1280x1995.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td><strong>Test results</strong></td>\n<td><strong>Inherited causes</strong></td>\n<td><strong>Acquired causes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged PT </strong></p>\n<p>Evaluates extrinsic pathway factors</p>\n<p>Normal PT: 11-13 seconds</p>\n</td>\n<td>Factor VII deficiency </td>\n<td>\n<p>Mild vitamin K deficiency</p>\n<p>Liver disease</p>\n<p>Warfarin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged aPTT </strong></p>\n<p>Evaluates intrinsic pathway factors</p>\n<p>Normal aPTT: 25-35 seconds</p>\n</td>\n<td>\n<p>Factors VIII, IX, XI deficiency</p>\n<p>Factor XII, prekallikrein, or HMW kininogen deficiency</p>\n<p>von Willebrand disease</p>\n</td>\n<td>Heparin, lupus anticoagulant, acquired von Willebrand disease</td>\n</tr>\n<tr>\n<td>\n<p>Prolonged PT + prolonged aPTT</p>\n<p>Evaluates common pathway factors</p>\n</td>\n<td>\n<p>Prothrombin (II), fibrinogen (I), factors V and factor X deficiencies</p>\n</td>\n<td>\n<p>Disseminated intravascular coagulation (DIC)</p>\n<p>Severe liver disease</p>\n<p>Severe vitamin K deficiency</p>\n<p>Direct thrombin inhibitor-argatroban, dabigatran</p>\n<p>Direct factor Xa inhibitor-rivaroxaban, apixaban, edoxaban</p>\n<p>Fondaparinux</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4719",
      "difficulty": "medium"
    },
    {
      "text": "A 62-year-old male patient with a history of fatiguability, weight gain, cold intolerance, and thick, dry skin for the last 6 months. He was brought to the casualty with reduced consciousness level, hypothermia, bradycardia, and hypotension and a recent history of pneumonia. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Septic shock"
        },
        {
          "id": 2,
          "text": "Cardiogenic shock"
        },
        {
          "id": 3,
          "text": "Myxedema coma"
        },
        {
          "id": 4,
          "text": "Hypoglycemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical history suggests of a typical case of<strong> hypothyroidism,</strong> and the likely diagnosis is <strong>myxedema coma</strong>.</p>\n<p>Myxedema coma is a severe neurological complication of hypothyroidism. It is mostly seen in the <strong>elderly</strong> and has a high mortality rate of 20-40%. It is often <strong>precipitated</strong> by:</p>\n<ul>\n<li><strong>Drugs</strong> like sedatives, antidepressants, anaesthetics</li>\n<li><strong>Infections</strong> like <strong>pneumonia</strong></li>\n<li>Congestive heart failure, myocardial ischemia</li>\n<li>Cerebrovascular accidents</li>\n<li>Gastrointestinal bleeding</li>\n<li>Exposure to cold</li>\n</ul>\n<p>All these cause <strong>hypoventilation</strong>, leading to hypoxia and hypercapnia. </p>\n<p>Clinical features include a <strong>reduced level of consciousness</strong>, seizures, <strong>hypothermia</strong> (can reach 23°C), metabolic disturbances, and symptoms and signs of hypothyroidism (fatiguability, cold intolerance, thick dry skin, weight gain, constipation, etc).</p>\n<p>Management of myxedema coma involves:</p>\n<ul>\n<li>Pharmacotherapy:\n<ul>\n<li><strong>Levothyroxine </strong>(T4): Single loading IV dose (200-400 mcg) and maintenance oral dose (1.6 mcg/kg/day)</li>\n<li><strong>Liothyronine </strong>(T3): Added along with T4 either via nasogastric tube or IV </li>\n<li><strong>Parenteral hydrocortisone</strong> (50 mg every 6 h): Given to correct the impaired levels of corticoid hormones</li>\n<li><strong>Broad-spectrum IV</strong> <strong>antibiotics</strong>: Given<strong> </strong>in case of infections</li>\n</ul>\n</li>\n<li>Supportive therapy:\n<ul>\n<li>Hypertonic saline or IV glucose if severe hyponatremia or hypoglycemia is present</li>\n<li>External warming if body temperature is &lt;30° to prevent circulatory collapse and use of space blankets to prevent heat loss</li>\n<li>Ventilatory support with regular blood-gas analysis in the first 48 h</li>\n<li>Avoidance of hypotonic fluids to prevent fluid retention</li>\n</ul>\n</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Septic shock </strong>occurs due to <strong>systemic infections</strong> like bacterial and fungal infections, toxic shock syndrome, pancreatitis etc, massive trauma, and severe burns, resulting in <strong>fatal organ failure</strong>. Massive release of inflammatory cytokines causes peripheral vasodilation and pooling, which causes the skin to look flushed. Vascular damage, DIC, and alveolar damage (shock lung) can be seen.</p>\n<p>Option B:<strong><span data-preserver-spaces=\"true\"> </span></strong><span data-preserver-spaces=\"true\"><strong>Cardiogenic shock</strong> occurs due to <strong>myocardial pump failure</strong>, resulting in low cardiac output. It is associated with conditions like myocardial infarction, arrhythmias, cardiac tamponade, and pulmonary embolism. Patients present with hypotension, a weak rapid pulse, tachypnea, and cool clammy skin.</span></p>\n<p>Option D: <strong>Hypoglycemia</strong> occurs due to <strong>insulin </strong>or <strong>insulin-producing drugs</strong> used to treat diabetes mellitus or other substances like <strong>alcohol</strong>. It is characterised by <strong>low plasma glucose levels</strong> and relief of symptoms after normalization of plasma glucose levels. Along with neurological symptoms (behavioural changes, confusion, fatigue, seizures, loss of consciousness), adrenergic symptoms (palpitations, tremors, anxiety), cholinergic symptoms (sweating, hunger), and diaphoresis are present. Increased heart rate and BP are mainly seen in individuals with repeated episodes.</p><hr><h3>Related Pearl: Causes of Hypothyroidism</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Primary </strong></p>\n<p>(Low T3, T4 &rarr; Raised TSH levels)</p>\n</td>\n<td>\n<p><strong>Secondary</strong></p>\n<p><strong> </strong>(Low TSH levels &rarr; Low T3, T4)</p>\n</td>\n<td>\n<p><strong>Tertiary</strong></p>\n<p><strong> </strong>(Low TRH &rarr; Low TSH &rarr; Low T3,T4)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hashimoto&rsquo;s thyroiditis</strong></p>\n<p>RAI therapy for Grave&rsquo;s disease</p>\n<p>Post thyroidectomy</p>\n<p>Excessive iodine intake - Wolff Chiakoff effect</p>\n<p>Subacute thyroiditis</p>\n<p>Medications: Antithyroid drugs, lithium</p>\n<p>Iodine deficiency, dyshormonogenesis</p>\n</td>\n<td>\n<p><strong>Pituitary tumour</strong></p>\n<p>Pituitary resection or ablation</p>\n</td>\n<td>\n<p><strong>Hypothalamic insufficiency</strong></p>\n<p>Resistance to thyroid hormone</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2878",
      "difficulty": "easy"
    },
    {
      "text": "A patient with a known history of peptic ulcers comes with hematemesis. The urea breath test is positive. The patient's gastric biopsy is taken, and the slide is shown below. The patient is at the highest risk of developing which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Gastric lymphoma"
        },
        {
          "id": 2,
          "text": "Esophageal adenocarcinoma"
        },
        {
          "id": 3,
          "text": "Gastroesophageal reflux disease"
        },
        {
          "id": 4,
          "text": "Gastric adenocarcinoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical history and gastric biopsy showing <strong>curved bacteria</strong> filling the lumen of a gastric foveola is indicative of <strong><em>Helicobacter pylori</em> </strong>infection.<em> </em>This patient is at the highest risk of developing <strong>gastric adenocarcinoma</strong>.</p>\n<div class=\"page\" title=\"Page 4804\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><em>H. pylori</em> is a <strong>gram-negative bacillus</strong> that lives in <strong>gastric mucus</strong> and duodenum. It is acid-resistant and motile due to its spiral shape and flagella.</p>\n</div>\n</div>\n</div>\n</div>\n<p><em>H. pylori</em> is a known risk factor for<strong> peptic ulcer disease</strong>, gastritis, <strong>gastric adenocarcinoma</strong>, and<strong> gastric lymphoma</strong>. However, the risk of developing gastric adenocarcinoma is much more than the risk of developing gastric lymphoma.</p>\n<p>Many studies have shown <em>H. pylori</em> is <strong>protective</strong> against peptic esophageal diseases, including <strong>esophageal adenocarcinoma </strong>and<strong> GERD</strong>. It is due to <strong>H. pylori-induced hypochlorhydria</strong>. </p>\n<p><strong>Diagnosis</strong> of <em>H. pylori </em>is by:</p>\n<ul>\n<li>Tests based on endoscopic biopsy - biopsy urease test, histology, and culture of the biopsy specimen.</li>\n<li>Non-invasive tests - <sup>13</sup>C <strong>Urea breath test</strong> and stool antigen test is useful for follow-up after treatment. <em>H. pylori </em>contains an enzyme called <strong>urease.</strong> It splits urea into carbon dioxide and ammonium ions. In urea breath test, <sup>13</sup>C is ingested by the patient. If <em>H. pylori</em> is present, the urease activity generates <span class=\"s1\">13</span>C-labeled CO<sub><span class=\"s1\">2 </span></sub>that then can be detected in the patient’s exhaled breath.</li>\n</ul>\n<p>The given image shows <em>Helicobacter pylori </em>on gastric mucosa stained with <strong>Warthin-Starry silver stain</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3051a9fb0ff044d5bd44959160acd41dx1280x1156.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: H. pylori eradication regimen</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>1<sup>st</sup> line</strong></p>\n<p><strong>[OCA/OCM - 14 days]</strong></p>\n</td>\n<td>\n<p><strong>2<sup>nd</sup> line</strong></p>\n<p><strong>[TOMB - 14 days]</strong></p>\n</td>\n<td>\n<p><strong>3<sup>rd</sup> line /Clarithromycin-resistant cases </strong></p>\n<p><strong>[LOA - 10 days]</strong></p>\n</td>\n<td>\n<p><strong>Sequential Regimen</strong></p>\n<p><strong>[OA (5days) + OCT (5days)]</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>O</strong>meprazole</p>\n</td>\n<td><strong>T</strong>etracycline</td>\n<td><strong>L</strong>evofloxacin</td>\n<td><strong>O</strong>meprazole</td>\n</tr>\n<tr>\n<td><strong>C</strong>larithromycin</td>\n<td><strong>O</strong>meprazole</td>\n<td><strong>O</strong>meprazole</td>\n<td><strong>C</strong>larithromycin</td>\n</tr>\n<tr>\n<td><strong>A</strong>moxicillin/</td>\n<td><strong>M</strong>etronidazole</td>\n<td><strong>A</strong>moxicillin</td>\n<td><strong>A</strong>moxicillin</td>\n</tr>\n<tr>\n<td><strong>M</strong>etronidazole</td>\n<td><strong>B</strong>ismuth</td>\n<td>&nbsp;</td>\n<td><strong>T</strong>inidazole</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Infectious Agents Associated with the Development of Lymphoid Malignancies</h3><table>\n<thead>\n<tr>\n<td>\n<p><strong>Infectious Agent</strong></p>\n</td>\n<td>\n<p><strong>Lymphoid Malignancy</strong></p>\n</td>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>\n<p>HTLV-I</p>\n</td>\n<td>\n<p>Adult T cell leukemia/lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Epstein-Barr virus</p>\n</td>\n<td>\n<p>Burkitt's lymphoma</p>\n<p>Post&ndash;organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkin's disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitt's lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C virus</p>\n</td>\n<td>\n<p>Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Helicobacter pylori&nbsp;</p>\n</td>\n<td>\n<p>Gastric MALT lymphoma (Extranodal marginal zone lymphoma)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human herpesvirus 8</p>\n</td>\n<td>\n<p>Primary effusion lymphoma</p>\n<p>Multicentric Castleman's disease</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9a8e5de32d7d4f4ab67cd5cbf91484ad.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME6517",
      "difficulty": "medium"
    },
    {
      "text": "A young male patient presents with sudden onset of pleuritic chest pain, breathlessness, and cramping pain in the right leg. He reports to have had deep vein thrombosis in the right leg 1 year ago. His BP was 128/88 mmHg and his pulse was 110 bpm. Which of the following is the investigation of choice for the diagnosis of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Echocardiography"
        },
        {
          "id": 2,
          "text": "CT pulmonary angiography"
        },
        {
          "id": 3,
          "text": "Ventilation perfusion (V/Q) scanning"
        },
        {
          "id": 4,
          "text": "MR pulmonary angiography"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>pulmonary embolism </strong>(PE). The investigation of choice for the diagnosis of this condition is <strong>CT pulmonary angiography </strong>(CTPA).</p>\n<p>PE and deep vein thrombosis (DVT) are part of the same spectrum of <strong>venous thromboembolism</strong>. PE occurs due to <strong>obstruction</strong> of the <strong>pulmonary arterial circulation</strong> by deep venous thrombi that detach from their site of formation and embolize to the vena cava, right atrium, and right ventricle.</p>\n<p><strong>Virchow’s triad</strong> of <strong>venous stasis</strong>, <strong>hypercoagulability</strong>, and <strong>endothelial injury</strong>, leading to recruitment of activated platelets, provides the ideal environment for thrombus formation.</p>\n<div class=\"page\" title=\"Page 1957\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>PE can be classified as:</p>\n<ul>\n<li><strong>High-risk massive PE</strong> (extensive thrombosis affecting at least half of the pulmonary vasculature): Characterised by dyspnea, syncope, hypotension, cyanosis, cardiogenic shock, multisystem organ failure</li>\n<li><strong>Intermediate-risk submassive PE</strong>: Characterised by right ventricular (RV) dysfunction with normal systemic arterial pressure.</li>\n<li><strong>Low-risk PE</strong>: Shows excellent prognosis</li>\n</ul>\n<div class=\"page\" title=\"Page 1957\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Symptoms of PE are nonspecific, the most common among them being <strong>unexplained breathlessness</strong>.</p>\n<p><strong>Well's criteria</strong> is used to assess the likelihood of PE in a patient. For a patient with <strong>low-to-moderate likelihood</strong> of PE, the initial investigation is measurement of <strong>D-dimer levels</strong>. Whereas, for a patient with <strong>high likelihood</strong> of PE, the choice of investigation is <strong>CTPA</strong>. </p>\n<p>In the given patient, clinical signs of DVT, past history of DVT, heart rate &gt;100 bpm, and a diagnosis other than PE being less likely contribute to the <strong>high likelihood</strong> of PE according to Well's criteria.</p>\n<p>A <strong>normal D-dimer test</strong> helps to <strong>rule out</strong> PE. However, <strong>increased D-dimer levels</strong> are <strong>nonspecific</strong> as they can be seen in patients with other systemic illnesses including myocardial infarction (MI), pneumonia, sepsis, and cancer.</p>\n<p><strong>CTPA</strong>, also known as CT chest angiogram with contrast, is performed in patients with high probability of PE or those with low-to-moderate probability but elevated D-dimer levels. It is highly specific and sensitive, and a <strong>positive CTPA</strong> showing a <strong>filling defect</strong> confirms the diagnosis of PE.</p>\n<p>The arrows in the image below show a large pulmonary embolism at the bifurcation of the pulmonary artery (saddle embolism):</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6787298a620e423ca779bb3a12876481x1152x907.PNG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Echocardiography</strong> is <strong>not reliable</strong> because most patients with PE have normal echocardiograms. However, it can be used for detecting conditions that mimic PE like acute MI, pericardial tamponade, and aortic dissection. The best indirect sign of PE on transthoracic echo is <strong>McConnell’s sign </strong>(hypokinesis of the RV free wall with normal or hyperkinetic motion of the RV apex).</p>\n<p>Option C:<strong> Ventilation-perfusion (V/Q) scanning</strong> is a <strong>second-line</strong> diagnostic test that detects absent or decreased blood flow due to PE. It is performed when CTPA is contraindicated or inconclusive and additional testing is required.</p>\n<p>Option D: <strong>MR pulmonary angiography</strong> may detect large proximal PE but is not reliable for smaller segmental and subsegmental PE. </p><hr><h3>Related Pearl: Clinical prediction for pulmonary embolism: Well’s, Modified Well’s and Pulmonary Embolism Rule out Criteria (PERC)</h3><table>\n<tbody>\n<tr>\n<td><strong>Signs/symptoms</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Clinical signs of DVT</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Diagnosis other than pulmonary embolism is less likely</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Heart rate &gt;100 bpm</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Immobilization for &gt;3 days or surgery in the last 4 weeks</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Past history of DVT/pulmonary embolism</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Hemoptysis</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Malignancy</td>\n<td>1</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Three-level score probability:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Well's criteria</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Low</td>\n<td>&lt;2</td>\n</tr>\n<tr>\n<td>Moderate</td>\n<td>2-6</td>\n</tr>\n<tr>\n<td>High</td>\n<td>&gt;6</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Two-level score probability:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Modified Well's criteria</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Pulmonary embolism unlikely</td>\n<td>&le;4</td>\n</tr>\n<tr>\n<td>Pulmonary embolism likely</td>\n<td>&gt;4&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>&nbsp;</p>\n<p><strong>Pulmonary embolism rule out criteria (PERC):</strong></p>\n<p>This is a quick OPD/casualty tool to rule out pulmonary embolism in patients with low clinical probability. It comprises <strong>eight clinical variables</strong>. If the patient meets all eight criteria, there is no need for further investigations. The variables include:&nbsp;</p>\n<ol>\n<li aria-level=\"1\">Age &lt;50 years</li>\n<li aria-level=\"1\">Heart rate &lt;100 bpm</li>\n<li aria-level=\"1\">SpO2 &ge;95%</li>\n<li aria-level=\"1\">No unilateral leg swelling</li>\n<li aria-level=\"1\">No hemoptysis</li>\n<li aria-level=\"1\">No recent trauma or surgery</li>\n<li aria-level=\"1\">No history of venous thromboembolism</li>\n<li aria-level=\"1\">No use of hormonal therapy.</li>\n</ol><hr><h3>Related Pearl: Chest X Ray signs in pulmonary embolism</h3><p><strong>Westermark's sign:&nbsp;</strong>Focal area of oligemia (decreased vascular markings) distal to the embolism.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1320503c26a8431b903e7e15089c8ed4x720x655.JPEG\" alt=\"Pearl Image\"><p><strong>Hampton's hump:&nbsp;</strong>Peripherally placed wedge-shaped or dome-shaped opacity due to infarction of lung tissue.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5faac4b6986f4b6da649d4ca027f99b3x1063x874.JPEG\" alt=\"Pearl Image\"><p><strong>Palla's sign:&nbsp;</strong>Increased size of the right descending pulmonary artery with a sausage-like appearance.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9d6849e258104848bfc976a72abaae15x1069x804.JPEG\" alt=\"Pearl Image\"><p><strong>Fleishner sign</strong>: enlarged pulmonary artery.</p>\n<p><strong>Melting sign</strong>:&nbsp;an infarct shows rapid clearing in contrast to pneumonic consolidation.</p>\n<p><strong>McConnell's</strong>&nbsp;<strong>sign</strong> (indirect sign of PE seen in transthoracic echo):&nbsp;<strong>hypokinesis</strong>&nbsp;of the right ventricular free wall with&nbsp;<strong>normal motion</strong>&nbsp;of the right ventricle apex.</p>\n<p><strong>Knuckle&nbsp;</strong>or<strong>&nbsp;sausage&rsquo; sign:&nbsp;</strong>dilatation of the pulmonary artery,&nbsp;proximal to the embolus with collapse or constriction of the distal arteries resulting in an abrupt tapering of these arteries. &nbsp;</p>\n<p>Note - A normal chest X-ray does not rule out pulmonary embolism in a patient with unexplained acute tachypnea or hypoxemia.</p><hr><h3>Related Pearl: Risk Factors for Venous Thromboembolism</h3><p>The risk factors for venous thromboembolism (pulmonary embolism and DVT) are as follows:</p>\n<ul>\n<li aria-level=\"1\"><strong>Major trauma</strong> like spinal cord injury or fracture of lower limb</li>\n<li aria-level=\"1\"><strong>Surgery</strong> like hip or knee replacement</li>\n<li aria-level=\"1\"><strong>Hospitalization</strong> for heart failure or atrial fibrillation/flutter within last 3 months</li>\n<li aria-level=\"1\"><strong>Myocardial infarction</strong>&nbsp;within last 3 months</li>\n<li aria-level=\"1\"><strong>Previous venous thromboembolism</strong></li>\n<li aria-level=\"1\">Infections and inflammatory bowel disease</li>\n<li aria-level=\"1\">Autoimmune diseases:\n<ul>\n<li aria-level=\"1\">Antiphospholipid antibody (APLA)</li>\n<li aria-level=\"1\">SLE</li>\n</ul>\n</li>\n<li aria-level=\"1\">Inherited thrombophilias:\n<ul>\n<li aria-level=\"1\">Factor V leiden mutation</li>\n<li aria-level=\"1\">Deficiency of antithrombin III</li>\n<li aria-level=\"1\">Deficiency of protein C or protein S</li>\n</ul>\n</li>\n<li>Hypercoagulable states:\n<ul>\n<li>Pregnancy and postpartum period</li>\n<li aria-level=\"1\">COPD</li>\n<li aria-level=\"1\">Nephrotic syndrome</li>\n<li aria-level=\"1\">Polycythemia vera</li>\n<li aria-level=\"1\">Malignancies</li>\n</ul>\n</li>\n<li aria-level=\"1\">Iatrogenic:\n<ul>\n<li aria-level=\"1\">OCPs</li>\n<li aria-level=\"1\">Hormone replacement therapy</li>\n<li aria-level=\"1\">Chemotherapeutic drugs</li>\n<li aria-level=\"1\">Insertion of central venous lines</li>\n</ul>\n</li>\n<li aria-level=\"1\">Varicose veins</li>\n<li aria-level=\"1\">Prolonged car or air travel.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8036",
      "difficulty": "easy"
    },
    {
      "text": "A  patient comes with complaints of fever, cough with foul-smelling sputum, and night sweats. She reported having undergone a tooth extraction a few days ago. On examination, clubbing is seen and cavernous breath sounds are heard over the right lung.  Her chest X-ray is shown below. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Aspergilloma"
        },
        {
          "id": 2,
          "text": "Loculated pleural effusion"
        },
        {
          "id": 3,
          "text": "Emphysematous bullae"
        },
        {
          "id": 4,
          "text": "Lung abscess"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The diganosis is <strong>lung abscess</strong>. </p>\n<p>The clinical points in the question pointing to this diagnosis are: </p>\n<ul>\n<li>History of fever, cough with foul-smelling discharge and night sweats</li>\n<li>History of<strong> tooth extraction</strong> pointing towards the <strong>possibility </strong>of<strong> aspiration</strong></li>\n<li>Clubbing and cavernous breath sounds are heard over the right lung</li>\n<li><strong>Chest X-ray </strong>image showing a<strong> thick-walled cavity</strong> with <strong>air-fluid level </strong></li>\n</ul>\n<p><strong>Lung abscess</strong> represents necrosis and cavitation of the lung following microbial infection. They are broadly divided into two categories:</p>\n<ul>\n<li><strong>Primary lung abscess </strong>usually occurs in the abscence of any underlying systemic or pulmonary condition. They usually occur in the <strong>posterior upper lobes </strong>and <strong>superior lower lobes</strong> of the lungs. The <strong>right lung</strong> is more commonly involved because of less angulated right mainstem bronchus. They are<strong> polymicrobial</strong> in nature including <strong>anaerobes</strong> and <strong>microaerophilic streptococci. Aspiration </strong>is a major risk factor (hence alcoholic patients are at higher risk).</li>\n<li><strong>Secondary lung abscess </strong>usually occurs in the presence of an underlying lung or systemic condition. The location of the abscess varies with the underlying condition. Generally they occur due to a broad bacterial spectrum including <em><strong>Pseudomonas aeruginosa</strong> </em>and other gram-negative rods.</li>\n</ul>\n<p>Clinical features include <strong>fever</strong>, night sweats, productive cough with <strong>foul-smelling sputum</strong>, and chest pain. </p>\n<p>Physical examination usually reveals <strong>poor dentition</strong>/gingival disease, <strong>digital clubbing</strong>, and absence of a gag reflex.<strong> </strong>Amphoric and/or cavernous breath sounds can be heard during auscultation.</p>\n<p>Chest X-ray features of lung abscess:</p>\n<ul>\n<li>A <strong>lung cavity</strong> with an <strong>air-fluid level</strong></li>\n<li>Thick and irregular cavity wall and a surrounding pulmonary-infiltrate</li>\n</ul>\n<p>Computed tomography (CT) is more sensitive than chest radiography and is used to detect small cavities.</p>\n<p><strong>Clindamycin</strong>, or <strong>amoxicillin-clavulanate</strong>, or moxifloxacin can be administered for<strong> primary lung abscesses.</strong> Antibiotics for secondary lung abscesses are prescribed according to the pathogen identified. The treatment is usually prolonged until the resolution of the abscess is achieved. </p>\n<p>The two radiograph images given below show thick-walled cavities with air-fluid levels on lateral and PA views respectively.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f43b3bae31474f25a8d16af8e5e76e2ex624x1150.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/032da72a34064443be803fb65cb6905ax1280x960.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7283e29313384ba5917ef60902d6ee4c.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0194",
      "difficulty": "easy"
    }
  ]
}